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Abstract
Complex molecular networks of living organisms primarily involve proteins, bio-macromolecules
which involve in every biochemical process of a living organism. As traditionally known,
each protein carries out a unique function associated with the unique structure of each
protein, which indeed is encoded in the amino acid sequence. Proteins acquire their unique
“native” structure following one of the most fundamental biological self-organization pro-
cess. The progress accomplished in understanding of this physical process, called protein
folding, significantly evolved our current understanding of how living organisms function.
More recently, a more complete picture of the proteome from many organisms revealed
that many proteins or regions in the proteins cannot form a stable structure, which are
predicted to form more than one third of eukaryotic proteins. These proteins, referred
as intrinsically disordered proteins, rather exist in a relatively huge conformational diver-
sity as the ensembles of rapidly interconverting conformers. However, on the contrary to
the traditional view, this group of proteins still perform many vital functions in the cell.
In fact, their functionality possibly benefits from their being ability of adopting multiple
conformers under similar conditions. While this versatile group of proteins modifies our
understanding of the functioning properties of living organisms, many aspects are still
remained much less well-understood, partly to blame the difficulty to work with them ex-
perimentally. In this regard, molecular simulations with accurate atomistic models provide
a particular advantage not only resolving the heterogeneity in the conformational ensemble
of these proteins but also providing the atomic level resolution of each conformer.
This dissertation mainly aims at broadening our understanding of IDPs and unfolded
proteins with the use of atomistic simulations. Many different coherent aspects of unfolded
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and disordered proteins are studied during the course of this dissertation, including but
not limited to sequence and temperature dependent responses of IDPs, post-translational
modifications and disease-related characteristics of some IDPs. Each of these aspects stud-
ied in this dissertation also addresses where the atomistic simulations are relatively lacking
and how the models and simulation techniques can possibly be improved.
2
Chapter 1
Introduction
When first synthesized, each protein exists as an unfolded polypeptide chain, which are
composed of twenty main different types of building blocks, called amino acids. Right
after their synthesis in the cell through translation from RNA, these unfolded polypeptides
arrange themselves into their unique, fixed three-dimensional structures and this process
is called “folding”. Protein folding is one of the most intriguing biological phenomenon
due to several reasons. First of all, folding of a polypeptide yields a highly stable, hardly
fluctuating, three dimensional structure, unlike the unfolded state, which is a collection of
short-lasting, flexible, structureless, or partially structured configurations of the peptide as
schematically depicted in Figure 1.1.
Another intriguing aspect of the protein folding is that the unique folded structure is
Unfold d Proteins
Unfolded state(s)       ⇋      Folded state
⇋
Figure 1.1: Schematic representation of folded and unfolded states for a β-barrel protein.
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purely encoded in the amino acid sequence of the polypeptide, also called its primary struc-
ture, as stated by Anfinsen’s dogma1. Also importantly, this three dimensional structure,
also refered as the native structure, is key to the function of the protein, such as catalyz-
ing an enzymatic reaction through a reaction-specific lock and key model for substrate
binding as recognized by Fischer in late 1800s2. The further studies following this view
up, have shown that the function of the enzyme is lost upon deformation of the structure,
i.e. denaturation, which can only be recovered when the assumed structure is re-formed.
This structure–function relationship have formed the central dogma in the biology for many
years then. And the deposition of atomic coordinates of native structures of more and more
proteins have evolved the structural biology3, substantially progressing our understanding
of living organisms.
However, more recently, a new class of proteins, so-called intrinsically disordered pro-
teins (IDPs)4, have been discovered, which do not have a particular stable structure. Ul-
timately defying the traditional structure-function paradigm, these structureless proteins
have been discovered to perform vital biological functions. Although this class of pro-
teins form a large percentage of eukaryotic proteome, around 30%5 as known so far, their
discovery happened to be relatively late. Before becoming a broad and coherent class of
proteins, they have been re-discovered several times with different names6. There have
been several potential reasons of their late discovery under a coherent class of proteins,
one obvious one being traditional structure–function paradigm7. Another obstacle on the
way of discovery of these proteins is their existence as highly heterogenous ensembles; in
contrast to a single deep funnel-like free energy landscape of foldable proteins, they have
a rough free energy landscape with many comparable minima (Figure 1.2). Unlike the
stable folded structures, they could not be crystallized to resolve their structure. They can
rapidly interconvert between multiple conformations of similar free energy. This rapid fluc-
tuations in their structure makes their experimental characterization highly challenging8.
As partly can be attributed to their late discovery and experimental challenges, there are
still many much less well-understood characteristics of unfolded and disordered proteins.
Given these features of IDPs, which also apply for unfolded state of foldable (globular) pro-
4
Reaction coordinate
Fr
ee
 e
ne
rg
y
Folded protein: Single deep funnel IDP: Several minima of comparable 
free energy
Figure 1.2: Schematic one-dimensional representation of free energy landscape for a typical
foldable protein (left) and an intrinsically disordered proteins (right).
teins, molecular dynamics (MD) simulations will serve as an invaluable tool to investigate
characteristic properties of IDPs and unfolded proteins.
This dissertation mainly aims at broadening our understanding of IDPs and unfolded
proteins addressing two major challenges of molecular simulations, potential energy func-
tion and sampling. Many different aspects of unfolded and disordered proteins are studied
during the course of this dissertation will be introduced and discussed through the next
seven chapters. Each chapter has an associated publication, which can be referred as
Chapter 29, Chapter 310, Chapter 411, Chapter 512, Chapter 613, Chapter 714, Chapter
8 (preprint to be submitted). In the bigger picture perspective, protein folding cannot be
thought decoupled from unfolded and disordered proteins. Last chapter (Chapter 915) will
present a compherensive study of the folding of a family of β-hairpin peptides. This disser-
tation, ultimately, contributes not only to better understanding of unfolded and disordered
proteins but also to to evaluation of shortcomings of current state-of-the art and therefore
development of better methodologies for the near future of atomistic simulations.
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Chapter 2
Sequence and Temperature
Dependent Physicochemical
Properties of Unfolded and
Disordered Proteins
2.1 Introduction
At the most coarse-grained level, unfolded and disordered proteins can be characterized in
terms of the chain size, shape, and polymer scaling, which may all influence their function,
for example, their binding16 or aggregation17 characteristics, or properties for tethering
other proteins18. Previous work on disordered proteins has revealed that the degree of
compactness of the chain depends on its sequence composition via the hydrophobicity and
number and distribution of charged residues19–23. IDPs are in general low in hydropho-
bic amino acids and have a larger mean net charge per residue than globular proteins19.
Moreover, the fraction of positively and negatively charged amino acids and distribution
of the charged amino acids over the sequence have been shown to have a direct effect
on the polymeric properties and chain dimensions of IDPs and IDRs via polymer scaling
laws23,24. Therefore, sequence composition, which also encodes the native structure for
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foldable proteins, provides the major contribution to the properties of unfolded and dis-
ordered proteins. Beyond the coarse properties of the polypeptide chain, it is clear that
most unfolded and disordered proteins are far from being ideal random coils25–27, with the
existence of residual or nascent structure being a prominent aspect of unfolded and dis-
ordered protein research. Other properties of interest for unfolded and disordered protein
states include the degree of long-range contact formation28,29 and solvent accessibility as
a function of protein sequence and temperature30–33.
Other than the constituent amino acid composition, environmental factors such as tem-
perature are also strong contributors to the properties of these peptides. In contrast to the
expected behavior for a polymer chain with a temperature-independent monomermonomer
interaction energy, which will cause chain expansion as temperature increases, several stud-
ies have shown that unfolded and disordered proteins become more compact with increasing
temperature34–36. Previous work has shown that the temperature-dependent solvation free
energies of the constituent amino acids play a key role in this temperature-dependent col-
lapse37. Thus, both sequence composition and temperature are important determinants of
many properties of unfolded and disordered proteins.
Using replica-exchange molecular dynamics simulations with an explicit solvent and all-
atom force field which provides better representation of unfolded and disordered proteins38
relative to the earlier versions of force fields, we generate equilibrium ensembles of selected
IDPs and unfolded states of globular proteins in aqueous solution to study the sequence
and temperature dependence of their properties: chain dimensions and polymer scalings,
secondary structure, and solvent accessibility. We find that the qualitative scaling behavior
of the chains matches the expectations from theory23,39 under ambient conditions. That
is, more disordered sequences tend to have a scaling approaching that expected for a good
solvent or for a theta solvent, while the unfolded states of proteins with a native structure
are closer to collapsed globules. In addition, inclusion of explicit solvent naturally captures
the temperature-dependent collapse without the need for temperature-dependent force field
parameters37. Remarkably, we find that as a result of the chain collapse with temperature,
some of the proteins switch from the good solvent limit of polymer scaling toward a more
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compact theta solvent limit as temperature increases. Largely independent of the specific
sequence in which they are located, the solvent accessible surface areas of different classes
of amino acids exhibit common trends as a function of temperature. Solvent accessible
surface areas (SASA) of hydrophobic amino acids share a U-shaped trend with a minimum
in SASA at intermediate temperatures. On the other hand, negatively charged amino
acids exhibit a monotonic increase in burial as temperature increases. These observations
explain the observed trends in collapse behavior of the various proteins studied here. Taken
together, our results help to rationalize at an atomistic level how the sequence encodes the
intrinsic disorder or order at ambient temperatures, as well as its temperature dependence.
2.2 Simulation and Analysis Methods
We use the Amber ff03w force field38 for the protein model and TIP4P/2005 as the water
model40 and perform constant pressure simulations using Gromacs 4.5.341. Amber03w
has been shown to provide an accurate representation of disordered and unfolded pro-
teins11,42,43, which is also verified by calculated chemical shift deviations from the sim-
ulations using this force field is compared with experimentally obtained ones44. For
an enhanced sampling of phase space we perform replica exchange molecular dynamics
(REMD)45 simulations by using 56 different parallel temperatures between 285 K to 493
K. Further details of the simulation conditions and analysis tools are given in supporting
information.
We use the Amber ff03w force field38 for the protein model and TIP4P/2005 as the
water model40 and perform constant pressure simulations using Gromacs 4.5.341. Am-
ber03w has been shown to provide an accurate representation of disordered and unfolded
proteins11,42–44. For an enhanced sampling of phase space we perform replica exchange
molecular dynamics (REMD)45 simulations by using 56 different parallel temperatures be-
tween 285 K to 493 K. Pressure is kept constant at 1 bar in each replica using isotropic
Parrinello-Rahman pressure coupling46. The systems are propagated using Langevin dy-
namics with a 1 ps-1 friction coefficient. Each replica are simulated at least for 200 ns
and 50 ns/replica from the beginning is discarded as an equilibration time. Electrostatic
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Table 2.1: Sequences of molecules simulated in this study. Residues shown in green, red,
blue and black are the hydrophobic, positively charged, negatively charged and other hy-
drophilic residues, respectively.
Sequences
CSP MRGKVKWFDS KKGYGFITKD EGGDVFVHWS AIEMEGFKTL KEGQVVEFEI QEGKKGPQAA HVKVVE
LR GPCLTQEQLE DARRLKAIYE KKKNELGLSQ ESVADKMGMG QSGVGALFNG INALNAYNAA LLAKILKVSV EEFSPSIARE CR
IN CFLDGIDKAQ EEHEKY HSNW RAMAS DFNLP PVVAKGIVA S CDKCQLKGE A MHGQVDC
PROT-C CEEGGEEEEE EEEGDGEEED GDEDEEAESA TGKRAAEDDE DDDVDTKKQK TDEDC
PROT-N CDAAVDTSSE ITTKDLKEKK EVVEEAENGR DAPANGNAEN EENGEQEADN EVCEEC
interactions are calculated using the particle mesh Ewald method47 with a real space cutoff
of 0.9 nm. For van der Waal interactions cutoff is used as 1.2 nm. All secondary structures
are assigned by dssp algorithm48. Hydrogen bonds and solvent accessible surface area are
calculated using g hbond and g sas49 tool of Gromacs. Contact maps are calculated for
each pair of residues (i, j) representing the fraction of time that at least one heavy atom
of backbone from i and one from j are within 0.8 nm of each other, averaged over the
equilibrium ensemble.
2.3 Results and Discussion
To investigate properties of unfolded and disordered proteins, we employ five sequences,
namely, the cold shock protein (CSP) from Thermotoga maritima, the DNA-binding do-
main of λ-repressor (LR), the N-terminal domain of HIV integrase (IN), C- (PROT-C)
and N- (PROT-N) terminal segments of human prothymosin-α (PROTα), which have all
been experimentally characterized using single-molecule Fo¨rster resonance energy transfer
(FRET) 21,35,50. CSP and LR are globular proteins, forming all-β and all-α folds respec-
tively in their folded state while IN is an IDP which folds only in the presence of Zn2+ ions
and has an all-α fold. PROT-C and PROT-N are the segments of a highly charged protein
which are disordered under any condition. The proteins studied here cover a large range of
charge and hydropathy encoded by their sequences (Table 2.1. To summarize this variance
and compare the sequence characteristics of the proteins, we locate all of the sequence on
an Uversky diagram19 (Figure 2.1, top-left), and a Das and Pappu diagram23 (Figure 2.1,
top-right). The Uversky diagram characterizes proteins as globular or intrinsically disor-
dered based on their hydropathy and mean net charge. Hydropathy indices in this diagram
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are the average Kyte-Dolittle51 scores with a window size of 5-residues and scaled to fit
between 0 and 1 (Figure 2.1, top-left). Mean net charge is | f+− f− | where f+ and f− are
the fraction of positively and negatively charged residues, respectively. While the proteins
falling above the dashed line, which have low net charge and high hydrophobicity, are clas-
sified as globular proteins, the ones below that line are generally classified as IDPs. The
Das and Pappu diagram23 predicts the compactness of IDPs under ambient conditions,
in terms of intra-chain distance dependence on the chain separation, in aqueous solution
based on the fractions of positively and negatively charged residues, f+ and f−.
As conformational sampling of all but the smallest proteins (even in the disordered
states) is limited if using brute force molecular dynamics simulations, we use a well-
established enhanced sampling technique, replica exchange molecular dynamics, to obtain
their equilibrium properties. In this technique, multiple simulations are performed in par-
allel at different temperatures (ranging from the temperature of interest to a very high
temperature) which are weakly coupled to each other by exchange attempts at periodic
intervals. As the simulations at higher temperatures can overcome energy barriers easier
than at the lower temperatures, this approach provides a convenient way to obtain con-
verged equilibrium data at low temperatures. The data from these simulations is used in
the following sections to provide insights into various questions related to the sequence-
and temperature-dependent properties of disordered proteins.
2.3.1 Chain dimensions
Polymer scaling laws characterize the conformational preferences of polymers such as
swollen coils or compact globules, which are governed by the balance of protein-solvent,
protein-protein, and solvent-solvent interactions. The scaling exponent characterizing the
conformational state can be determined from the ensemble-averaged internal distances,
〈Rij〉, with respect to chain separation, | i − j |. Here, we average Rij at every chain
separation ∆ = |i − j|, over the possible residues i within the sequence and over every
conformation found in the equilibrium ensemble. Figure 2.1 (bottom) shows 〈Rij〉 for each
protein at a temperature of 300 K. We find that at this temperature, PROT-C (strong
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Figure 2.1: Top left: Uversky diagram of IDPs and globular proteins, Top right: Das and
Pappu diagram of IDPs (see the text); symbols indicate peptides studied in this work.
Bottom: Ensemble averaged intra-chain distance (Rij) profiles of the polypeptides with
respect to chain separation. Theoretical polymer scaling limits are shown with dashed
lines.
polyelectrolyte), conforms closely to the excluded-volume (EV) scaling limit The EV limit
predicts 〈Rij〉 ∝| i− j |0.6, and the chain explores an expanded set of conformations with
the interactions between monomers being effectively repulsive52. At the other extreme, the
chain samples compact conformations in the globule-limit for which 〈Rij〉 ∝| i−j |0.33. The
globular protein sequences CSP, LR and IN are found to approximately follow this regime
and the interactions between monomers are effectively attractive. In addition, there is an
intermediate regime falling between the EV and globule limit referred to as Flory random
coil (FRC) limit52 for which 〈Rij〉 ∝| i − j |0.5 and monomer interactions are balanced,
i.e., neither repulsive nor attractive. We find that at 300 K, PROT-N (strong polyam-
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pholyte) fits best to the FRC regime. Here, the trends in calculated polymer scalings of all
proteins broadly match the expectations from recent literature, based on their hydropa-
thy and charge characteristics (Figure 1B)23,24,53. There are two primary experimental
sources of information on the dimensions of disordered chains, namely small-angle X-ray
scattering (SAXS) and Fo¨rster resonance energy transfer (FRET). SAXS experiments per-
formed in high concentrations of denaturant for a wide range of proteins fit very well to
an EV-type scaling with a power-law exponent of ∼ 0.6 for the dependence of radius of
gyration on chain length54; similar dimensions for the unfolded state are obtained from
FRET experiments at high denaturant concentration35,55,56.
We further investigate the chain dimensions by determining the average radius of gy-
ration, 〈Rg〉, as a function of temperature (Figure 2.2A). At 300 K, we obtain 〈Rg〉 (Fig-
ure 2.2, dashed lines) values for the different proteins which are qualitatively consistent
with their scaling. Moreover, the temperature dependence of 〈Rg〉 clearly reproduces the
experimentally observed temperature induced collapse for all globular protein sequences
and for PROT-C. The globular proteins (CSP, LR and IN) share a very similar trend of
collapse followed by re-expansion with slightly different temperatures of maximum com-
paction. Similar to globular proteins PROT-C also shows an initial collapse, but as opposed
to the globular proteins, it continues to collapse as temperature is increased further. On
the other hand, PROT-N shows a slight expansion followed by a collapse only at very
high temperatures. In a recent single molecule FRET study, all five of these proteins were
shown to collapse initially as temperature was increased, in qualitative agreement with our
results37. Due to the limited temperature range in experiment, expansion at even higher
temperatures was only observed for λ-repressor. The strongest collapse was observed in
experiment for the most hydrophilic chains (PROT-C and PROT-N)37. In our simulations
we also observe a strong collapse in PROT-C, but very little temperature dependence of Rg
for PROT-N. The mismatch in PROT-N may arise partly because we simulate a truncated
N-terminal segment of PROTα, while in the study of Wuttke et al., the N-terminal seg-
ment is labelled in the context of the complete PROTα sequence. Quantitatively, although
we capture the approximate rank order of the dimensions of the proteins, the radius of
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gyration of each protein was smaller than that measured in experiment. This is most likely
due to the tendency of current force fields to favor structures which are too collapsed57,58.
2.3.2 Secondary structures
To investigate the formation of secondary structure, we calculate the secondary structure
populations for each sequence, as a function of temperature. For all proteins, the aver-
age fraction of residues in coil conformation is given by dashed lines in Figure 2.2B-left
column whereas α-helix and β-sheet fractions are shown by dashed lines in Figure 2.2B-
right column. For all three globular proteins, the fraction of residues in coil conformation
decreases with increasing temperature up to the turnover temperature, then it increases
again. Populations of secondary structure found in the native state (β-sheet for CSP and
α-helix for LR and IN) show the opposite, increasing with temperature to a maximum and
then decreasing. The limited degree of native secondary structure formation in unfolded
CSP is consistent with the ∼ 20% β-structure observed for CSP by Hoffmann et al.59.
Notably, non-native secondary structures (α-helix for CSP and β-sheet for LR and IN) do
not show this trend, in general decreasing with temperature. For PROT-C and PROT-
N, which have no native structure, there is essentially no secondary structure formed, as
expected. Overall, we observe for all globular proteins that increasing temperature ini-
tially favors the formation of the type of secondary structure found in the native state
in parallel with protein collapse. An obvious question which arises is whether the initial
increase in structure formation is a local effect or instead a secondary effect, driven by
protein collapse. This question has received conflicting answers in the literature. Work by
Yang et al.60 indicated β-like structures form prior to aggregation. Similarly, the study of
Kimura et al.61 suggested that collapse can be initiated by β-sheet structure. However,
Doniach et al.62 found that collapse should not be driven by secondary structure according
to their models. Moreover, the work by Sadqi et al.34 suggested that when time scales are
compared, chain collapse appears faster than the formation of secondary structure. This
rapid chain dynamics is supported by the ∼ 100 ns reconfiguration times determined for
unfolded proteins by Nettels et al.63. To address this issue in the context of our results,
13
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Figure 2.2: A. Radius of gyration (Rg) of peptides B. Secondary structures defined by dssp
algorithm, Left column: Coil fraction assigned by dssp, Right column: α -helix and β-
sheet fractions. Dashed thick lines: Total data averages, solid lines with error bars: narrow
Rg based-window averages, Rg-windows: 1.2-1.3 nm for CSP and IN, 1.3-1.4 nm for LR,
2.0-2.1 nm for PROT-C, 1.6-1.7 nm for PROT-N. Rg interval represented here is selected
differently for different proteins to consider commonly sampled Rg in all temperatures for
different proteins.
14
we consider, in addition to the global secondary structure average (dashed lines) discussed
above, an average over configurations lying within a 0.1 nm thick slice of Rg (solid lines).
We see an overall similar trend for both, suggesting that increased formation of the type
of secondary structure found in the native state is not merely a consequence of collapse,
but appears to be driven by similar temperature-dependent effects. An increase in overall
hydrophobicity would indeed be expected to stabilize more compact secondary structures.
We also calculate intramolecular protein and scaled intermolecular protein-water hy-
drogen bond formation with respect to temperature (Figure 2.3), which shows that more
compact chains form more intramolecular hydrogen bonds. To account for the loss in wa-
ter’s hydrogen bond propensity with increasing temperature, we normalize protein-water
hydrogen bonds to water-water hydrogen bonds at a given temperature. Again, there
is clearly a non-monotonic trend 2.3 with the number of protein-water hydrogen bonds
decreasing first as a function of temperature (up to the collapse temperature) and then
increasing again for all the globular proteins. This clearly highlights the specific role of
temperature-dependent water-mediated interactions in the observed behavior. In sum-
mary, it appears that native-like secondary structure is stabilized initially by increasing
temperature, and that this structure formation occurs in the same temperature range as
overall collapse. However, it is likely that the same overall forces (namely increased hy-
drophobicity) are driving both the collapse and secondary structure formation.
In addition to the temperature-dependence of secondary structures, we also calculate
the per-residue secondary structure fractions at room temperature which are shown in SI
along with their native structures for globular proteins (Figure 2.4). All the unfolded popu-
lations of globular proteins sample a significant amount of secondary structure of the same
type found in the native state, supporting the idea that unfolded globular proteins have
an intrinsic ability to form their local secondary structures in aqueous solution. Similarly,
the residue-residue contact propensities of these peptides at room temperature (Figure 2.5
reflects the structure formed in the unfolded state essentially reflects nativelike contacts
with small sequence separation for globular proteins10.
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Figure 2.3: Change in average number of protein-protein (top) and protein-water (bottom)
hydrogen bonds with respect to temperature. Symbols and dashed lines show window
averages (same Rg window as defined in the main text) and global averages, respectively.
Protein-water hydrogen bonds are normalized with the water-water hydrogen bonds.
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Figure 2.4: Per-residue secondary structure propensities of CSP (left), LR (middle) and
IN (right) at 300 K (black lines). Red circles indicate the secondary structures of residues
in their native conformations.
2.3.3 Solvent accessibility
What are the factors influencing the change of protein dimensions with temperature? To
gain some insight into this question, we have calculated the solvent-accessible surface area
(SASA) for each type amino acid side-chain, in each sequence and determined an ensemble-
averaged 〈SASA〉. To account for the different sizes of the side-chains and their abundance
in the sequence, we normalize the 〈SASA〉 based on the fully exposed surface area of the
side-chain of each residue X in in Gly-X-Gly tripeptides64, and by the total number of
the particular amino acid in the sequence. The normalized 〈SASA〉 for each amino acid is
shown in Figure 2.6 for a narrow window of Rg (0.1 nm). Using a narrow Rg window again
ensures that samples at each temperature are of similar compactness so that 〈SASA〉 trends
are not biased by overall compactness level, but reflect true differences between amino acids.
The normalized 〈SASA〉 is lower than or about 0.5 on average for all hydrophobic amino
acids (Ala, Phe, Ile, Leu, Pro, Trp, Val, Tyr) in globular sequences in general. However,
there is clearly an overall effect of sequence context, since both polar and hydrophobic
amino acids are each more exposed in IDP sequences than in globular sequences, due to
the solvation characteristics of the full length chain. The amino acids Cys, His, Met, Asn,
Ser, Thr have normalized 〈SASA〉 of around 0.5 for globular proteins whereas all charged
17
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Figure 2.5: Per-residue contact maps of all five peptides studied (backbone atoms only)
within 0.8 nm cutoff distance. Color scale indicates fraction of contact formed between
residue i (x-axes) and j (y-axes).
amino acids (Asp, Glu, Lys, Arg) and Gln have that of greater than 0.5 on average as
consistent with their hydrophobicity based on the Kyte and Doolittle scale51, as shown
by the correlation scatter plot 2.7 between 〈SASA〉 at 300 K and the Kyte and Doolittle
hydrophobicity scale51.
The temperature dependence of 〈SASA〉 shows that all hydrophobic amino acids share
a common U-shaped trend, going through a minimum of solvent accessibility (maximum
of burial). Remarkably, this observation is independent of the context, in other words, the
same trend is found in hydrophobic amino acids for all proteins, from hydrophobic glob-
ular ones to highly charged ones. This trend is consistent with the well-known minimum
in solvation free energy for idealized hydrophobic solutes, which occurs at a similar tem-
perature65. On the other hand, the burial of the negatively charged amino acids, Asp and
Glu, monotonically decreases with temperature, across almost all sequences. This trend
can also be understood based on the solvation free energy of charged species, which tends
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globular sequences.
to decrease with temperature due to the large negative entropy of solvation. The picture
for the positively charged amino acids is more complex. Arg shows a tendency to get more
exposed to water on average as temperature increases, whereas the 〈SASA〉 of Lys does
not seem to be much affected by temperature. While there is no simple explanation for the
different properties of the cationic side-chains, it is worth noting that each has a significant
hydrophobic portion, and so the overall properties of these residues may reflect competing
effects between hydrophobic and hydrophilic regions (which should have opposite changes
in solvation free energy at high temperature). Other hydrophilic amino acids His, Asn,
Gln, Ser and Thr do not have a clear trend in common. Since high-hydrophobicity amino
acids are more prevalent in the primary structure of globular proteins in general and are
less well solvated, they are more likely to be in contact, which helps to explain the col-
lapse followed by re-expansion for globular sequences. Since more than 50% of constituent
amino acids of PROT-C are the negatively charged amino acids, the abundance of these
residues in PROT-C may explain its monotonic collapse. On the other hand, the sequence
of PROT-N is more balanced in hydrophobic, charged and other hydrophilic amino acids,
20
which may explain its less clear trend in 〈Rg〉.
As a complement to this picture, we have also computed hydrophobic-hydrophobic,
hydrophilic-hydrophilic, hydrophobic-hydrophilic (cross) and total contact formations for
both backbone and side-chains of all proteins (Figure 2.8), Hydrophobic contacts clearly
support the observations from 〈SASA〉, as they are increasing at collapse temperatures
then decreasing. This is not only true for globular sequences but also true for the highly
charged sequnces PROT-N and PROT-C. The trends are less clear for hydrophilic contacts,
largely because all non-hydrophobic amino acids have been collected within the hydrophilic
ones.
2.3.4 Temperature dependence of polymer scaling
The change in overall chain dimensions with temperature raises the intriguing question
of whether the corresponding polymer scaling will also be temperature dependent. We
have therefore further investigated the polymer scaling with respect to temperature, as
shown in Figure 2.9. The scaling did not show a clear temperature dependence in the only
previous work – to the best of our knowledge – in which this was studied23. Here we find
that globular proteins initially move to a slightly more compact regime, then they move
back to more expanded regimes with further increase in temperature, consistent with their
temperature dependent collapse trend. Overall, however, they remain firmly within the
globule limit. On the other hand, PROT-C continuously moves to more compact regimes
such that it switches from EV limit to FRC limit, as can be anticipated from its strong
collapse. The change in PROT-N is not as marked as other sequences.
The scaling indications can further be supported with ensemble-averaged asphericities
which are given in Figure 2.10. As expected for the globular limit, the asphericity parame-
ter, 〈φ〉, of all globular proteins indicate sphere-like shapes whereas PROT-N and PROT-C
have a more prolate shape, on average. As temperature increases, globular proteins become
even more sphere-like (decreasing 〈φ〉) whereas PROT-N hardly shows a change.
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2.3.5 Characterization of unfolded ensembles at different temperatures
with same average 〈Rg〉
Lastly, we investigate how similar are the sampled conformations at pairs of temperatures
at which the protein has the same Rg. This question is limited to globular proteins, which
show an initial collapse followed by re-expansion. To answer this question at a residue
level, we select two temperature couples from Rg curves of these proteins such that each
member of a couple has the same average Rg (Figure 2.11A). We employ a significant
difference in temperature of 100-125 K in T-couple 1 and a smaller one of 20-60 K in T-
couple 2. Distributions of Rg at selected temperatures are shown in Figure 2.11B. They,
in fact, show only little difference for both couples. For T-couple 1, the difference looks
more pronounced; distributions are smoother for the higher temperature (red curves).
However, this diffence is most likely an effect of limited sampling. Because of the much
faster kinetics at high temperature, smoother distributions are obtained. At a residue level,
secondary structures do not indicate a significant difference between low temperature and
high temperature ensembles either (Figure 2.11C). Additionally, backbone contacts show
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that both ensembles are almost equivalent both in the context of short- and long-range
contacts (Figure 2.11D).
2.4 Conclusions
We have employed long replica exchange molecular dynamics simulations at constant pres-
sure with an all-atom protein force field and explicit solvent to obtain equilibrium ensem-
bles for selected IDPs and unfolded states of globular proteins with variety of different
primary structures in aqueous solution. The inclusion of explicit solvent naturally cap-
tures the temperature dependence of hydrophobic interactions that are expected to govern
the observed behavior. We find that the difference in polymeric properties of unfolded
and disordered proteins arises from the differences in their sequence composition, which
already encodes their intrinsic disorder or order. Specifically, we observe that the degree of
burial of hydrophobic and negatively charged amino acids exhibits temperature dependent
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Figure 2.11: Comparison of properties at different temperatures at same Rg. A. Selected
temperature couples are indicated on Rg change plot, B. Rg distribution of couples, black:
low-T, red: high-T, green: average Rg C. Secondary structure propensities per residue
black: low-T, red: high T, D. Backbone contacts of couples, upper triangle: low-T, lower
triangle: high-T.
characteristics (presumably due to variations in solvation free energy) which are consistent
with the continuous collapse of PROT-C, and with the collapse followed by re-expansion
of unfolded states of globular proteins, CSP, LR and IN. Thus our results explain how the
temperature dependent properties of each chain are modulated by those of its constituent
amino acids. A;though the dimensions of the proteins in the simulations may quantita-
tively be too collapsed compared to the experimental values, our simulations are able to
successfully capture size relevant features of these proteins qualitatively, including temper-
ature dependent collapse and the relative compactness of these proteins with respect to
each other as shown by radius of gyration and polymer scaling based on internal distances.
One particularly important observation is that while collapse can be expected for the
proteins which are mostly dominated by hydrophobic amino acids because of the temper-
ature dependence of the hydrophobic effect65, the largest amplitude of collapse was found
for the most hydrophilic negatively charged case, as also determined experimentally 37.
Thus those IDPs which have a large fraction of negatively charged amino acids may in gen-
eral be expected to exhibit a sharp collapse with increasing temperature. Additionally, the
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temperature dependence of the intrachain distance scaling analysis reveals that solvation
characteristics can also change with temperature such that scaling regime can switch from
the limit of good solvent to effective theta solvent conditions. We also find evidence for
residual structure in all cases, which are mostly dominated by secondary structures popu-
lated in the native state for the globular proteins as well as long-range contacts. Lastly, for
globular proteins which show collapse followed by re-expansion, we find that equilibrium
ensemble at high temperature appears to be quite similar to the low temperature ensemble
at the same average Rg.
Our work has principally focused on the gross properties of unfolded and disordered
chains in solution. In future work, it will be very interesting to perform a more detailed
examination of structure formation in disordered polypeptides. In this regard, the recent
availability of high-resolution experimental studies of IDPs by NMR spectroscopy, provid-
ing information on local and cooperative structure formation 66–68 as well as long-range
interactions28,29 will be an important benchmark. In addition, while we have focused on
variation of temperature as an environmental parameter, an equally physiologically im-
portant parameter is the salt concentration, whose effect would also bear investigation in
future work.
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Chapter 3
Influence of FRET Choromophores
on Properties of Unfolded and
Disordered Proteins
Fo¨rster resonance energy transfer (FRET)69,70 is a biophysical technique that can yield
information on distance distributions and dynamics in unfolded proteins50,71–76, including
inside cells77. Single molecule FRET can even be used to investigate separately the dy-
namics for sub-populations of a sample, for example the unfolded and folded states of a
protein78,79. The principle behind the method is that the efficiency of non-radiative en-
ergy transfer between two fluorophores is dependent primarily on their separation in space
(although orientational factors may need to be considered in certain cases, as we discuss be-
low)69,70,80. FRET and small-angle X-ray scattering (SAXS) studies have produced diver-
gent views of the dimensions of the unfolded states of proteins in low denaturant73,74,81–85.
There are many possible explanations for this inconsistency, which is still unresolved, but
one concern is that the inclusion of large organic chromophores conjugated to the protein
may somehow interfere with the properties of the protein – for example by stabilizing a col-
lapsed state of the chain. The controversy has largely centered around protein L73,74,81,85,
which has been studied by both methods; however, qualitatively similar results have been
obtained for the unfolded states of other proteins by either FRET (collapse as denaturant
27
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Figure 3.1: Contact maps of ensembles without (upper left triangle) and with (lower right
triangle) extrinsic chromophores for three proteins (left column) along with their native
contacts (right column). A. CSP, B. LR, C. IN. Folded structures of each protein are shown
in the left corner of native contacts maps, with secondary structures colored as yellow and
the C-terminal α-carbon atom of each protein is a grey sphere.
is diluted)86 or SAXS (no collapse)87.
A commonly used pair of fluorophores, due to their stability and favorable spectro-
scopic properties, consists of AlexaFluor 488 as “donor” and AlexaFluor 594 as “accep-
tor”. These dyes have been shown to yield self-consistent information on distances in
model systems88,89. The effect of the dyes also appears to have at most a limited effect
on protein stability, where this has been checked90. However, the potential effects of these
extrinsic fluorophores on the intrinsic properties of unfolded and intrinsically disordered
proteins still needs to be addressed, something which has not been systematically done to
date. Obtaining this information from experiment, while certainly possible, is challenging.
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Figure 3.2: Per-residue secondary structure propensities calculated based on the DSSP
definition. A. CSP, B. LR, C. IN. Black curves represent averages of ensembles without
dyes and red curves indicate averages of ensembles in presence of dyes. Standard errors
are calculated using block averaging. Vertical green lines indicate the residues to which
the dyes are attached.
Molecular simulations offer one avenue to compare the properties of the unfolded states
of proteins with and without FRET chromophores. In this paper, we use molecular sim-
ulations with a state of the art protein force field and water model to address the effects
of dyes on the formation of long-range contacts, distance distributions, and per-residue
secondary structure propensities of the unfolded state of three different proteins. We find
that the dyes have little effect on the structure formation and dimensions of the unfolded
state, and that one the key assumptions underlying quantitative distance calculations from
FRET measurements is justified by our results.
3.1 Simulation and Analysis Methods
Table 3.1: Number of non-protein molecules in simulated systems.
CSP CSP Dyes LR LR Dyes IN IN Dyes
Water 8339 8329 8294 8234 8422 8353
Sodium ions 10 10 9 11 12 16
Chloride ions 10 6 10 8 8 8
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We use the Amber ff03w force field38 for the protein model and TIP4P/2005 as the
water model40 to perform simulations using Gromacs 4.5.341. Parameters for the dyes were
derived using the AnteChamber feature of AmberTools91, with the charges derived from
the electrostatic potential from an HF/6-31+G* calculation with the Gaussian program92.
Full parameters are available upon request from the authors. Temperature replica exchange
temperatures ranging from 285 to 493 K at constant pressure of 1 bar, maintained in each
replica using isotropic Parrinello-Rahman pressure coupling46. The trajectory is propa-
gated using Langevin dynamics with a 1 ps-1 friction coefficient. Electrostatic interactions
are calculated using the particle mesh Ewald method47 with a real space cutoff of 0.9 nm.
For van der Waals interactions, a 1.2 nm cutoff is used. A key feature of these simulations
is the optimized protein model Amber ff03w, which results in an improved reproduction of
the properties of unfolded proteins relative to earlier force fields in conjunction with TIP3P
water, as has been demonstrated in previous studies11,43,44. Sizes of the systems have been
shown in Table 3.1 by number of water molecules present in simulation boxes. Monomers
of each peptide have been solvated in their simulation boxes. For such large systems, tem-
perature replica exchange, which provides much more enhanced sampling of phase space
compared to molecular dynamics, is not a common method because of its computational
cost. In this work, that large system of each peptide has been simulated for 200 ns using
56 replicas.
3.2 Results and Discussion
Table 3.2: Sequences of molecules simulated in this study. *Dyes are attached to cysteine
residues given in red.
Sequences
CSP MRGKVKWFDS KKGYGFITKD EGGDVFVHWS AIEMEGFKTL KEGQVVEFEI QEGKKGPQAA HVKVVE
CSP Dyes* MCRGKVKWFD SKKGYGFITK DEGGDVFVHW SAIEMEGFKT LKEGQVVEFE IQEGKKGPQA AHVKVVEC
LR GPCLTQEQLE DARRLKAIYE KKKNELGLSQ ESVADKMGMG QSGVGALFNG INALNAYNAA LLAKILKVSV EEFSPSIARE CR
LR Dyes* GPCLTQEQLE DARRLKAIYE KKKNELGLSQ ESVADKMGMG QSGVGALFNG INALNAYNAA LLAKILKVSV EEFSPSIARE CR
IN CFLDGIDKAQ EEHEKYHSNW RAMASDFNLP PVVAKGIVAS CDKCQLKGEA MHGQVDC
IN Dyes* CFLDGIDKAQ EEHEKYHSNW RAMASDFNLP PVVAKGIVAS CDKCQLKGEA MHGQVDC
To generalize how FRET dyes might affect the properties of unfolded polypeptides, we
employ three different proteins with a variety of hydrophobic and electrostatic character-
istics: namely the cold shock protein (CSP) from Thermotoga maritima, the DNA-binding
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domain of λ-repressor (LR) and the N-terminal domain of HIV integrase50,75. CSP and λ-
repressor are respectively 66-residue and 82-residue globular proteins, while the 57-residue
integrase is an intrinsically disordered protein which only folds in the presence of Zn2+ ions.
The three proteins have quite different sequence and structural characteristics. CSP is an
all-β fold, while LR and IN have all-α folds; the average hydrophobicities of the sequences,
based on the Kyte-Doolittle score51, are -0.55 for CSP, -0.25 for LR and -0.49 for IN. The
fraction of charged residues is 0.36, 0.26 and 0.32, respectively for CSP, LR and IN. In
particular, both CSP and IN have been shown to collapse when denaturant is diluted93
(although there for IN is a small re-expansion at the lowest concentrations of guanidinium
chloride, due to reduction in ionic screening).
In each case we consider both the free protein, as well as a variant with the FRET
chromophores ligated to cysteine residues added at or near the termini, with the N- and
C-terminal cysteines respectively labelled with the chromophores AlexaFluor 488 and Alex-
aFluor 594. The labelled forms of each protein are denoted Csp Dyes, LR Dyes and IN
dyes. The full sequences of each system are shown in Table 3.2. Unfolded proteins are noto-
riously difficult to treat with standard force fields and water models, as evident by analysis
of the unfolded states in the atomistic folding simulations by Shaw and co-workers94–96, as
well as earlier comparisons with FRET data on unfolded proteins75. To address this issue,
we have adopted the most accurate four-site water model for describing the properties of
liquid water40, essential for accurately capturing the hydrophobic effect97, and we have
tuned a protein force field, Amber ff0398, for compatibility with this model99. While not
perfect, this combination has resulted in improved properties in simulations of disordered
and unfolded proteins.11,43,44.
To compare the properties of all three proteins with and without dyes, we have per-
formed replica-exchange molecular dynamics (REMD) simulations of each system in ex-
plicit solvent. We focus on the 300 K replica, for which we use 150 ns of data, after
neglecting an initial equilibration period of 50 ns. As a measure of global structure for-
mation, we have computed contact maps (Figure 3.1), in which the entry for each pair
of residues (i, j) represents the fraction of time that at least one heavy atom of backbone
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from i and one from j are within 0.8 nm of each other, averaged over 150 ns. For native
contacts maps and structures, the PDB entries 1G6P100, 1LMB101 and 1WJA102 were
used for CSP, LR and IN, respectively.
Residue-residue contact formation for the simulation ensembles with and without dyes
(Figure 3.1, left column), implying that the trajectories with and without dyes are sampling
quite similar conformations. Additionally, all contact maps reveal a general absence of long-
range contacts, reflecting a disordered chain. The structure formed in the unfolded state
essentially reflects native-like contacts with small sequence separation (Figure 3.1, right
column).
To assess local structure formation, we have computed the average residual secondary
structure formation over the trajectory. In Figure 3.2 we show α-helix and β-sheet sec-
ondary structure assignments obtained using DSSP definitions48. This shows that both
CSP and CSP Dyes are sampling mostly coil conformations (Figure 3.2). The per-residue
populations of secondary structure are similar for both chains. One apparent exception
is in the region spanning residues 64 to 67, giving higher propensity to be in β-sheet for
the chain with dyes, which may reflect a small effect of the dye at the C-terminus. For α-
helix, the populations with and without dyes are very similar, considering the error range,
except for the region spanning residues 24 to 30, where α-helix propensity is higher for
naturally-occuring CSP than that for CSP Dyes. For LR a difference appears for α-helical
propensities in residues 59-65, and residues 6-11 near the N-terminus. These regions might
be affected from presence of the dyes, however, they are still small regions when compared
to total length of sequence. For IN, the only clear difference appears at helical propensity
for a limited region, but despite the difference in numbers, both IN and IN Dyes keep same
trend for that region as well. Overall, the dyes at both termini have very little effect on
the secondary structures populated, when viewed at a residue level. Although our REMD
sampling provides a representative ensemble for each system, it is nonetheless limited and
so small differences between ensembles should not be overinterpreted.
Since FRET primarily reports on inter-residue distances and dimensions of the chain,
we have also computed distributions of the radius of gyration (Rg) (Figure 3.3 top row)
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Table 3.3: Average values of radius of gyration (Rg), end-to-end (E2E) and dye-to-dye
(D2D) distances and orientational factor (κ2) from simulations indicated in nm
〈Rg〉 w/o dyes 〈Rg〉 w/ dyes 〈E2E〉 w/o dyes 〈E2E〉 w/ dyes 〈D2D〉 κ2
CSP 1.23 ± 0.01 1.42 ± 0.02 2.06 ± 0.03 2.35 ± 0.09 2.34 ± 0.15 0.61 ± 0.05
LR 1.41 ± 0.04 1.40 ± 0.01 3.04 ± 0.08 3.24 ± 0.08 2.72 ± 0.09 0.58 ± 0.04
IN 1.19 ± 0.01 1.27 ± 0.01 1.19 ± 0.01 2.09 ± 0.09 1.93 ± 0.09 0.68 ± 0.03
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Figure 3.3: Distance distributions of proteins with and without dyes and orientational
factor distribution of dyes. From top to bottom: Radius of gyration (Rg) with and without
dyes, End-to-end (E2E) distance without dyes, E2E distance with dyes, Dye-to-dye (D2D)
distance and Orientational factor κ2 distributions of our data and isotropic case. Red curves
on E2E and D2D distance distributions are Gaussian chain fits whereas green curves are
self-avoiding chain fits.
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and end-to-end (E2E) distance (Figure 3.3 second and third rows) and dye-to-dye (D2D)
distances (Figure 3.3 fourth row) from the simulations86,103. E2E distance distributions
are calculated from the distances between the backbone nitrogen at the N-terminus to
the backbone oxygen at the C-terminus. D2D distances are calculated from the distances
between the centers of masses of the dye molecules in the simulations of proteins with
dyes. Average values of Rg and E2E distance both with and without dyes as well as
average values of D2D distance obtained from our data are summarized in Table 3.3. In
order to have a clearer comparison of the results with and without dyes, each E2E and D2D
distance distribution is fitted to an ideal (Gaussian) chain model (red curve in Figure 3.3)
and self-avoiding random walk model104 (green curve in Figure 3.3). The E2E distance
distribution P (x) for an ideal chain is given by the following equation,
P (x) = 4pix2
(
3
2piNl2k
) 3
2
exp
(
−3
2
x2
Nl2k
)
, (3.1)
in which N is the number of residues and lk is the segment or Kuhn length. The only free
parameter in the ideal chain models is lk, for which the fits yield very close numbers for E2E
without and with dyes and D2D distributions for all proteins. All yielded fit parameters
are summarized in Table 3.4. These segment lengths are slighly smaller than the α-carbon-
to-α-carbon distance which is always close to 0.38 nm; because the Cα-Cα-Cα angles are
relatively inflexible however, the shorter distances may reflect a projection of the Cα-Cα
distance onto the local chain direction. The absolute values of lk are comparable to, though
slightly smaller than, those estimated from single molecule fluorescence experiments93.
Independent of the value of the parameters, their similarity indicates that the properties
of the chain are relatively unaffected by the chromophores. Particularly, D2D distribution
fittings reflect almost same distribution E2E distance without dyes. A more accurate
representation of the chain should be given by a self-avoiding random walk (SAW). The
end-end distance distribution for a SAW is given by the following equation 3.2,
P (x) =
a
〈x〉
(
x
〈x〉
)2+θ
exp
[
−b
(
x
〈x〉
)δ]
, (3.2)
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Table 3.4: Fit parameters lk (nm) for Gaussian fitting and 〈E2E〉 (nm) for SAW fitting.
Values indicated in parentheses are correlation coefficients of fits.
Gaussian fitting Gaussian fitting Gaussian fitting SAW fitting SAW fitting SAW fitting
lk (E2E w/o dyes) lk (E2E w/ dyes) lk (D2D) 〈E2E〉 w/o dyes 〈E2E〉 w/ dyes 〈D2D〉
CSP 0.28(0.92) 0.33(0.82) 0.29(0.93) 2.26(0.91) 2.60(0.86) 2.28(0.95)
LR 0.36(0.91) 0.40(0.90) 0.34(0.92) 3.08(0.92) 3.48(0.91) 3.01(0.92)
IN 0.28(0.80) 0.30(0.92) 0.27(0.93) 2.18(0.80) 2.18(0.91) 1.96(0.92)
where θ, δ, a and b are numerical parameters equal to 0.3, 2.5, 3.67853 and 1.23152,
respectively104. Thus, the average value of the end-to-end distances (〈x〉) are the only
fit parameters which are summarized in Table 3.3. Similar to Gaussian chain fitting,
self-avoiding random walk fits show a close similarity between different distributions of
proteins with and without dyes. Additionally, 〈E2E〉 distance values from fits (Table 3.4)
and our data (Table 3.3) are not particularly different from each other except E2E distance
distribution of IN.
While the distributions of end-end distance are challenging to sample, because thorough
exploration of essentially all internal degrees of freedom is required, sampling the Rg is
easier because of a higher degree of self-averaging. The Rg distributions of all proteins
with and without dyes are overall quite similar (Figure 3.3 top row) with the average Rg
value slightly higher in the presence of dyes for CSP and IN. The tendency of proteins with
dyes to sample higher Rg values can be rationalized at the simplest level by the excluded
volume effect of the dye molecules. For the case of CSP, the difference is a little more
pronounced, most likely because of the difference in the total number of residues for CSP
and CSP Dyes. Note, however, that this would not help to explain the discrepancy between
FRET and SAXS results, as Rg estimates from FRET (with dyes) are generally smaller
at low denaturant concentrations than those obtained by SAXS (without dyes). However,
it may partially explain the fact that Rg computed from simulations is often smaller than
that estimated from FRET.
In order to determine average distances from FRET efficiencies, one in principle has to
consider the mutual orientation of the two chromophores, and not just their distance. The
orientational contribution to the transfer efficiency is captured by the factor κ2 in which
κ is given by κ = µ̂D · µ̂A − 3(r̂ · µ̂A)(r̂ · µ̂D)89 where r̂ is the unit vector between donor
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ALEXA488 
(Donor)
ALEXA594 
(Acceptor)
Command that I 
used for dye 
dynamics extraction:
g_dyecoupl -f /raid/data/idp/
UnfoldedProteins/CSP_dyes/data/xtc_prot/
csp_dyes_amber03w_dyes_trex_all_nd6_pr
ot.xtc -n dye_couple.ndx -o -ot -oe -rhist -
khist -b 50000 -R0 0.54 -norm
For Anton trajectory I did not skip any time.
Index file that I used:
[ dye2_alexa488_c10_c11 ]
  50   40
[ dye2_alexa488_c9_c12 ]
  37   53
[ dye68_alexa596_c18_c19 ]
1174 1187
[ dye68_alexa596_c17_c20 ]
1186 1175
Once it asked, I select 0 for donor and 2 for 
acceptor.
The atom pairs to 
describe vectors for 
donor and acceptor 
are shown left on 
dyes with the local 
names of atoms.
Figure 3.4: Blue molecule is the Alexa 488 attached at the N-terminus and red molecule is
the Alexa 594 attached at the C-terminus. Both are shown with the paperchain represen-
tation in VMD. Transition dipole vectors used for orientational factor κ2 calculation are
shown with white arrows.
and acceptor and µ̂A and µ̂D are the unit vectors along the donor and acceptor transition
dipoles, which are shown in Figure 3.4. In an ideal situation in which the dyes are reorient-
ing fast with respect to each other and adopting an approximately isotropic distribution of
relative orientations, an average κ2 value of 2/3 can be assumed. If this assumption were
invalid, it would complicate the interpretation of FRET efficiencies in terms of distances,
even for qualitative applications. In experiment, anisotropy measurements can be used to
support κ2 ∼ 2/3, but the distribution cannot be measured directly in real samples.
As we run replica exchange simulations, we do not have direct access to the time scales of
reorientiation, but we can nonetheless compute the equilibrium average, and distribution
of κ2 from the simulations for comparison with their ideal isotropic counterparts105 in
addition to distance distributions. We find that the average values of κ2 which are tabulated
in Table3.3, are within 1.5 standard deviations of the isotropic value (2/3). Comparison
with the isotropic distibution (Figure 3.3 bottom row), shows a close similarity between
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the isotropic and simulation distributions. Thus, at least at an equilibrium level, it seems
that the inter-dye κ2 factor may safely be assumed to be 2/3; however the dynamics of the
dyes would also ultimately have to be considered (i.e. does κ2 average to 2/3 within the
fluorescence lifetime?).
3.3 Conclusions
We have compared the unfolded ensembles of naturally-occuring CSP, LR and IN and a
CSP, LR and IN with AlexaFluor 488 and AlexaFluor 594 fluorophores attached to it,
similar to that used in FRET experiments. We find that both ensembles with and without
dyes yielded negligible long-range contacts for all three sequences, indicating that they are
disordered, and that the distributions of dye-to-dye distance of sequences with dyes and
end-to-end distance of sequences without dyes are remarkably similar, and that the dyes did
not affect the average secondary structure sampled by each residue. The major effect of the
chromophores was a very slight expansion of the chain. Overall, our findings that extrinsic
chromophores have little effect on the chain properties – at least for sequences studied
here –, and that the average κ2 ∼ 2/3, lend confidence to the use of FRET chromophores
to extract true dimensions for unfolded proteins. Even though we have studied a limited
number of sequences, we believe results here can be generalized as these three sequences
accomodate a variety of different chain characteristics.
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Chapter 4
Prediction of Mutational Effects
on the Disease Relevant
Characteristics of an IDP: IAPP
4.1 Introduction
Aggregation of normally soluble proteins to form insoluble amyloid fibers characterizes
amyloidosis. These deposits, forming a cross-beta structure composed of misfolded proteins
with β-sheet structure, affect normal tissue function and are associated with pathology in
more than twenty diseases including Alzheimer’s, Parkinson’s, and type II diabetes106,107.
Some peptides found to be connected to these diseases lack a well-defined three-dimensional
structure, i.e. IDPs.108. Structural and amyloidogenic properties of IDPs are generally
hard to explore experimentally, as is their aggregation pathway109. Hence, many groups
are working on computational analysis of IDPs, and a significant number of computational
studies of disease-linked IDPs are beginning to appear44,110–120.
One such protein, Human Islet Amyloid Polypeptide (hIAPP) or human amylin is a
37 amino acid peptide that readily aggregates in vitro. The peptide, which is produced
by β-cells in the pancreas and cosecreted with insulin as a soluble monomer in vivo, has
been found to form amyloid fibers in the pancreas of those with type II diabetes121–124.
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Although the formation of these fibers is not the cause of type II diabetes, it is believed
to be correlated with insulin secreting β-cell death125. Rat amylin (rIAPP), which differs
from human amylin by six residues (Figure 4.1), does not form fibrils and is nontoxic to
β-cells126,127.
A variety of hIAPP mutants are reported as potential inhibitors of amyloid formation.
Single point mutations of hIAPP have been shown to have a potential to inhibit aggrega-
tion in the case of mutants I26P128 and G24P129. The naturally-occurring S20G hIAPP
mutation found in a small Asian population is linked with early onset in type II diabetes
and forms amyloids more quickly in vitro than wild type hIAPP130–133. Because of its
extraordinarily fast aggregation rate134, it is difficult to explore the structural features of
hIAPP S20G in its monomeric state experimentally. Molecular dynamics simulations of
the monomeric state show an L-shaped motif bending at the His18 residue of this mutant
in one of its conformational families, and this conformational preorganization into fibril-like
topology is thought to be a possible explanation for its fast aggregation rate135.
Despite being an intrinsically disordered protein, hIAPP is not a classical random coil,
and the N-terminal residues 5-20 have been shown via NMR to transiently sample α-helical
structures in solution with low levels of persisting helical structure125,136,137. rIAPP also
displays helicity in the N-terminal half of the sequence in aqueous solution as well as in the
presence of bicelles136,137. Previous simulation studies have found a conformation of rIAPP
in solution with an α-helix stretching across residues 7-17138. It is thought that the forma-
tion of helical structures may serve as an important step preceding the formation of β-sheets
associated with amyloid fibrils, as correlations between helix stability and fibril formation
have been observed 137,139,140. Helical structure is more readily adopted in the presence
of a membrane137. Because β-cell death, which is associated with membrane disruption,
is thought to result from interactions between hIAPP and the cell membrane140–142, this
further suggests that the helical conformations may play an important role in the disrup-
tion of normal β-cells. Though the mechanism of the fibril assembly of hIAPP is not yet
understood, a β-hairpin monomer conformation has been suggested to play an important
role in fibrillation. Molecular dynamics simulations have demonstrated the stability of this
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conformation in hIAPP113, the absence of this conformation in rIAPP114, and the pres-
ence in hIAPP of a strong turn region over residues 20-25, stronger in S20G than wild
type hIAPP143. Models of helix intermediates leading to beta sheet formation have been
proposed139,144, as well as oligomerization mechanism145,146 and a fibril structure based on
solid NMR data147.
Despite the aforementioned studies, there is still much that is unknown about amylin
and the pathways that lead to its aggregation. Due to aggregation, structural properties
of IAPP peptides in solution are often difficult to determine experimentally, and little is
known about the effects of the above mutations on secondary structure, in particular for
the entire length of the sequence (residues 1-37). Thus, it is desirable to use molecular
dynamics simulations in order to examine the structure of these on a monomeric level. It
is only by such comparisons that we may understand how different structural features in
mutant peptides may inhibit or promote aggregation. In addition, it will be advantageous
to compare solution structural ensemble with known amylin structures in the presence of
micelles137 or while fused to another stable protein148. Such comparison will be helpful
in identifying stable secondary structure elements that may be induced or stabilized in
the presence of membranes. Furthermore, a favorable comparison may provide necessary
support for obtaining information on functionally relevant structures from such constructs.
As a result, we have utilized molecular dynamics simulation to model hIAPP, rIAPP,
hIAPP I26P, and hIAPP S20G monomers in aqueous solution. Structural characteristics,
including dimensions and secondary structure assignments, of the peptides were compared
with one another and with previous data from experiments and simulations. These compar-
isons provide insight into what structural characteristics may influence aggregation, which
regions may be most important in aggregation, and the relationship between structures in
solution and near membranes.
4.2 Simulation and Analysis Methods
Gromacs 4.6.141 is used to perform simulations with Amber ff03w protein force field38 along
with TIP4P/2005 water model40. This force field, Amber03w, has been shown to provide
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Figure 4.1: The FASTA sequences of the four peptides studied. All peptides have a disulfide
bond between the cysteine residues at position 2 and 7.
Table 4.1: Number of non-protein molecules in the systems.
Water molecules Sodium ions Chloride ions
hIAPP 3165 5 7
rIAPP 3162 5 8
hIAPP I26P 3169 5 7
hIAPP S20G 3173 5 7
an accurate representation of disordered and unfolded proteins43,44. In addition, this force
field has the secondary structure balance needed to fold proteins from different structural
classes such as α or β proteins. The peptides are solvated in a truncated octahedron
simulation box. The number of water molecules and ions (to neutralize system charge) are
given in Table 4.1 for all peptides. Short 100 ps equilibration runs are performed in NPT
ensemble at 300 K and 1 bar with Berendsen barostat149 followed by 100 ps NVT simulation
at 300 K. Replica exchange molecular dynamics (REMD)45 simulation is performed in the
NVT ensemble with 40 replicas in a temperature range of 300 K to 575 K. Temperatures (in
K) are: 300, 304, 308, 312, 316, 320.5, 325, 330, 335, 340, 345, 350, 355.5, 361, 366.5, 372,
378, 384, 390, 396.5, 403, 410, 417, 424, 431.5, 439, 447, 455, 464, 473, 482, 491, 500, 510,
520, 530, 541, 552, 563 and 575. Each replica is simulated for 200 ns with a time step of 2 fs
and exchange attempted at every 500 steps. The first 50 ns is discarded as equilibration for
which justification is shown in Supporting information (SI), Figure S1. Time needed to be
discarded is decided from end-to-end distance, radius of gyration and secondary structure
convergence of all peptides. The system is propagated using stochastic Langevin dynamics
with a 1 ps-1 friction coefficient. Electrostatic interactions are calculated using the particle
mesh Ewald method47 with a real space cutoff of 0.9 A˚. For van der Waal interactions, a
1.2 A˚ cutoff is used.
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Figure 4.2: Average number of residues in various types of secondary structure based on
dssp criteria. From left to right, hIAPP (black), rIAPP (red), hIAPP I26P (green), and
hIAPP S20G (blue). Structure includes α-Helix, β-Sheet, β-Bridge, and turn.
4.3 Results and Discussion
4.3.1 Average Secondary Structure Propensity
The simulation trajectory at 300 K temperature for each of hIAPP, rIAPP, hIAPP I26P,
and hIAPP S20G was analyzed using the DSSP algorithm48 to determine secondary struc-
ture propensity. This analysis yielded a measure of the number of residues displaying each
particular structure for each configuration, from which mean values for secondary struc-
ture propensity were calculated. These results are summarized in Figure 4.2. Overall, we
do not observe a dramatic difference between the four sequences. Comparison of these
averages showed that rIAPP exhibited the lowest propensity for structure (α-Helix + β-
Sheet + β-Bridge + Turn), followed by hIAPP I26P, hIAPP, and hIAPP S20G, in order
of increasing average number of residues showing structure. The same qualitative trend
appears in α-helix structure. Specifically, for hIAPP and rIAPP, an average of five and
three residues, respectively, are found in α-helical structure, which is about 13 and 8% of
residues, respectively. This finding is consistent with circular dichroism measurements of
these peptides in aqueous solution, which give around 10% helical structure for both hI-
APP and rIAPP140. An increased propensity for random coil formation is also observed in
rIAPP when compared to hIAPP I26P, hIAPP, and hIAPP S20G. No particularly striking
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trends were observed in β-bridge, bend, and turn structures, for which the four peptides
shared similar results with one another. For β-sheet structure, though the four peptides
display similar averages, it is worth noting that these values are low among all four IAPP
peptides.
Though the IAPP monomers show an appreciable tendency for a coil conformation
(between 37 and 48 percent of residues), as expected of IDPs, they also appear to sample
metastable structured conformations in solution. The trends in structure, together with
the relative susceptibilities of each of the peptides to aggregate, indicate a correlation
between aggregation and secondary structure, in particular α-helicity. rIAPP, which does
not form fibrils, shows the least amount of structure and α-helicity while also displaying the
greatest propensity to form random coil. The I26P mutant of hIAPP, which both resists
and potentially inhibits fibrillization, also shows decreased structure when compared to wild
type hIAPP. Conversely, the S20G mutant of hIAPP, which displays increased fibrillization
in vivo, shows increased structure when compared with hIAPP. This lends support to the
idea that a structured state at the monomer level, may, in part, be responsible for the
observed trends in their propensity for aggregation. A possible explanation for such a trend,
as previously suggested by Lin and Shell, is that the more structured peptides sacrifice
less conformational entropy in undergoing aggregation150. Additionally, formation of α-
helices may play an important role in the initial aggregation steps of amylin, in support of
models based on previous data that propose α-helix structure to be an intermediate in the
formation of the cross-beta structured fibrils for a broad class of peptides139. Additionally,
on the monomeric level there does not appear to be any appreciable formation of β-sheet
structure associated with fibril formation, lending further support to the importance of
some intermediate in aggregation.
We have further calculated α, β and ppII fractions from the Ramachandran maps,
which are shown in Figure 4.3. We classify the (φ, ψ) space as, α: −160◦ < φ < −20◦ and
−120◦ < ψ < 50◦, β: −180◦ < φ < −90◦ and 50◦ < ψ < 240◦ or 160◦ < φ < 180◦ and
110◦ < ψ < 180◦, ppII: −90◦ < φ < −20◦ and 50◦ < ψ < 240◦ and others: everything
else151. The calculated fractions are 0.51, 0.38, 0.48 and 0.50 for α, 0.22, 0.26, 0.21 and 0.23
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Figure 4.3: Ramachandran maps of IAPP equilibrated trajectories, averaged over each
contributing residue, free-energy contoured in kcal/mol.
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for β, and 0.23, 0.32, 0.26 and 0.22 for ppII, where the order of the numbers correspond
to hIAPP, rIAPP, hIAPP I26P, and hIAPP S20G, respectively. The comparison suggests
that the α fraction is much lower for rIAPP when compared to other variants of human
IAPP and the β fractions are much lower than the α fractions for all the chains even at
this single-residue level.
In previous simulation studies, a variety of structures for monomeric hIAPP and rIAPP
have been reported using various different protein and water models. Similar to our ob-
servations, a mostly disordered conformation with transient α-helical structures using the
OPLS-AA/L force field with SPC/E water model152, as well as mixed helical and β-sheet
structures using the Amber99SB protein model along with GBSA implicit solvent112 have
been reported. Contrary to our observation of little β-structure, some of the existing simu-
lation studies have shown dominant β-hairpin structures for hIAPP monomers. Dupuis et
al. with the Amber ff96 protein model along with implicit solvent (igb5) reported that many
structures of an extended β-hairpin family were observed in hIAPP but they were absent
in the case of rIAPP114. Similarly, Reddy et al.113 reported that a β-hairpin conformation
is the most stable for the hIAPP monomer in their simulations using the GROMOS96 53a6
protein model along with simple point charge water model. Additionally, in their rIAPP
study138 using the same protein and water models, they have reported that a folded state
of rIAPP is found to contain a helical segment spanning residues 7-17, with hIAPP ex-
hibiting similar α-helical structures in this region, but no β-hairpin structure appeared in
the case of rIAPP. In another study with the CHARMM27 force field and TIP3P water110
monomeric hIAPP and rIAPP were shown to exhibit little β-propensity, similar to our
case. More recently, by using Amber 96ff protein model coupled with implicit igb5 solvent,
Wu and Shea153 have shown that non-amyloidogenic sequences of IAPP (pig and rat) pop-
ulate helix-coil and helix-hairpin structures, whereas, amyloidogenic ones (human and cat)
adopt an additional β-hairpin structure. In a more recent study Chiu et al.154 have found
that hIAPP can adopt various β-sheet conformations and rIAPP-type proline substitu-
tions at positions 25 and/or 28 and 29 perturb the formation of long β-sheets and reduce
their stability. Eventhough, above mentioned models are extensively tested for well-folded
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native proteins, they are possible to have some shortcomings in accurate representation of
unfolded or intrinsically disordered proteins. In the present study, we simulate a family of
IAPP using an optimized protein force-field model (Amber03w with TIP4P/2005 explicit
water) which has been found to reproduce some key experimental trends of unfolded pro-
teins and whose ability to accurately produce secondary structure balance, peptide-solvent
interactions, entropic and enthalpic contributions to hydration thermodynamics has been
tested for several cases38,43,44.
4.3.2 Per Residue Secondary Structure
In order to identify important regions that differ between each peptide, the structure as-
signments for each residue produced by the dssp algorithm were also used to compare
structure on a per-residue basis. Results were similar among the four sequences through
residue six; conformation in this region is likely governed by the disulfide bond between
cysteine residues two and seven, which is common to these four tested polypeptides. Par-
ticularly striking from the results was comparison of the peptides over residues 7-16. When
comparing α-helicity over these residues, the same trend seen for overall secondary struc-
ture is observed: hIAPP S20G shows the greatest amounts of helical propensity, followed
by hIAPP, hIAPP I26P, and rIAPP, in order of decreasing helicity. (Figure 4.4) In fact,
over these residues, rIAPP shows no helicity for most residues, and the residue that shows
the greatest helical structure in rIAPP (residue 16) does so during less than 4 percent of
the time sampled. For comparison, helicity over this region reaches peak values at residues
9 and 10 for the hIAPP peptides as a common region, with the percent of time spent in
α-helical structure peaking at about 22, 17, and 57 percent for hIAPP, hIAPP I26P, and
hIAPP S20G, respectively. A comparison of the fractions of time spent in random coil over
residues 7-16 shows significantly higher values for rIAPP and somewhat increased values
for hIAPP I26P when compared to hIAPP and hIAPP S20G. (Figure 4.4) Over residues
7-16, the mean fraction of time displaying coil conformation for rIAPP was 0.52, while that
for hIAPP was 0.28. The two hIAPP mutants analyzed, I26P and S20G, gave respective
average fractions of 0.32 and 0.18 of time spent in coil structure over residues 7-16.
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Figure 4.4: Per residue fraction of time spent in secondary structure over last 150 ns for
wild type hIAPP, rIAPP, hIAPP S20G, and hIAPP I26P.
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Among all four peptides, β-sheet propensity, as was observed in overall structure av-
erages, was found to be quite low across all residues. The highest values reached by any
residue for percent time spent in a β-sheet were only 16.5, 8.2, 1.8, and 15.9 percent for
hIAPP, rIAPP, hIAPP I26P, and hIAPP S20G, respectively, and percentages were below
10% for most residues. Despite low amounts of β-sheet formation across all four sequences,
hIAPP I26P showed a further reduced β-sheet propensity when compared to the three
other peptides over most of the sequence. In those regions where other IAPP peptides
show slightly increased β-sheet propensity, fraction of time spent in β-sheet for hIAPP
I26P remains close to zero for each residue.
Secondary structure over residues 7-16 displays the same trend seen in overall secondary
structure. Helicity in this region tracks well with the relative propensity to aggregate,
while prevalence of coil conformation in this region appears to be inversely related to fibril
formation. Due to these correlations, it is possible that formation of α-helices over residues
7-16 may be an important intermediate in amyloid formation. One possible mechanism,
as suggested by Abedini and Raleigh139, suggests that the helical states sampled promote
association of the peptide over the helical region. These associations lead to subsequent high
local concentrations in the rest of the peptide, possibly bringing together those sequences
most inclined to aggregate and allowing for formation of the cross-beta structure seen in
fibrils. As such, the increased helical propensity seen in hIAPP S20G over residues 7-16
may help to explain the rapid aggregation rate of this mutant. Similarly, the reduced
helical propensity, in favor of coil conformation, of hIAPP I26P when compared to wild
type hIAPP may contribute to the slowed aggregation of this peptide. In addition, at the
monomeric level, resistant and inhibitory characteristics of the I26P mutant to fibrillization
may largely be due to its distinctly low β-sheet formation tendency, rather than its α-helical
characteristics.
Toward the C-terminus, all four amylin peptides display similar trends in secondary
structure after position 22. This is despite the fact the fact that the I26P mutant differs
from hIAPP within this region and five of the six differing residues between rIAPP and
hIAPP fall between residues 22 and 37, including prolines at positions 25, 28 and 29. Be-
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cause five of the six differences in sequence between hIAPP and rIAPP are found in region
20-29, amyloidogenicity of hIAPP is mostly attributed to region 20-29. In previous frag-
mental studies, the hIAPP 20-29 peptide was found to be amyloidogenic and disruptive to
the cellular membrane, whereas rIAPP 20-29 was found to be non-amyloidogenic155–157;
however, there is evidence showing regions outside these residues can affect amyloidogenic-
ity of hIAPP158,159. Furthermore, it is already known that region 1-19 of hIAPP is more
toxic than the same region of rIAPP160. Even the hIAPP 30-37 peptide has been shown
to form amyloid deposits, though this region is identical in hIAPP and rIAPP161. In fact,
keeping in mind that the ability to form amyloid fibrils is not an unusual property for
a peptide147,162, fragmental studies may not represent the core of amyloidogenic region.
Additionally, kinetics of amyloid formation differ between short fragments and full-length
amylin145. We have found that the C-terminal region including residues after position 22
seems similar for all peptides in terms of secondary structure propensities (Figure 4.4). This
does not necessarily mean that C-terminal is not involved in islet amyloid formation, but
can support that region 20-29 may not be the only responsible region associated with fibril
formation triggered by helical intermediates. More importantly, although major mutations
causing changes in amyloidogenecity are found in region 20-29, effects of these mutations
are observed in the region outside of 20-29, leading us to believe long-range interactions
are responsible for these effects. In their NMR spectroscopic investigation of IAPP, Mishra
et al.163 reported that their data strongly suggests that rather than the 20-29 region, the
N-terminal region spanning residues 1-17 of hIAPP is involved in self-association of the
peptide in bulk, which supports our emphasis on the importance of α-helical intermediates
on aggregation in the same region of amylin peptides.
Our findings show that residues 31-34 have increased alpha helical propensity, whereas
last three residues, 35, 36 and 37, have almost 100% coil propensity. Similarly, in an
NMR experiment, the region 33-35 is observed as a 3(10) helix164. An overall look at sec-
ondary structure analysis confirms that even though monomeric forms of all four peptides
sample mostly coil conformations as IDPs, all sample helical structures in a considerable
propensity, too.
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4.3.3 Comparison with Known NMR and X-ray Crystal Structures
In the protein data bank (PDB), there are three full-length human amylin structures in
different membrane-mimicking environments, two of which are solution NMR and one of
which is x-ray crystallography. In an NMR study (PDB ID: 2KB8) in a micelle environ-
ment, it has been shown that residues 5-28 are in helical conformation with a kink between
residues 18-22165. In the same study, it was stated that the most rigid part of the he-
lix is observed in region 5-17, which is consistent with our findings in per residue helical
propensity (Figure 4.4). An NMR study (PDB ID: 2L86) has also shown that regions
7-17 and 21-28 of hIAPP sample helical conformations in lipid bilayer-mimicking deter-
gent micelle environment164. In the third study (PDB ID: 3G7V), the crystal structure of
maltose-binding protein fused hIAPP is shown to adopt α-helical structure over residues
8-18 and 22-27148. Similarly, we have found the highest helical propensity in region 7-16
(Figure 4.4).
Considering all existing PDB structures of hIAPP, the most common helical regions are
found in residues 8-17 and 22-28. For the region 18-22, a distortion in helices or kink-like
structures is generally observed, depending upon the environment. On the other hand,
for the regions 8-17 and 22-28 in common, stable helical conformations are reported to
be independent of environment. To observe any similarity between these structures and
our amylin trajectories, we have calculated the root-mean-square deviation (RMSD) for
regions 8-17 and 22-28 (Figure 4.5). Trends observed in Figure 4.5A, B and C are all
similar, implying that all three existing structures are quite similar in these regions 8-17
and 22-28, even though performed in very different environments. This suggests a strong
intrinsic propensity to form α-helices in these regions. Our hIAPP peptide (thick black line
with circles in Figure 4.5) in aqueous solution shows that it samples conformations having
an RMSD between these structures lower than 0.1 nm with relatively low stabilities, even
though most sampled conformations in our trajectories are disordered. The lower stability
in RMSD lower than 0.1 nm is due to the stabilizing effect of the membrane environment
in existing PDB structures. Hence, our findings further confirm that membranes have
helix-stabilizing effects on amylin. This means that although our trajectories are in aque-
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Figure 4.5: Free energy with root-mean-square-deviation (RMSD). Left column represents
region 8-17 and right column represents region 22-28 of amylin peptides. Black circles:
hIAPP, red squares: rIAPP, green diamonds: hIAPP I26P, blue triangle ups: hIAPP
S20G. RMSD of peptides with respect to PDB structure 2KB8 (A), PDB structure 2L86
(B), PDB structure 3G7V (C).
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Figure 4.6: Aligned hIAPP peptides, all peptides are truncated to region 8-28, Blue: our
trajectory frame, Red: 2KB8, Green: 2L86, Grey: 3G7V. Left: Aligned region 8-17. Right:
Aligned region 22-28.
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Figure 4.7: Free energy with RMSD between rat amylin and PDB 2KJ7. Left column
represents region 8-17 and right column represents region 22-28 of rat amylin peptides.
52
ous solution rather than a membrane mimicking environment, they sample conformations
similar to membrane mimicking environment conformations, albeit with much lower sta-
bility. As an illustration of the similarity between existing PDB structures and our hIAPP
trajectory, we have selected a representative frame from our hIAPP trajectory having low
RMSD between all PDB structures for regions 8-17 and 22-28. Aligned structures clearly
show the similarity between all PDB structures and our selected frame (Figure 4.6) over
these regions.
Our hIAPP S20G trajectory (blue line in Figure 4.5) samples lower free energies at
RMSD of about 0.1 nm than hIAPP, implying more stable similar conformations to exist-
ing PDB structures than hIAPP, which further supports α-helical structures could be an
intermediate step in fibril formation, knowing that the S20G mutant has higher propensity
to form fibrils. On the other hand, rIAPP and hIAPP I26P trajectories do not show such
a similarity to existing hIAPP structures in membrane mimicking environments (red and
green lines respectively in Figure 4.5).
In a solution NMR study of rIAPP with PDB ID of 2KJ8 in membrane mimicking
detergent micelle environment, region 5-23 is characterized as helical with a distortion in
the helix at region 18-19166. The study found a disordered C-terminus and suggested the
N-terminal region to have a crucial role in self-association and toxicity of amylin peptides.
In contrast with this study, we find especially the 7-21 region has higher propensity to be
in coil conformation, except L12 residue (Figure 4.4). We have performed similar RMSD
analysis for our rIAPP trajectory (Figure 4.7), showing that there is not much similarity in
sampled conformations between aqueous solution and a membrane mimicking environment.
This presents a striking difference between aqueous solution sampling of rIAPP and hIAPP.
It is clear that because of its helix stabilizing effect, a membrane environment overem-
phasizes the helix formation, especially for rIAPP. The hIAPP monomer in aqueous solution
samples helices similar to helices observed in experimental membrane like environments;
with a considerable percent, however, being an IDP, the hIAPP monomer does not have a
persistent similar structure in solution. As opposed to hIAPP, the rIAPP monomer simula-
tions in solution reveal significantly lower helical propensity for the region 8-17 than hIAPP
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in solution. Evaluation of our findings for regions 8-17 and 22-28, together with experimen-
tally obtained structures, suggests that helical conformations of these regions may have a
crucial role in membrane interactions ending with fibril formation. Even though region
8-17 of rIAPP contains no mutations from hIAPP, this long region shows the greatest dif-
ference in α-helical propensity (Figure 4.4), as well as similarity to known PDB structures
(Figures 4.6 and 4.7). These findings imply the context dependence of amylin structures
and importance of long-range interactions in fibril formation initiated by helical structures
in amylin peptides.
4.3.4 Structural Clustering
Clustering analysis has been conducted to identify persistent conformations in our simu-
lated equilibrium ensembles. It is performed using the gromos method167, with a cut-off
distance of 0.3 nm. Central structures of the top five clusters for each peptide are shown in
Figure 4.8 along with their corresponding contact maps. Darker regions observed especially
near the edges of contact maps suggest an evidence of formation of long-range contacts.
For hIAPP, rIAPP, hIAPP I26P and hIAPP S20G; 34, 32, 34 and 44% of trajectories are
represented by their top 5 clusters, respectively. For both hIAPP and rIAPP clusters, the
most populated ones do not show significant secondary structure, as expected from their
natively disordered nature. However, they differ in their relatively less populated clus-
ters in that hIAPP is more structured than rIAPP. Specifically, cluster 4 of hIAPP, with
4.7% population, has long helical regions including regions 4-9, 11-20 and 23-30; kinked at
positions 10 and 21-22.
From the populations represented by the clusters, it can be easily seen that most of
the rIAPP and hIAPP I26P trajectories sample coil conformations more often; in other
words, they are less structured than hIAPP and hIAPP S20G. More strikingly, clusters
of the hIAPP S20G mutant show that it is the most structured among all four peptides.
Even its most populated cluster, with 18.3% population, includes long helical regions in its
structure. In addition to its helical structures, it also samples longer beta-sheet structures
(clusters 4 and 5, Figure 4.8). Because the S20G mutant shows more structured popu-
54
Figure 4.8: Top five clusters (from left to right) formed upon clustering analysis of hIAPP
(top row), rIAPP (row 2), hIAPP I26P (row 3), and hIAPP S20G (row 4), together with
the corresponding contact map for each cluster. Clusters are colored with N-terminal as
red and C-terminal as blue, and percent population is indicated in bottom left corner.
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lations, specifically more helical structures than all the others, its tendency to aggregate
in vivo can be thought to correlate well with being more structured. Moreover, we also
observe a hairpin structure with 0.92% population (not shown here), whereas we never
observe a hairpin in our hIAPP monomer trajectory. This finding further supports that
the S20G mutant has higher tendency to form amyloid fibrils under in vitro conditions.
In addition, clusters were also produced using clustering based upon only residues 7-
16. IDPs sometimes display a relatively significant population displaying stable structure
over short stretches of the peptide44, and this clustering would provide an indication of
whether such regions of structure are stable in solution. Clustering analysis over the
aforementioned backbone residues was performed with a cut-off distance of 0.15 nm. The
most populated cluster for hIAPP, rIAPP, hIAPP I26P, and hIAPP S20G comprised 13.2,
14.0, 12.5, and 19.6 percent of the total population, respectively. These percentages do not
show a significant change from clustering done based upon the entire backbone, indicating
that the peptides do not show a stable structure over the region of increased helicity of
residues 7-16. Rather, this region, like the sequence as a whole, transiently samples multiple
conformations in solution. This is suggestive of an induced-fit binding model168 in which
the stability in the helical region observed in the membrane-bound peptides is induced by
the membrane, rather than binding occuring between the membrane and an existing stable
conformation.
4.3.5 Radius of Gyration, End-to-End Distance, and Solvent-Accessible
Surface Area
Previous work has indicated differences in the dimensions of hIAPP and rIAPP. In order
to understand how radius of gyration, end-to-end distance, and solvent-accessible surface
area may vary among the four peptides, the equilibrium trajectory of each peptide was
analyzed to determine these properties. These results are summarized in Figure 4.9.
Radius of gyration (Rg) distributions show that hIAPP samples Rg most probably
between 0.4 and 1.8 nm with a flat distribution. Unlike hIAPP, rIAPP and hIAPP I26P
each have two distinct peaks in the Rg probability distributions. One is located at less than
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Figure 4.9: Distribution of results from radius of gyration, end-to-end distance, and total
solvent-accessible surface area calculations over last 150 ns of each 200 ns trajectory. Panel
A shows the cumulative distribution functions for each property, while panel B shows
the probability distribution for each. Black circles: hIAPP, red squares: rIAPP, green
diamonds: hIAPP I26P and blue triangles down: hIAPP S20G. Distances are in nm and
area is in nm2.
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1 nm and the other around 2 nm. rIAPP has a broader peak around 2 nm than hIAPP I26P,
implying hIAPP I26P samples more compact conformations than rIAPP. Additionally, the
probability of Rg being higher than 1.8 nm is drastically lowered for hIAPP, meaning
that hIAPP samples more compact structures than hIAPP I26P. For hIAPP S20G, the
Rg distribution has a significantly sharper single peak around 1.1 nm, in contrast with
hIAPP’s broad distribution between 0.4 to 1.8 nm, showing that the S20G mutant samples
even more compact conformations than hIAPP. Overall, Rg distribution results show that
hIAPP S20G samples the most compact conformations and hIAPP, hIAPP I26P and rIAPP
sample less compact conformations, in the order of decreasing compactness. Therefore, this
further supports the same order of aggregation tendency in vitro together with secondary
structure analysis.
From the cumulative distribution, it can be observed that rIAPP shows longer end-
to-end distances than hIAPP and the other two mutants across the distribution, as well
as having a relatively broader distribution. Among the three hIAPP peptides, hIAPP
I26P shows a greater mean end-to-end distance than both wild type hIAPP and hIAPP
S20G, while hIAPP S20G shows a slightly lower mean end-to-end distance than the wild
type hIAPP, though sampling a broader distribution. The broader distribution of rIAPP
in end-to-end distance is consistent with the greater amount of disorder observed in this
peptide from the secondary structure analysis. Also, the finding that rIAPP generally shows
greater end-to-end distance than hIAPP is consistent with the observations from previous
literature169. Also, it appears that the mean end-to-end distance shows a correlation with
propensity for aggregation, with the shortest mean end-to-end distances corresponding
to the peptides that most quickly aggregate and increasing mean end-to-end distances
corresponding to the peptides that aggregate more slowly or, in the case of rIAPP, not
at all. The results of the solvent-accessible surface area calculations show rIAPP has
greater surface area than the three hIAPP peptides across the distribution, again with a
comparatively wide distribution. The results for hIAPP and hIAPP I26P were relatively
similar, though the mutation showed a slightly higher mean area and a slightly broader
distribution than the wild type hIAPP. The S20G mutation of hIAPP, though, displayed
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less surface area than the other peptides across the entire distribution.
4.3.6 Comparison without Disulfide Loop
Another characteristic of IAPP peptides is the presence of a disulfide bond between the
cysteines located at residues two and seven (Figure 4.1). Vaiana et al. observed a de-
crease in end-to-end distance, believed to result from interactions between the disulfide
and the backbone of the chain, in both human and rat amylin relative to peptides in which
the disulfide was reduced169. Additionally, a decrease in helicity over residues 1-22 was
observed in the same with the disulfide bond reduced137.
Both hIAPP and rIAPP were also simulated here in the absence of the disulfide loop
between cys 2 and cys 7. These results were then compared to their disulfide counterparts
to evaluate any structural characteristics introduced by the disulfide bond. Comparison
of per-residue secondary structure is summarized in Figure 4.10. Near the N-terminus,
rIAPP shows similar low helical propensity both with and without the disulfide bond.
The unbonded hIAPP peptide shows an increase in helicity over residues 7-12 and 15-18.
Opposite the disulfide bond, near the C-terminus, however, an increase in coil propensity
and decrease in helicity is evident in both hIAPP and rIAPP when the cystine is reduced.
This decrease in helicity is seen in both peptides over residues 31-34. Upon examining the
radius of gyration and end-to-end distance distributions (not shown), hIAPP and rIAPP
both also sampled a broader distribution of distances in the presence of the disulfide loop.
This change in structure at the end opposite the disulfide bond further illustrates the
context dependence and importance of long-range contacts in structures sampled by the
amylin monomers.
4.4 Conclusions
Accurate molecular dynamics simulations are used to provide useful information on monomeric
solution states of amylin polypeptides that may lead to fibril formation. Analysis compar-
ing wild type hIAPP and rIAPP monomers in solution along with hIAPP I26P and hIAPP
S20G has yielded evidence that formation of helices may be important in fibril formation.
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Figure 4.10: Per residue fraction of time spent in secondary structure over last 150 ns for
wild type hIAPP and rIAPP, as well as both hIAPP and rIAPP without the disulfide bond.
Starting at the both hIAPP and rIAPP show slightly decreased or little change in helicity
over much of the peptide. At the C-terminus however, both see a significant increase in
helicity with the SS bond present at residues 31-34.
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In particular, the extent of helicity in the region of residues 7-16 appears to be a factor
contributing to relative aggregation propensities among the polypeptides. This is despite
the fact that the I26P mutation as well as 5 of the 6 differences in sequence between hIAPP
and rIAPP fall outside this region. This implies that, contrary to what would be expected
of an IDP, long-range contacts play a role in the structural differences between the amylin
proteins, making study of the full-length sequences important to possibly understanding
aggregation pathways. Furthermore, it has been seen that previous structural information
gathered by others from NMR or crystal structures appear to represent stabilized structures
that are transiently sampled in solution. Though noteworthy relationships between struc-
ture and fibril formation have been proposed here, future work, including that of multiple
polypeptides in solution, will offer a clearer understanding of aggregation mechanisms.
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Chapter 5
Comparison between temperature
replica exchange molecular
dynamics and bias-exchange
metadynamics for the free energy
surface an intrinsically disordered
protein: IAPP
5.1 Introduction
Many proteins naturally exist in unstructured states and are hence referred to as intrin-
sically disordered proteins (IDPs)109,170,171. Despite their lack of a well-defined structure,
many of these proteins perform various biological functions, and many of these proteins are
implicated in human diseases108,172. Heterogeneous nature of disordered proteins makes the
experimental characterization of IDPs challenging. Therefore, IDPs are ideal candidates
for molecular dynamics (MD) simulations, which provide the ability to probe molecular
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characteristics on length and time scales that are not easily accessible to current experimen-
tal methods. However, many molecular events take place on much longer time scales than
those which are feasible using standard brute force MD simulations. As a result, relevant
regions of the configuration space often remain unexplored in a given simulation time. To
alleviate this problem, several enhanced sampling methods have been introduced173–177, in-
cluding temperature replica exchange molecular dynamics (T-REMD)45 and bias exchange
metadynamics (BEMD)178.
T-REMD involves simultaneously running multiple simulations of a system at differ-
ent temperatures. At high temperatures, energetic barriers are more easily overcome, and
regularly attempted exchanges between adjacent replicas enhance the sampling of lower
temperature replicas. The canonical probability distribution at each temperature is main-
tained by an acceptance probability of exchange between replicas, based on the Metropolis
criteria, P ∝ exp(∆β∆E), where β = (kBT )−1 and ∆E is the potential energy difference
between the two states. Because of the dependence of E on system size, a disadvantage of
the T-REMD method is that larger system sizes require closer temperature spacing, and
therefore a greater number of replicas, to maintain sufficient exchange probability. The
T-REMD method has been successfully employed in the investigation of various IDPs in-
cluding amyloid-β 115,179, α-synuclein180,181, NCBD43,182, p53 peptides44 and islet amyloid
polypeptide (IAPP)11,113,114,153.
The recently introduced BEMD technique is designed to both accelerate the confor-
mational transitions and reconstruct the free energy landscapes of complex biological sys-
tems178,183,184. As in standard metadynamics175, sampling is enhanced by a bias that acts
on a set of order parameters. These parameters are referred to as collective variables (CVs)
and provide a low-dimensional description of the system. The bias is a history-dependent
potential constructed as a sum of Gaussian distributions deposited along the trajectory of
the CVs175, filling the CV space. In standard metadynamics, the computational cost in-
creases exponentially with the number of CVs and the method usually becomes inefficient
for more than three variables; however, BEMD overcomes this problem with a replica-
exchange approach45. The bias is applied on several CVs, which act singularly on separate
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replicas of the same temperature, providing the framework to study larger systems and
more complex behavior, such as protein folding184 and aggregation185 as well as confor-
mational sampling of IDPs186.
In this paper, we present a comparative analysis of human islet amyloid polypeptide
(hIAPP), an IDP, in aqueous solution using two different enhanced sampling techniques:
T-REMD and BEMD. hIAPP is a 37 residue-long polypeptide which normally exists as a
soluble IDP under physiological conditions but forms amyloid deposits in the pancreas of
patients with type II diabetes108,187–189. In vitro, hIAPP can aggregate very quickly125,
making its monomeric properties difficult to characterize experimentally. As a result,
the hIAPP monomer is the subject of many simulation studies11,112–114,152–154,190. Here,
comparison of the free energy profiles and secondary structures populated in the hIAPP
ensemble given by each method reveals very similar results. BEMD simulations show
the capability to assess the free-energy for larger regions of conformation space with less
simulation time than T-REMD. However, BEMD simulations require the expense of initial
benchmark runs to find the best set of CVs and CV parameters as well as computational
expense of CV evaluation and bias potential calculation. Additionally, BEMD simulations
require additional steps during analysis, while T-REMD simulations are straightforward to
set up and analyze.
5.2 Simulation and Analysis Methods
In this work, we compare two different enhanced sampling methods, T-REMD and BEMD,
to obtain equilibrium properties of an IDP. Thirty seven residue-long hIAPP was simulated
in each case using the Amber03w force field38 and TIP4P/2005 water model40. The Am-
ber03w force field has previously been shown to accurately model intrinsically disordered
proteins10,11,43,44,191,192. The hIAPP monomer was solvated in an octahedron box with
3165 water molecules, with 5 sodium and 7 chloride ions added to neutralize the system
charge. Electrostatic interactions were calculated using the particle-mesh Ewald method47
with a real space cutoff of 0.9 nm, and a 1.2 nm cutoff was used for van der Waals inter-
actions. Both T-REMD and BEMD simulations of the system were performed in an NVT
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ensemble, employing the GROMACS 4.5.3 package as the MD engine41,193. Further details
specific to our T-REMD and BEMD methods are provided in the following sections.
5.2.1 T-REMD
The enhanced sampling in the case of T-REMD is achieved by high temperature replicas,
which can easily overcome barriers within the configurational landscape. The temperature
spacing of replicas is chosen such that the potential energy distributions overlap, and
exchange attempts are accepted with a sufficient probability of about 10-20%45. Because
the distribution of potential energy, E, broadens with increasing temperature, geometric
spacing of the replica temperatures, given by eq. 5.1, is a useful way of assigning replica
tempearatures.194
Ti = T0
(
TN−1
T0
)i/N−1
(5.1)
Here the indices of replicas are i = 0, 1, . . . , N−1; and N is the total number of replicas,
so that T0 is the lowest replica temperature, and TN−1 is the highest replica temperature.
Forty replicas from 300 to 575 K were used, with the temperature spacing between
them adjusted according to equation (1). The system dynamics were propagated using
stochastic Langevin dynamics with a 1/ps friction coefficient. Each replica was simulated
for 200 ns, for a total simulation time of 8 µs, using a time step of 2 fs, and exchanges
attempted every 1 ps. We find that, on average, around 12-13% of exchange attempts are
accepted. The 300 K trajectory was analyzed, discarding the first 50 ns of the trajectory
as equilibration time.
5.2.2 BEMD
In bias-exchange, multiple metadynamics simulations are run in parallel at the same tem-
perature (300 K), each one biased using a different CV. Exchanges between the bias poten-
tials of different replicas are periodically attempted according to a Metropolis scheme: if
the exchange move is accepted, the trajectory that was previously biased in the direction of
the first variable continues its evolution biased by the second and vice versa. In this man-
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Figure 5.1: Evolution of the one-dimensional free energy profile for the α-RMSD CV over
simulation time in the first BEMD simulation of 600 ns per replica, employing only 4 CVs.
The profiles show the presence of a clear hysteresis, denoted by the fact that they are not
growing parallel with time.
ner, a relatively large number of different variables can be biased, and a high-dimensional
space can be explored with a computational cost which increases linearly with the number
of CVs195. Once the bias potentials become stable, a multidimensional free energy surface
can be reconstructed, following an accurate reweighting scheme described by Marinelli et
al.183, as a function of the CVs used in the sampling.The convergence is typically assessed
by considering the difference between the one-dimensional free energy profiles of the first
and second halves of the simulation after the equilibration time154,196.
Choice of the collective variables: As in other methods that reconstruct the free
energy as a function of a set of generalized coordinates, in BEMD the choice of the CVs
plays an essential role in determining the convergence and efficiency of the free energy
calculation. If the chosen set of CVs is not able to capture the slowest degrees of free-
dom to trigger the conformational transitions or does not distinguish between different
metastable states of the system, the simulation will be affected by hysteresis, and not all
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Figure 5.2: Correlation of collective variables including coordination number of hydropho-
bic side-chain contacts, α-RMSD, anti-parallel-β-RMSD, coordination number of Cα-Cα
contacts, and correlation of dihedral ψ angles
.
of the important regions of the conformational space will be explored. In order to choose
an appropriate set, one needs to exploit some basic knowledge of the topological, chemical,
and physical properties of the system. Although there is no a priori recipe for finding the
correct set of CVs, in the BEMD method the number of variables can be relatively large,
making the selection less critical.
In order to develop a preliminary idea of the conformational space of the system ex-
plored by BEMD, we first performed BEMD of 600 ns per replica at 300 K with only
four replicas. This informed our final selection of CVs and relevant parameters for pro-
duction. Given the intrinsically disordered nature of hIAPP, we chose CVs which are able
to rapidly sample the secondary structure of the system: α-RMSD, paraβ-RMSD, and
antiβ-RMSD197 on the full length chain, as well as the coordination number of hydropho-
bic side-chain contacts184, in order to rapidly open or collapse the protein conformation.
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In the given simulation time, all CVs except the α-RMSD CV converged, while this CV
displayed an evident hysteresis (see Figure 5.1). While the β-sheet content is expected to
be low11, this IDP has been shown to populate primarily helical conformations in varied
and independent regions of the sequence. This heterogeneous behavior, together with the
relatively short simulation length (2.4 µs of total simulation time), did not allow the system
to explore all relevant states along the α-RMSD CV.
Accordingly, we decided to divide this CV into two different residue spans in two sep-
arate replicas. We employed the region spanning residues 8-22 in one and residues 22-36
in the other. We excluded the first seven residues because this region is characterized by
a disulfide bond between cysteine residues 2 and 7, and we expected it would not sample
extended helical conformations. We then exploited all the structures collected in the previ-
ous BEMD run in order to understand the proper set of collective variables to use. Based
on this analysis, we decided to introduce two additional CVs: dihedral correlation, which
measures the similarity between adjacent ψ dihedral angles, and the coordination number
of Cα-Cα contacts. The first was chosen to enhance the exploration of local structures (for
example, PPII) which are quite common in IDPs198, while also helping the convergence of
the α-RMSD CVs and the sampling of the first 7 residues. The Cα-Cα coordination was in-
troduced because the number of hydrophobic side-chain contacts alone may not effectively
sample the compactness of the molecule, given the relatively low content of hydrophobic
residues in IDPs compared to natively-folded proteins199. Correlation plots for these two
CVs are shown in Figure 5.2. Neither α- nor antiβ-RMSD are correlated with dihedral
correlation (Figure 5.2-right). Remarkably, while the Cα coordination is highly correlated
with the radius of gyration (a less ambiguous measure of compactness), it appears to be
uncorrelated with hydrophobic side-chain contacts. It is important to stress that non-
correlation among a set of chosen CVs ensures the rapid exploration of larger regions of
the phase space and allows discrimination between different structural states by projecting
the system on orthogonal directions in the free energy reconstruction. Therefore, we de-
cided to perform a BEMD simulation employing these 7 collective variables (antiβ-, paraβ-
and two α-RMSD, hydrophobic and Cα coordination numbers, and dihedral correlation)
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and an additional unbiased (neutral) replica to compare with the final free energy recon-
struction and with the T-REMD simulation. Functional forms of bias potentials associated
with these CVs are described below.
Application of BEMD and functional forms of CVs: We have performed a bias-
exchange metadynamics simulation (BEMD) on 8 different replicas, 7 of which are each
biased by a different metadynamics potential acting on one collective variable (CV). The
eighth replica is unbiased and is compared with the reweighted BEMD and temperature
replica exchange molecular dynamics (T-REMD) results in Figs. S2 and S3. The total
simulation time was 650 ns per replica. One-dimensional Gaussian functions of height w =
0.30 kJ/mol were deposited every 5 ps, and exchanges of the bias potentials were attempted
every 20 ps.
The CVs we selected to bias BEMD simulations were likewise used in the PMF calcu-
lations in order to study the free energy landscape of hIAPP. The explicit functional form
of the collective CVs that we use are the following:
• Coordination Number. This CV, which is used to quantify the number of hy-
drophobic contacts in CV1 and the Cα-Cα contacts in CV6, is defined as
CN =
∑
i,j
Cij
with
Cij =
1− ( rijr0 )n
1− ( rijr0 )m
(5.2)
where rij is the distance between atoms or groups i and j, r0 is the cutoff distance
to consider two atoms in contact, and the exponents m, n are parameters that allow
the smoothness of the function to be tuned. We used m=8, n=4, and r0=0.4 nm for
CV1 and r0=0.8 nm for CV6.
• AlphaRMSD (for CV2 and CV3), ParaBetaRMSD (CV4), AntiBetaRMSD
(CV5). These CVs count how many fragments of 6 residues (6 in a row for α-
helices and 3+3 for β-sheets) belong to an α-helix or β-sheet, by computing the
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RMSD of each possible 6-residue sequence with respect to an ideal α-helix or β-sheet
conformation197:
S =
∑
α
f
[
RMSD
({Ri}i∈Ωα , {R0})] (5.3)
f (RMSD) =
1− (RMSD/0.1)n
1− (RMSD/0.1)m (5.4)
where f is a function switching smoothly between 0 and 1, the RMSD is measured
in nm, {Ri}i∈Ωα are the atomic coordinates of a set Ωα of six residues of the protein,
and
{
R0
}
are the corresponding atomic positions of the ideal α-helical or β-sheet
conformation; m, n are exponents that allow one to tune the smoothness of the
function. We used m=6, n=12 and r0=0.1 nm for all four CVs.
• Dihedral Correlation (CV7). This CV measures the similarity between ψ dihedral
angles of consecutive residues, highlighting the presence of regular structural ele-
ments, including secondary structure. A higher value, therefore indicates a greater
number of similar adjacent ψ angles. It is defined as:
SDC =
∑
i
1
2
[1 + cos(ψi − ψi−1)] (5.5)
All the CVs are available with the PLUMED plugin200 for Gromacs.
The values of the widths (σ) of the Gaussians were chosen by measuring the spontaneous
fluctuations of each CV during a 2 ns standard molecular dynamics simulation and are
reported in Table S1. After 100 ns of BEMD simulation, during which very wide regions
of the CVs were explored, we introduced upper interval limits to help converge the bias
potentials and lower interval limits to avoid the deposition of finite Gaussians beyond hard
limits (e.g. 0 for positive-defined CVs), as described by Laio and coworkers201. Outside
the interval regions, no forces due to the biasing potential are applied. The presence of
the intervals is taken into account in the WHAM analysis of BEMD using the METAGUI
plugin. The interval ranges for each CV are reported in Table S1, as well as the values
used to divide the CV space into hypercubes. This grid defines the microstates in the
free energy reconstruction for BEMD and the one-dimensional free energy profiles for the
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T-REMD simulation.
Once the free energy of each microstate is determined, the ensemble average of any
observable of the system can be calculated by
〈O〉 =
∑
αOαe
−Fα/T∑
α e
−Fα/T (5.6)
where the sums run over all the microstates and Oα is the arithmetic average of the
observable among all the configurations within microstate-α. This formula has been used
to reweight the secondary structure propensities of the system as well.
In the first BEMD simulation employing only 4 CVs (hydrophobic contacts coordination
number and α-, paraβ-, and antiβ-RMSD of the entire sequence) for 650ns, the values of
the metadynamics parameters previously described were used.
Errors of REMD data are calculated by dividing the data into two blocks. Error on
each bin is assigned based on the error propagation formula applied to the number of events
observed in the two blocks for each bin:
err = kT
|N1 −N2|
〈N〉 (5.7)
where N1 is the number of events observed in the first half, N2 is the number of events
observed in the other half and 〈N〉 is the average number of events observed in the first
and second half.
The system dynamics is propagated using a leap-frog algorithm with a 2 fs timestep.
The temperature is kept constant at 300 K using the Nose´-Hoover thermostat202,203 with
a 1 ps coupling constant. The exchanges between the replicas were attempted every 20 ps
and each replica was simulated for 650 ns, for a total simulation time of 4.5 µs (excluding
the neutral replica which is used only for monitoring purposes). The initial 300 ns from all
replicas are discarded as an equilibration time.
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Table 5.1: For each CV, the Gaussian width, interval range used in the simulation, and
range and bin size for the free energy reconstruction of BEMD and for PMF calculations
of T-REMD and the BEMD neutral replica.
Collective variable σ Interval Range Bin size
CV1: Hydrophobic contacts coordination 2 6-120 0-130 10
CV2: α-RMSD for residues 8-22 0.15 0.5-9.5 0-9 1
CV3: α-RMSD for residues 22-36 0.15 0.5-9.5 0-9 1
CV4: parallel β-RMSD 0.1 0.3-5 0-5 0.5
CV5: antiparallel β-RMSD 0.1 0.3-6 0-6 0.5
CV6: Cα-Cα contacts coordination 2 0-150 10-150 10
CV7: ψ-dihedral angle correlation 0.5 0-34 4-30 3
5.3 Results and Discussion
In order to compare the T-REMD and BEMD methods, we first calculated the free energies
of the system as a function of individual collective variables. For the analysis of the BEMD
simulation data we divided the 7-dimensional CV space by applying a grid on each direction
(see Table S1 for grid dimensions). In this way, all states after the equilibration time are
grouped into sets (microstates), using the METAGUI196 tool, a graphical user interface for
Visual Molecular Dynamics (VMD)204. The free energy of each microstate was estimated
by the weighted-histogram analysis method (WHAM)205 as described by Marinelli et al.183,
considering both the metadynamics bias potential and the number of times that portion
of the CV space was visited. We then integrated the free energies of the microstates over
each collective variable to obtain one dimensional free energy profiles projected onto the
corresponding direction. This integration also takes into account the error associated with
the free energy of each microstates as obtained from the METAGUI plugin, estimated as
described by Marinelli et al.183. Conversely, for the T-REMD simulation we evaluated the
collective variables for the 300 K trajectory, calculating the potential of mean force (PMF)
for the equilibrated 150 ns data on each CV based on the same grid dimensions used for
the BEMD reconstruction (Table 5.1). In this case the corresponding errors are calculated
by dividing the data into two blocks (eq. 5.7).
As plotted in Figure 5.3, the two methods show free energy minima on each collective
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Figure 5.3: Comparison of free energies projected along a single collective variable obtained
from T-REMD, reweighted BEMD, and the BEMD neutral replica. Collective variables
are CV1: hydrophobic contacts coordination number, CV2: α-RMSD of residues 8-22,
CV3: α-RMSD of residues 22-36, CV4: parallel-β-RMSD, CV5: anti-parallel-β-RMSD,
CV6: Cα-Cα contacts coordination number, CV7: correlation of dihedral ψ angles. Error
bars for BEMD are calculated as described by Marinelli et al.(see the text) and for REMD
and neutral replica by dividing the data into two blocks.
variable at the same values for most of the CVs: 15, 0.5, 0.5, 0.25, 0.25, 95 and 21, respec-
tively, for coordination number of hydrophobic side-chain contacts, α-RMSD of residues
8-22, α-RMSD of residues 22-36, parallel β-RMSD, anti-parallel β-RMSD (here, BEMD
shows a minimum 0.4 kJ/mol lower at 0.75 than at 0.25), coordination number of Cα-Cα
contacts (here T-REMD shows a minimum 0.7 kJ/mol lower at 115 than at 95), and cor-
relation of ψ dihedral angles. In general, the free energy profiles of both methods show
agreement within their error ranges. In particular, the shapes of the one dimensional pro-
files indicate the same behavior up to about 10 kJ/mol for all the CVs. Only CV3 shows a
slight discrepancy over the range of values from 1.5 to 3.5, which is due to a computational
detail in the calculation of secondary structure as discussed later. The neutral replica also
shows similar profiles, too. It is worth noting that BEMD usually allows the free energy to
be determined for CV values of higher free energy and, consequently, over a greater part
of the conformational space of the peptide than with T-REMD. This also explains why
we see greater deviation between the T-REMD and BEMD free energy profiles at higher
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free energies, where the PMF evaluation of the T-REMD trajectory is based on very few
events.
For IDPs, which have a flat free energy landscape, one cannot assess convergence based
on the free energy between two states (characterized by different CV values), as in the case
of a two-state folder. However, one can still obtain useful information from the convergence
of free energy surface as a function of simulation time. As shown in Figure 5.4 free energy
profiles for both T-REMD and BEMD converge rapidly for most CVs, but the slowest CVs
require significant additional time.
Naturally, secondary structures are of great importance for an IDP such as hIAPP,
which has an amyloidogenic nature, as amyloid fibrils are described by a high content
of β-sheets147. Moreover, helical intermediates are proposed to serve as an intermediate
preceding the formation of β-sheets137,206. Therefore, one must be able to obtain secondary
structures accurately, independent of the simulation technique, in order to definitively
evaluate biophysical properties.
Secondary structure assignments for each frame of the output trajectories were de-
termined using the DSSP algorithm48. Both mean and per-residue secondary structures
were averaged over the equilibrated T-REMD trajectory. In order to determine the cor-
rect ensemble averages for the BEMD, the number of residues assigned to each secondary
structure was reweighted based upon the free energy of the microstate to which each frame
belongs (see methods), taking the relative error into account as well. Figure 5.5A shows the
average number of residues of hIAPP in each particular structure; 5-helix, which was negli-
gibly populated is not shown here. For the 37 residue long hIAPP, both methods compare
extremely well with each other for all structure types, usually within 1 residue. Consistent
with the disordered nature of the peptide, we observe a high preference for unstructured
motifs (coil, bend and turn), moderate residual helical conformations (around 20%), and
very low β-sheet-like structures (6%). In order to further elaborate on the secondary struc-
ture comparison, assignment of per-residue secondary structures is shown in Figure 5.5B.
While propensities for particular structures agree very well for the majority of the struc-
tures at per-residue level, appreciable differences appear in α- and 3(10)-helical structures.
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A. REMD
B. BEMD
Figure 5.4: The one-dimensional free energy profiles along each CV, shown as they develop
with simulation time per replica, for A. T-REMD and B. BEMD. Each curve shows the
free energy profile calculated from the trajectory over the given time interval.
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Figure 5.5: A. Average number of residues in various types of secondary structures from
T-REMD, reweighted BEMD, and the BEMD neutral replica. B. Per-residue fractions of
secondary structures from T-REMD, reweighted BEMD, and the BEMD neutral replica.
Error bars are calculated from block averages for REMD and neutral replica of BEMD and
from errors of microstate free energies for BEMD.
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When summed together as the total helix fraction, α + 3(10)-helices (Figure 5.5B) shows
fairly strong agreement between BEMD and T-REMD, especially over residues 8-37. This
further explains the discrepancy between the one dimensional profiles along CV3 (α-RMSD
for residues 22-36), shown in Figure 5.3. This collective variable detects only the presence
of standard α-helices, whereas the T-REMD simulation shows a lower α-helix propensity
than BEMD over this region in favor of 3(10)-helices. As a result, the T-REMD simulation
is assigned a higher free energy for more extended helices. Given the close match of the
probability distributions for the total helix fraction in this specific region, the relative free
energy projections for α+3(10)-helices would also be the same. Conversely, in the same
panel of Figure 5.5B there is poor agreement over residues 2-7. Here, helical propensity is
reduced in favor of increased turn propensity for BEMD (Figure 5.5B). This is likely due
to the fact that the first 7 residues were excluded from the α-RMSD bias (see Methods).
Consequently, this exclusion slows down the convergence of helical fraction in that region
and causes the mismatch between the results from BEMD and T-REMD. The formation of
α-helices is a relatively simple process (compared to β-sheet formation), yet including these
residues in CV7 (dihedral angle correlation) was not sufficient. This finding clearly high-
lights the importance of extending all relevant collective variables in the biasing scheme to
the entire sequence for higher efficiency, and in particular indicates the value of secondary
structure collective variables for appropriate sampling.
The multidimensional reconstruction of the free energy in BEMD allows for the more
meaningful representation of free energy surfaces in higher dimensions, such as in the
three dimensional projection along the two α-RMSD variables and the coordination of Cα
contacts in Figure 5.6A. The red, blue and yellow isosurfaces correspond to free energy
surfaces at 1, 2 and 3 kcal/mol, respectively. Representative structures from the lowest
free energy microstates of the BEMD simulation are also shown. As expected given the
intrinsically disordered nature of the peptide, the system shows a shallow, flat region
of low free energy which is characterized by unstructured conformations or very short
secondary structure elements. Beyond this region, the free energy increases rapidly, as
shown previously in the one dimensional profiles of Figure 5.3. For comparison with the
77
2.4 kJ/mol 
CV2=0.5 
CV3=1.5 
CV6=95
2.2 kJ/mol 
CV2=3.5 
CV3=2.5 
CV6=95
CV3 CV2
40
50
60
70
80
90
100
110
120
CV6
130
2.6 kJ/mol 
CV2=4.5 
CV3=2.5 
CV6=95
1
2
3
4
5
6
7
1
2
3
4
5
6
0.0 kJ/mol 
CV2=0.5 
CV3=3.5 
CV6=115
2.3 kJ/mol 
CV2=0.5 
CV3=2.5 
CV6=95
10.6 %  
CV2=0.5 
CV3=1.5 
CV6=115
8.3 % 
CV2=0.5 
CV3=0.5 
CV6=95
6.1 % 
CV2=1.5 
CV3=1.5 
CV6=115
4.7 % 
CV2=7.5 
CV3=4.5 
CV6=125
4.1 % 
CV2=2.5 
CV3=2.5 
CV6=95
A.
B.
Figure 5.6: A. The free energy landscape of hIAPP as a function of three collective
variables—CV2: α-RMSD of residues 8-22, CV3: α-RMSD of residues 22-36, and CV6:
coordination number of Cα-Cα contacts. Isosurfaces are shown at 1 (red), 2 (blue), and 3
(yellow) kcal/mol. Low free-energy clusters from BEMD simulation are also shown with ar-
rows; their weights are indicated as free energies (kJ/mol). The C-terminus of the peptide
is indicated with a blue sphere. B. Central structures of the five most populated back-
bone clusters from T-REMD simulation within a 0.3 nm cutoff distance. The population
percentages and average values of collective variables are indicated below each structure.
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BEMD simulations, we also performed backbone clustering analysis of the equilibrated
300 K T-REMD trajectory using the gromos method167 with a 0.3 nm cutoff distance.
The representative structures of the top five populated clusters are shown along with
their corresponding average CV values 5.6B. Though the two clustering algorithms are
completely different, the low free energy regions of the BEMD simulation and top populated
clusters of the T-REMD simulation also show similar structures. Both methods capture
similar disordered and partially helical states, as shown by collective variable values. Again,
the small visual differences are mainly due to the lower helicity over residues 2-7 in BEMD.
5.4 Conclusions
The exploration of the configuration space, while possible207, is not always feasible by brute
force MD. Here we investigate an IDP ensemble employing two enhanced sampling methods,
T-REMD and BEMD. We perform a comparative analysis of all-atom explicit solvent
simulations of hIAPP and describe the steps we took to perform T-REMD and BEMD
simulations for appropriate sampling and analyze the respective data. Using the data,
we determine the free energy landscape and secondary structures. Our results show that
both methods yield highly consistent results, based on free energies projected along several
different reaction coordinates (especially at lower free energy values) and on secondary
structure analysis. Results from the two methods agree not only in the average secondary
structure values of the entire peptide, but also on the local per-residue level of secondary
structure analysis. Though BEMD yields lower helical propensity than T-REMD, it is due
to the selection of CVs, as we excluded residues 2-7 from α-RMSD biasing. This finding,
however, reveals the necessity of exercising great caution in the selection of CVs to obtain
the most efficient sampling. We have also employed an unbiased (neutral) replica in BEMD
which yields comparable free energy surfaces and secondary structures.
Fundamentally, both methods appear to be highly suitable for studying the structural
properties of intrinsically disordered proteins. In particular, BEMD simulations show the
capability to assess the free energy for larger regions of the conformational space, with
less simulation time. In principle, BEMD simulations can assess the free energy for larger
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regions of the conformational space with less simulation time. However, an additional
computational cost is associated with evaluating CVs and can be quite high depending
on the complexity of the CV calculation. Initial benchmarking of the system in order to
decide on appropriate CVs, as well as additional steps for data analysis are also needed
in BEMD. Additionally, T-REMD inherently provides temperature dependent data on the
system. Though we do not use temperature dependent data in this work, such information
can provide the means to investigate the temperature dependence of IDPs properties37,208
or folding thermodynamics for globular proteins209,210. We note that it is feasible to
extract temperature dependent properties over a small temperature range from BEMD
simulations performed at a single temperature using the approach described by Marinelli
et al.183 The suitability of BEMD for IDP sampling was already shown in a recent work
by Do et al. for a 20 residue-long peptide186 together with a comparison with a long
unbiased MD simulation and well-tempered metadynamics. Here, we present comparison
of BEMD results for a longer IDP (37 residues) with another well-established enhanced
sampling method, T-REMD. In addition, we highlight the practical differences in both
performing and analyzing simulations with these two popular methods and provide useful
guidelines to investigate the properties of IDPs. We can suggest a similar set of CVs for
IDPs of similar or even greater length, but depending on the length, regional division of
secondary structure collective variables may need to be reconsidered. As mentioned in
the introduction, enhanced sampling methods are not limited to T-REMD and BEMD.
Promising methods include parallel tempering in the well-tempered ensemble177,192,211–215
and solute tempering176,216–218, both of which can alleviate the computational expense of
T-REMD and will also be worth studying in future.
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Chapter 6
Effects of Post-translational
Modifications on IDPs
6.1 Introduction
Post-translational modifications (PTMs), such as the formation of disulfide bridges, acety-
lation, amidation, methylation, phosphorylation and glycosylation, are ubiquitous in eu-
karyotic cells219. PTMs can regulate protein function by introducing functional groups on
protein surface that can provide recognition sites for binding to their target molecules220.
Alternatively, PTMs can also regulate the protein function by modulating folding/misfolding
mechanism and stability221–223. Glycosylation is one of the most common PTM which pro-
vides the largest proteome diversity compared to other PTMs, as glycosylation incorporates
diverse selection of sugars, branching and length of glycan chains as well as glycosidic link-
ages224. Previous experimental work on glycosylation of globular proteins have indicated
that glycosylation can affect folding of a protein in terms of its structure, dynamics and
stability225–231.
IDPs can more readily be exposed to the PTMs due to their flexible nature171,232,233.
Larger focus in the literature has been directed to the PTMs of IDPs and IDRs which
are associated with specific disease conditions. Phosphorylation of several IDPs including
tau234,235, disordered region of Cx43236, p53237 and CREB KID238,239 proteins have been
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shown to carry functional and disease relevant effects. Several IDPs are also known to be
O-linked glycosylated including amylin240, tau241–243 and amyloid precursor protein243,244.
However, our understanding of how glycosylation affects the physical properties of IDPs is
limited compared to the globular proteins. In principle, glycosylation can modulate func-
tional properties of IDPs by imparting structural changes and/or by introducing functional
groups on protein(s) that can change their binding affinity. In this part of the work, we
specifically focus on the first question, that is what are the changes caused by O-linked
glycosylation in the IDP structural ensemble? To address this question faithfully, we per-
form replica exchange molecular dynamics simulations of glycosylated and unglycosylated
tau174−183 fragment as well as full-length human islet amyloid polypeptide (hIAPP). Our
simulation data for both peptides indicate that size and transient sampling of residue-level
secondary structures are only affected modestly in the presence of O-linked glycosylation.
Based on these results, we hypothesize that the functional role of O-linked glycosylation on
IDPs is primarily in terms of changing their binding characteristics rather than monomeric
structural properties.
6.2 Model and Simulation Methods
To investigate the effects of glycosylation on IDP structure, we select two different IDPs
– a 10-residue fragment of tau protein, tau174−183 and 37-residue human islet amyloid
polypeptide (hIAPP). Using GROMACS-4.5.641,193, we perform replica-exchange molec-
ular dynamics (REMD)45 simulations to sample the heterogenous ensembles of these
IDPs113,153,179,181,182. The enhanced sampling in REMD is achieved by periodic exchanges
with high temperature replicas, which can overcome barriers in the potential energy land-
scape. Swaps between adjacent temperature replicas are periodically attempted, and ac-
ceptance of exchange is based on a Metropolis criterion, which ensures Boltzmann distri-
bution at each simulation temperature. We adjust replica temperatures, initially based
on geometric spacing between 300 K and highest temperature of interest, to obtain uni-
form acceptance probability (of approximately 20%) between all adjacent replica pairs245.
Tau174−183 and hIAPP monomers are solvated in a truncated octahedron box with 3.8 nm
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and 6.6 nm spaced faces, respectively, and ions are added to neutralize the system charges.
Electrostatic interactions are calculated using the particle-mesh Ewald method47 with a
real space cutoff of 0.9 nm. A 1.2 nm cutoff is used for the van der Waals interactions.
System are propagated using stochastic Langevin dynamics with a friction of 1 ps−1.
Amber ff03* (Amber ff03246 with modified Ψ potential247) and Charmm36248 are
two modern force fields for protein simulations for which carbohydrate parameters GLY-
CAM06j249 and Charmm36-carbohydrates250–252, respectively, are also available. We note
that recent protein force fields in conjunction with TIP4P/2005 (or TIP4P-Ew or TIP4P-
D) water model may be more suitable253–255 for IDP simulations but their integration with
available carbohydrate parameters has not been validated. Nonetheless, the protein force
fields used here can capture accurate secondary structure balance209, solution properties
of short disordered peptides247, mutational effects on peptide folding stability15, etc. We
perform our simulations for each unglycosylated and glycosylated peptide by employing
both the force fields along with the TIP3P water model256. For Amber03* simulations,
we generate initial coordinates and topology using AmberTools257 and convert these to
the GROMACS compatible coordinates and topology using ACPYPE258. For Charmm36
simulations, we implement the necessary monosaccharides and glycosylated amino acids in
the GROMACS version of the Charmm36 force field.
Twenty four replicas within a temperature range of 300-545 K and forty replicas in a
temperature range of 300-500 K are used for tau174−183 and hIAPP peptides, respectively.
Exchanges between adjacent replicas are attempted every 1 ps. Each tau or hIAPP peptide
is simulated for 100 ns per replica and 150 ns (at least) per replica, respectively. All
the replicas in each simulation are initiated from extended coil structures. We check the
convergence and equilibration time by measuring the radius of gyration (Rg) and end-to-
end (E2E) distance of the peptides with respect to time of 300 K replica and also show
their distributions for two equal non-overlapping blocks after equilibration time (Figures 6.1
and 6.2, for tau174−183 and hIAPP, respectively).
We also calculate dihedral angle ω, the angle of right-handed rotation around C-N
bond (Xaa-Pro), for all proline residues of tau peptides for both force fields and for both
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Figure 6.1: Normalized Rg and E2E distance distributions of unglycosylated and glyco-
sylated tau peptides for first (black) and second (red) halves of the equilibrated data for
Amber03* (left) and Charmm36 (right) force fields.
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Figure 6.2: Normalized Rg and E2E distance distributions of unglycosylated and glycosy-
lated amylin peptides for first (black) and second (red) halves of the equilibrated data for
Amber03* (left) and Charmm36 (right) force fields.
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Figure 6.3: Top: Change in dihedral angle ω, the angle of right-handed rotation around
C-N bond, of proline residues of tau peptide for both force fields and both for unglycosy-
lated/glycosylated forms. Value returns zero, when CA-C bond of preceding residue is cis
to N-CA bond. Bottom: Normalized probability distributions of diheral angles ω plotted
in top panels.
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Figure 6.4: Simulated peptides in this work. Cyan circles and green rectangles represent
unmodified amino acids and peptide termini cappings, respectively. Amino acids repre-
sented with yellow and red circles indicate disulfide bonded amino acids and O-glycosylated
amino acids, respectively. Glycans are represented with a nomenclature consistent with
CFG notation (see the main text) Yellow circle: D-Galactose (Gal). Yellow square: D-
Galactosamine (GalNAc). Blue square: D-Glucosamine (GlcNAc).
unglycosylated and glycosylated forms (Figure 6.3). As all our simulations start from trans
configurations for all prolines and we observe trans-cis isomerization only rarely during our
simulations (1 or 2 replicas), our results are not significantly affected by the presence of
proline cis configurations. While cis isomers of Xaa-Pro bonds might be an important
component of the biologically relevant conformational fluctuations of IDPs, disordered and
ordered proteins have similar occurrence percentages of cis isomers of Xaa-Pro peptide
bond (∼5-10%), on average259. Therefore, the use of these classical protein force fields
should reasonably be reflecting cis/trans isomerization of Xaa-Pro peptide bond for IDPs,
too. Though, our timescales might be short to observe statistically significant number of
cis/trans isomerization events, it is known that O-glycosylation does not particularly affect
cis/trans occurrences, at least for prolines following glycosylation sites259,260.
Structural clustering analysis is performed based on the gromos method167.
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6.3 Results
6.3.1 Tau
Tau is a microtubule-associated protein in the brain that is up to 441-residue long for the
longest isoform; it has multiple functional domains including proline-rich domain (PRD)
and tubulin-binding domain (TBD) with four repeats261. Tau is a highly soluble protein in
its monomeric unbound state which is classified as an IDP262, however it forms abnormal
fibers in several neurodegenerative diseases (taupathies) including Alzheimer’s disease263.
Alzheimer’s disease is characterized by the deposits of fibrils formed by amyloid-β (Aβ)
peptide and tangles of hyperphosphorylated forms of tau which contain paired helical
filament (PHF) structures243. Many potential phosphorylation sites in aggregated tau has
been identified in the PRD of tau264. It has also been shown recently that single O-linked
β-N-acetylglucosaminylation (O-GlcNAcylation) can compete with phosphorylation and
affect the phosphorylation state of the protein265–269. Here, we simulate a short fragment
from PRD of tau protein, tau174−183. O-GlcNAcylated and phosphorylated forms of the
same fragment were previously used by Zondlo and coworkers242. Sequences of selected
fragment both in the absence and in the presence of O-GlcNAcylation are illustrated in
Figure 6.4, where glycans are represented with the Consortium for Functional Glycomics
(CFG) notation270. Equilibrium ensembles of tau174−183 peptides, which will be referred
shortly as tau hereafter, are obtained from REMD simulation and further analyzed both
in the absence and presence of a type of O-linked glycosylation, O-GlcNAcylation.
As a measure of characteristic chain dimensions, we calculate the distributions of ra-
dius of gyration (Rg) and end-to-end (E2E) distance from unmodified and O-GlcNAcylated
ensembles of tau as shown in Figure 6.5. Both force fields (Amber03* with GLYCAM06j
and Charmm36) yield very similar distance distributions showing peak population around
similar values of Rg (∼0.8 nm) and E2E distance (∼2.5 nm) for unglycosylated ensembles.
For Amber03* force field, the distance distributions for the O-GlcNAcylated tau peptide
are essentially unchanged from the unglycosylated form, thereby suggesting no effect of gly-
cosylation on peptide dimensions. However, unglycosylated tau ensemble with Charmm36
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Figure 6.5: Radius of gyration (Rg) and end-to-end (E2E) distance distributions of un-
modified (black) and O-GlcNAcylated (red) tau for both Amber03*/GLYCAM (left) and
Charmm36 (right) protein and glycan force fields. Errors are the blocked standard errors
calculated from the standard deviation among the block averages by dividing data into
10 equal non-overlapping blocks. Snapshots represent typical configurations sampled in
subpopulations indicated by arrows (green residues illustrate attached glycans).
force field has an additional peak around a smaller Rg (∼0.5 nm) and E2E distance (∼0.9
nm), which disappears from the glycosylated peptide distributions. The third most popu-
lated structural cluster of unglycosylated tau (Figure 6.6, row three, column three) shows
typical structures corresponding to this region.
Number of studies have previously suggested that heterogenous ensembles of IDPs can
transiently sample functionally important partially structured conformations66,271,272. As
a direct measure of structure formation, we calculate the populations of common secondary
structure elements in unmodified and O-GlcNAcylated ensembles of tau using the DSSP
algorithm48. Top row of Figure 6.7 shows average fraction of particular structures for
both force fields. As expected for a 10-residue peptide, with five proline residues, coil-
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Figure 6.6: Top three clusters (from left to right) formed upon clustering analysis of ung-
lycosylated and glycoyslated tau174−183 trajectories at 300 K for both Amber03* (top)
and Charmm36 force fields (bottom). Clustering analysis are perfomed within 0.15 nm
RMSD cutoff distance. Complete population of clusters are illustrated with coloring based
on residue numbers. From red to blue: from C-terminus to N-terminus. Two pictures in
each cluster of glycoyslated ensembles are identical except that the one on the right side
additionally shows glycans with paperchain representation.
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Figure 6.7: DSSP-based secondary structures of unmodified (black) and O-GlcNAcylated
(red) tau with Amber03* and Charmm36 force field both for total fractions of secondary
structure elements (top) and per-residue secondary structure propensities (bottom). Errors
are the blocked standard errors calculated from the standard deviation among the block
averages by dividing data into 10 equal non-overlapping blocks. Glycosylation sites are
given in underlined bold font.
like states (based on DSSP definition, for which ppII helices are also counted in “coil”
configurations) are populated mostly for both the force fields and insignificant fractions of
α and β structures are found. All three DSSP defined secondary structure elements, coil,
bend and turn, fractions are also very similar for both the force fields. Additionally both
force fields show little differences between unglycosylated and glycosylated forms of the
peptide. To further elaborate the picture, we also show per-residue secondary structure
fractions in Figure 6.7 (bottom) for both the force fields. At the residue-level, Amber03*
simulations yield little differences between unglycosylated and glycosylated tau, with the
largest change being a ∼15% increase in the “bend” propensity in one of the glycosylated
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threonines (THR-8). Dominant clusters of unglycosylated and glycosylated peptides with
Amber03* force field also exhibit very similar structural features (Figure 6.6, top) which
are further evidences of unchanged structural properties of tau with O-GlcNAcylation.
For Charmm36, while all residues are mostly found in coil-like configurations (similar to
Amber03*), PRO-6 and LYS-7 residues of unglycosylated tau show ∼15% turn propensity,
which is significantly decreased in the O-GlcNAcylated form of the peptide. The third
most persistent structural cluster of unglycosylated tau (Figure 6.6, row three, column
three) shows a relatively compact population, in which the residues PRO-6 and LYS-7
are in the turn structure. Residues PRO-6 and LYS-7 in the unglycosylated tau ensemble
with Amber03* have ∼7% turn fraction, which also decreases in the O-glycosylated tau.
However, this decrease is more prominent in the case of Charmm36 force field, as the
unglycosylated tau has higher turn fraction in this force field as compared to the Amber03*.
In addition to the DSSP based secondary structures, we also calculate secondary struc-
tures based on the (φ, ψ) angles of each residue in the Ramachandran map, which will allow
us to assign ppII helices separately. We classify the (φ, ψ) space as, αR: −160◦ < φ < −20◦
and −120◦ < ψ < 50◦, β: −180◦ < φ < −90◦ and 50◦ < ψ < 240◦ or 160◦ < φ < 180◦ and
110◦ < ψ < 180◦, ppII: −90◦ < φ < −20◦ and 50◦ < ψ < 240◦, αL: 30◦ < φ < 100◦ and
0◦ < ψ < 80◦ and coil: everything else151.
Average fractions sampled in αR, β, ppII and αL regions in (φ, ψ) maps are calculated
for each residue as shown in Figure 6.8. With Amber03* force field, O-GlcNAcylated THR-
2 residue shows the largest change; ∼15% reduction in ppII and increase in β population as
compared to the unglycosylated THR-2. Similar decrease in ppII population was reported
by Zondlo and coworkers242, however the observed change is less pronounced in our case
(15% for a single residue as opposed to over the whole sequence). Other residues exhibit
very small changes in the secondary structure population due to O-GlcNAcylation with
Amber03* force field.
To identify the formation of cooperative secondary structures,we also calculate “SS-
maps” of unglycosylated and glycosylated tau peptides for both the force fields. SS-maps
are further informative on the length and propensity of secondary structure elements as
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Figure 6.8: Per-residue secondary structure propensities of unglycosylated (black) and O-
GlcNACylated (red) tau with Amber03* (left) and Charmm36 (rigth) force field based on
the fraction sampled in (φ, ψ) map (see main text). Glycosylation sites are given in bold
text. Errors are the blocked standard errors calculated from the standard deviation among
the block averages dividing data into 10 equal non-overlapping blocks.
they find the longest possible block of a particular secondary structure based on (φ,ψ)
sampling. Figure 6.9 shows SS-maps of ppII structure for both the force fieldsx- and y-
axes indicate the length of the secondary structure block and the residue interval of that
block, respectively. To interpret the data on these maps, we can consider the following
example. There is a 5-residue-long light blue block on ppII map of unglycosylated tau
peptide for Amber03*, and an arrow points a typical structure involving the secondary
structure (ppII) in that particular block (opaque region of the snapshot). This light blue
block indicates that there is 5-residue-long (x-axis) ppII helix between residues 2 and 6
(y-axis) with an approximate propensity of 0.15-0.2 (color code). If there is any common
residue in different blocks of same length, propensity will add up for that particular residue
index. As we use the same (φ, ψ)-based description of α (αR), β and ppII structures as
above, the sum of propensities over x-axis for each residue (indicated on y-axis) corresponds
residual propensity of the same structure (Figure 6.8). By comparing unglycosylated and
glycosylated tau peptide SS-maps (Figure 6.9), one can observe that most features are
conserved for both the force fields, which is a further evidence that glycosylation has
relatively little effect on the structural properties of this peptide. As a further evidence,
we also compute the contact maps of both unglycosylated and glycosylated ensembles, in
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Figure 6.9: SS-maps representing ppII helices for tau ensembles in unglycosylated (top) and
O-GlcNAcylated (bottom) forms for Amber03* (left) and Charmm36 (right) force fields.
Color code indicates propensities. Snapshots represent typical ppII helical configurations
sampled in ensembles, which are also observed in SS-maps as indicated by arrows (green
residues illustrate attached glycans).
which the entry for each pair of residues (i, j) represents the fraction of time that at least
one heavy (i.e. non-hydrogen) atom of backbone from residue i and one from residue j are
within 0.8 nm of each other, averaged over the ensemble. Contact maps also show that
high propensity interactions of glycans with protein residues are only local (Figure 6.10).
Next, we study the unglycosylated and O-glycosylated forms of a longer hIAPP peptide
to further identify the structural changes induced by O-glycosylation.
6.3.2 hIAPP
In addition to a short tau fragment, we also perform simulations of a 37-residue peptide,
human amylin, which functions as a synergistic partner of insulin273. In its monomeric
state, hIAPP is normally a soluble protein and can be classified as an IDP274. Pan-
creatic islet amyloids with hIAPP as the major protein component characterize type II
diatebetes125, however. hIAPP has several potential O-linked glycosylation sites. Among
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Figure 6.10: Contact maps of tau ensembles without (upper left triangle) and with (lower
right triangle) O-linked glycosylation. Contoured are contact probabilities of all heavy
atoms, i.e., non-hydrogens, in 8 A˚ cutoff distance, averaged over the equilibrium ensembles.
Residue indices are indicated on peptide sequences (right) where glycans are counted as
separate residues (13 and 14) to distinguish their contacts with other glycans and/or amino
acids.
them, THR-6 and THR-9 are known to have O-linked glycans275,276. Literature data has
not shown a clear association between hIAPP glycosylation and type II diabetes so far.
But as 50% of circulating hIAPP is found to be glycosylated276,277, there might be an
associated functional role. We simulate O-glycosylated hIAPP with the core of its known
O-linked glycans275, as previous studies have shown that primary conformational effects of
glycosylation comes from the core of glycans227,278.
First, we calculate the distributions of Rg and E2E distance in unglycosylated and
glycosylated forms of hIAPP as shown in Figure 6.11 both for Amber03* and Charmm36
force fields. The average Rg of glycosylated hIAPP monomer (based on protein backbone
atoms, 0.92 nm and 1.22 nm, respectively for Amber03* and Charmm36) are similar to
that of unglycosylated hIAPP monomer (0.91 nm and 1.20 nm, respectively for Amber03*
and Charmm36). The Rg and E2E distributions are also quite similar for the Amber03*
force field but these are slightly different for the Charmm36 force field, especially for short
E2E distances. Similar to the tau peptide (Figure 6.5), we find that this short E2E distance
population is reduced in the glycosylated peptide for the Charmm36 force field.
Next, we calculate the propensities of DSSP-defined secondary structure elements in
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Figure 6.11: Radius of gyration (Rg) and end-to-end (E2E) distance distributions of un-
modified (black) and O-Glycosylated (red) ensembles of hIAPP with Amber03*/GLYCAM
(left) and Charmm36 (right) force fields. Errors are the blocked standard errors calculated
from the standard deviation among the block averages by dividing data into 10 equal
non-overlapping blocks.
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Figure 6.12: DSSP-based secondary structures of unmodified (black) and O-Glycosylated
(red) hIAPP with Amber03* and Charmm36 force field both for total fractions of secondary
structure elements (a) and per-residue secondary structure propensities (b). Errors are the
blocked standard errors calculated from the standard deviation among the block averages
dividing data into 10 equal non-overlapping blocks. Glycosylation sites are indicated with
red dashed lines in per-residue plots.
the equilibrium ensembles of unmodified hIAPP and O-Glycosylated hIAPP. Figure 6.12a
shows average fraction of particular structures for both the force fields. Similar to tau pep-
tide, again for both force fields in either form of the peptide (unglycosylated/glycosylated),
coil-like structures (coil/bend/turn) are the most dominant type of DSSP based secondary
structures, as expected for an intrinsically disordered peptide. However, unlike tau, hIAPP
has significant helical and β-sheet fractions for Amber03* and Charmm36 force fields, re-
spectively. In the presence of glycosylation, these total helical and β sheet fractions, respec-
tively for Amber03* and Charmm36, are observed to decrease in favor of coil-like structures.
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Figure 6.13: Per-residue secondary structure propensities of unglycosylated (black) and O-
glycosylated hIAPP (red) with Amber03* (left) and Charmm36 (right) force fields based
on the fraction sampled in (φ, ψ) map (see main text). O-glycosylation sites are indicated
with red dashed lines. Errors are the blocked standard errors calculated from the standard
deviation among the block averages dividing data into 10 equal non-overlapping blocks.
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To check if these changes are localized nearby glycosylation sites, we show residue-based
secondary structure propensities in Figure 6.12b. With Amber03* force field, α-helical
structures are populated in two regions of the unglycosylated form of the peptide: N-
terminal region, residues 6-16 and C-terminal region, residues 22-30. α-helical propensity
in the N-terminal region of hIAPP, which also covers the glycosylated residues of the pep-
tide, is significantly decreased in the presence of glycosylation. For this peptide, α-helical
propensity in a certain region, residues 20-29, has a particular importance as several stud-
ies have emphasized that formation of α-helical structures may serve as an important step
preceding the formation of amyloid fibrils11,137,139,206,279. However, we do not observe a
significant change due to glycosylation in this amyloidogenic region (residues 20-29), sug-
gesting that early events in the aggregation process (which are dependent on interactions
between α-helical structures) may not be affected. At the same time, there still might be a
change in the aggregation propensity of these peptides in the presence of glycans, something
that need to be addressed in future. In addition to the DSSP based secondary structures,
Figure 6.13 shows fractions sampled in αR, β, ppII and αL regions (classified as described
in the section above) per-residue. (φ, ψ) fractions of unglycosylated and O-glycosylated hI-
APP for Amber03* (Figure 6.13, left) are very similar except for changes in the αR fraction
observed in N-terminal region. There is an overall decrease in αR fraction in a region close
to the O-linked glycans (residues 7-10) as a local effect of glycosylation, which is consistent
with DSSP based data. With the Charmm36 protein/carbohydrate model, DSSP based
secondary structure assignment of hIAPP show that there is significant β-sheet propensity
in addition to the coil-like structures for the unglycosylated peptide (Figure 6.12). β-sheet
fraction is affected only slightly in the presence of glycosylation, with a decrease in certain
small regions, specifically 12-15 and 27-32, while the fractions of other secondary struc-
tures remain very similar. (φ-ψ) based structures (Figure 6.13-right) also yield very similar
fractions, both in unglycosylated and glycosylated forms of the peptide.
We also calculate SS-maps of unglycosylated and glycosylated hIAPP ensembles for
both the force fields to identify the formation of cooperative structures. For this peptide,
α (Amber03*) and β (Charmm36) structures are most prominent, therefore, SS-maps of
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Figure 6.14: SS-maps representing α (Amber03*) and β (Charmm36) structures for hI-
APP ensembles in unglycosylated (top) and O-Glycosylated (bottom) forms for Amber03*
(left) and Charmm36 (right) force fields. Color code indicates propensities. Snapshots
represents relatively longer structured conformations (α-helical for Amber03* and β-sheet
for Charmm36) found in SS-maps (green residues illustrate attached glycans).
these structures are illustrated in Figure 6.14. While most prominent structure (β) is not
significantly affected in the presence of glycans for Charmm36 force field, N-terminal α-helix
structures disappear for the Amber03* force field in the presence of glycans. Three most
populated clusters (using 0.3 nm RMSD cutoff applied to backbone atoms) of glycosylated
and unglycosylated hIAPP ensembles with both force fields can also be seen in Figure 6.15
(Amber03*) and Figure 6.16 (Charmm36). As the unglycosylated forms of the hIAPP
peptide populates different secondary structures with the two force fields used here, it is
somewhat difficult to make conclusions about the role of O-linked glycosylation in this
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Figure 6.15: Top three clusters (from left to right) formed upon clustering analysis of
unglycosylated and glycoyslated hIAPP trajectories at 300 K for Amber03* force field.
Clustering analysis are perfomed within 0.30 nm RMSD cutoff distance. Two pictures in
each cluster of glycoyslated ensembles are identical except that the one on the right side
additionally shows glycans with paperchain representation.
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Figure 6.16: Top three clusters (from left to right) formed upon clustering analysis of
unglycosylated and O-glycoyslated hIAPP trajectories at 300 K for Charmm36 force field.
Clustering analysis are perfomed within 0.30 nm RMSD cutoff distance. Two pictures in
each cluster of glycoyslated ensembles are identical except that the one on the right side
additionally shows glycans with paperchain representation.
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particular case. We do note that β-sheet structures are known to be over-stabilized in the
Charmm36 force field280.
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Figure 6.17: Contact maps of hIAPP ensembles without (upper left triangle) and with
(lower right triangle) O-linked glycosylation. Contoured are contact probabilities of all
heavy atoms, i.e., non-hydrogens, in 8 A˚ cutoff distance, averaged over the equilibrium
ensembles. Residue indices are indicated on peptide sequences (right) where glycans are
counted as separate residues (39, 40, 41, and 42) to distinguish their contacts with other
glycans and/or amino acids.
Contact maps of glycosylated ensembles (Figure 6.17, below diagonal) reveal that high
propensity contacts of glycan residues are mostly short range with residues adjacent to the
glycosylated residue in the primary sequence. The moderate propensity contacts of glycans
in a longer range in Amber03* case is likely to be natural consequence of protein itself being
compact in the ensemble. Similarly, for Charmm36 force field, a moderate propensity
contacts of glycans in region 25-32 is likely to be a consequence of the peptide having
β-hairpin structures, rather than being specific to certain protein-carbohydrate pairs. As
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evident from DSSP and SS-map plots, this region (25-32) corresponds to a complimentary
strand of β-hairpins formed, hence, it naturally forms contacts with residues 6-15, which
includes glycosylated residues, as well.
6.4 Conclusions
Due to the intrinsic diversity of monosaccharides and glycosylation patterns, glycosyla-
tion is an effective way to increase proteome diversity after translation. Because of their
flexible nature, IDPs have larger access to O-linked glycosylation, which can be associ-
ated with their function or disease relevant mechanism like amyloidosis or aggregation.
As known from globular proteins, glycosylation can modulate functional properties of pro-
teins by altering (i) protein structure or (ii) their binding mechanisms. In this work, we
particularly address the first aspect for O-linked glycosylation. Specifically, we investigate
O-glycosylated and unglycosylated tau174−183 fragment and hIAPP in aqueous solution via
replica exchange molecular dynamics simulations employing two state-of-the-art all-atom
protein and carbohydrate force fields. For tau fragment, we find no significant difference be-
tween unglycosylated and glycosylated ensembles with Amber03* force field, while a small
population of compact structures, which disappears in glycosylated ensemble, is present
in the Charmm36 simulations. Previous work has shown that N-linked glycosylation can
increase the size unfolded proteins, which can be as high as 10%281,282, whereas we found
insignificant size increase with O-linked glycosylation for the cases studied here.
We also perform simulations of unglycosylated and O-glycosylated full-length, 37-
residue hIAPP. DSSP based secondary structure fractions plots for both force fields indicate
that there is a modest decrease in relevant structures (α-helices for Amber03* and β-
sheet for Charmm36) in favor of increased coil propensity especially nearby O-glycosylated
residues. We find that residual secondary structure sampling, specifically α-helices in N-
terminal region, are affected to the largest extent with Amber03* without affecting the
size of the peptide. (φ, ψ) fraction plots show that both for Amber03* and Charmm36,
αR fraction of residues nearby O-glycosylation sites slightly decreases in the glycosylated
ensemble, which is consistent with loss of α-helices in N-terminal region for Amber03*
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force field. It is also important to note that Charmm36 may have a bias towards β-sheet
structure which may yield overstabilized β-structures280 which can explain the reason why
Amber03* and Charmm36 force fields yield different secondary structure characteristics
for the same peptide. However, the major focus of this work is to understand structural
effects of glycosylation on IDPs, and in this respect, both force fields yield highly simi-
lar outcomes: the structural effect of O-linked glycosylation is relatively modest for the
peptides that we study here.
PTMs, for example phosphorylation, might have dramatic structural effects on IDPs
like inducing folding as reported recently by Forman-Kay and coworkers283. Here, we find
that only modest structural changes are introduced by O-linked glycosylation; in some cases
we find a small decrease in secondary structure propensity due to glycosylation or slight
increase in disorder. However, the effect of PTMs could be highly context dependent, for
example, the work by Ganguly and Chen has reported that phosphorylation of KID protein
has shown only marginal changes in average structure, especially helicity239, as opposed
to the induced folding (by phosphorylation) of 4E-BP2 protein of the other study283. Yet,
the underlying conformational substates in phosphorylated KID protein have been reported
to possibly affect its binding and folding upon binding significantly in the same study by
Ganguly and Chen239. In a similar respect, our results highlight that O-linked glycosylation
does not cause a significant secondary structure change at least for disordered peptides that
we study, which might indicate that the function modulating effects of glycosylation on
IDPs could be more relevant with the binding characteristic changes of the IDPs.
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Chapter 7
End-to-end Contact Formation
Kinetics in the Unfolded State
7.1 Introduction
Characterizing the configuration distribution and dynamics within unfolded or disordered
peptides is a first step toward understanding more complex processes such as protein fold-
ing and aggregation284. To this end, contact quenching pump-probe experiments are a
sensitive measure of dynamics in disordered peptides, which can be used to determine loop
formation rates285–288, helix-coil dynamics289,290 and even the folding rate of small pro-
teins291. In these experiments, a probe is excited to a long-lived electronic state which can
be quenched by contact with a second species distant in sequence, allowing chain dynamics
to be monitored. However, as in other experiments monitoring a single intramolecular
distance, interpretation of the data usually requires fairly strong assumptions about the
nature of the probe-quencher distance distribution and dynamics; inclusion of additional
data such as Fo¨rster resonance energy transfer (FRET) efficiencies can help to constrain
the distance distributions292.
No simplifying assumptions are needed if molecular simulations are used to compute
quenching rates directly293 and the distance dependence of the contact quenching rate
is known. In previous insightful work using atomistic simulations to interpret contact
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quenching rates in short disordered peptides it was found that the rates obtained from
simulation needed to be reduced by a factor of 2-3 to match experiment, attributed to
the viscosity of the simulation water model being too low293. However, this assumes
that all rates, including the quenching rate, are slowed by the same factor, which may
not be realistic. In addition, the interpretation is complicated by the collapsed nature
of the disordered ensemble, relative to estimates from FRET, SAXS or light scattering
experiments 57,75,96. Recent physically motivated refinements of protein force fields, have
yielded more accurate equilibrium properties for disordered chains57,58, and should not
require viscosity correction, as they use accurate water models 58,294.
Here, we focus on a set of experiments in which the dynamics of a series of peptides of
composition C(AGQ)nW-NH2 (hereafter: AGQn) was monitored from the rate at which the
triplet state of the tryptophan (W) at one end of the chain was quenched by van der Waals
contact with the cysteine residue (C) at the other end286–288. After optical excitation,
the termini of the peptide will diffuse relative to each other, and may be quenched on
contact. In the extreme “diffusion-limited” scenario, the quenching on contact is so fast
that the observed rate of triplet quenching kobs is just the diffusion-limited rate of contact
formation, kD+. In the opposite “reaction-limited” extreme, quenching is very slow and
the termini must contact many times on average before a quenching event occurs, in which
case the overall quenching rate depends only on the population of the contact states. The
actual rate of quenching is usually somewhere between these scenarios, and so contains
information on both the distance distribution and the dynamics of quenching.
7.2 Simulation and Analysis Methods
7.2.1 Simulation Methods
In order to test the sensitivity of the experiments to the configurational sampling and dy-
namics, we have carried out extensive molecular dynamics simulations of a series of AGQn
peptides, for n = 1 − 6, using three related force fields: the Amber ff03* protein force
field98,295 together with the TIP3P water model296; the Amber ff03w protein force field99,
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which is used in combination with a more accurate water model, TIP4P/2005294; and the
Amber ff03ws protein force field57 which also uses TIP4P/2005 water, but with strength-
ened protein water interactions. Specifically, in ff03ws the values of Lennard-Jones  for all
protein-water atom pairs are scaled by a factor 1.10 relative to the standard combination
rule, in order to correct the overly-collapsed nature of the disordered ensemble57. The sim-
ulations were run using Gromacs 4.5 or 4.6297 at a constant pressure of 1 bar and a constant
temperature of 293 K for a total time of 2-10 µs for each peptide and force field. Initial
conditions were obtained either from short temperature replica exchange simulations, or
from high-temperature runs at constant volume.
In order to obtain initial conditions of serial simulations of n=1,2 peptides, we ran
50 ns/replica parallel tempering in well-tempered ensemble (PTWTE)177,211 simulations,
using 1.2 kJ/mol and 500 kJ/mol as the Gaussian height and width, respectively, for energy
biasing. Eight replicas were used in a temperature range from 300 K to 503 K, using a
bias factor of 8. We keep the 300 K replica neutral, i.e. no energy bias is applied, while
allowing it to exchange with the adjacent replica (a similar application as in214). The last
24 frames of the 300 K replica were picked, which were saved in every 2 ns, to serve as the
initial conditions of serial runs.
Initial conditions for peptides with n = 3 − 6 were obtained by running a 200 ps
constant pressure simulation at 293 K to equilibrate the box size, followed by a 20 ns
constant volume simulation at 500 K. The last frame of the 500 K run was used to initiate
long runs at constant pressure for computing the quenching rates. Simulations were run in
one of three force field combinations: (i) Amber ff03*295 with TIP3P water296, (ii) Amber
ff03w99 with TIP4P/2005 water294, and (iii) Amber ff0ws57, also with TIP4P/2005 water.
Molecular dynamics simulations were run at constant pressure of 1 bar using a Parinello-
Rahman barostat with a coupling time of 5 ps and a compressibility of 4.5 × 10−5 bar−1,
and constant temperature of 293 K using a velocity-rescaling thermostat298 with coupling
time of 1 ps. This thermostat was chosen because it should have a minimal effect on
the dynamics (compared to e.g. Langevin dynamics at high friction). Lennard-Jones
interactions were evaluated every step for atoms separated by up to 0.9 nm and every 10
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steps for atoms separated by between 0.9 and 1.4 nm. Mean-field corrections to energy
and pressure were included for Lennard-Jones interactions beyond 1.4 nm. Long-range
electrostatics were included via the particle-mesh Ewald scheme299 with a grid spacing of
∼ 0.12 nm and a real-space cut-off of 0.9 nm. A summary of the number of runs and
cumulative simulation time for each peptide and force field are listed in Table 7.1.
Table 7.1: Number of runs and total length of runs for each force field and peptide
ff03* ff03w ff03ws
Peptide runs time/µs runs time/µs runs time/µs
AGQ1 24 2.4 24 2.4 24 2.4
AGQ2 24 4.8 24 4.8 24 4.8
AGQ3 8 7.9 8 7.6 8 7.6
AGQ4 8 7.8 8 7.5 8 7.4
AGQ5 8 7.7 8 7.5 8 7.5
AGQ6 5 4.4 5 4.2 10 9.6
7.2.2 Calculation of diffusion coefficients
Fitting of the 1D diffusion model followed a similar method to previous work300–302. The
all-atom simulation trajectories were projected onto the Trp-Cys distance rcw, which was
then discretized into regularly spaced bins spanning the populated range of that coordinate.
The number of bins used was 30 for n = 1− 3 and 60 for n = 4− 6. The increased number
of bins is required in order to described accurately the shorter distances where contact
formation occurs for the longer peptides. Count matrices of the number of observations
Nij from bin j to bin i after a given lag time ∆t were constructed. Best-fit diffusion coef-
ficients and free energies were fitted to these data using the previously described Bayesian
procedure. A lag time of ∆t = 0.1 ns was used for n = 1−2 and a lag time ∆t = 0.5 ns for
n = 3 − 6, in order that the resulting dynamics was approximately Markovian. In Figure
7.1 we show the convergence of the slowest relaxation time of the model with lag time. A
smoothing prior on the similarity of diffusion coefficients Di, Di+1 for adjacent bins i, i+ 1
of the form
P (Di, Di+1) = exp
[
− (Di −Di+1)
2
2γ2(min(Di, Di+1))2
]
(7.1)
was used. A stiffness coefficient of γ = 0.1 was chosen.
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Figure 7.1: Convergence of relaxation times with lag time ∆t for the diffusion model.
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7.3 Calculation of rates from diffusion model using SSS the-
ory
Given the one-dimensionalD(rcw) and equilibrium distribution peq(rcw), the Szabo-Schulten-
Schulten theory303 allows the rate of diffusion-limited contact formation kD+ to be calcu-
lated as287 (for instantaneous quenching at rc):
k−1D+ =
∫ rmax
rc
[ ∫ rmax
r peq(s)ds
]2
D(r)peq(r)
dr (7.2)
For a distance-dependent reaction rate q(rcw), the diffusion-limited rate can be estimated
via:
k−1D+ = k
−2
R
∫ rmax
0
[ ∫ rmax
r (q(s)− kR)peq(s)ds
]2
D(r)peq(r))
dr (7.3)
where kR is the reaction-limited rate:
kR =
∫ rmax
0
peq(r)q(r)dr (7.4)
The above integrals were evaluated over the discretized bins of the diffusion model,
counting for the first bin only the range between rc and the outer edge of the bin.
Lastly, we note that experimental data are usually fit, for simplicity, to a model with a
constant, position-independent, diffusion coefficient Dconst, i.e. D(r) ≡ Dconst. In order to
facilitate comparison with experiment, we can determine the effective Dconst that would re-
sult in the same diffusion-limited quenching rate as we obtain with our distance-dependent
D(r), by defining Dconst via:
1
Dconst
∫ rmax
0
[ ∫ rmax
r (q(s)− kR)peq(s)ds
]2
peq(r))
dr (7.5)
=
∫ rmax
0
[ ∫ rmax
r (q(s)− kR)peq(s)ds
]2
D(r)peq(r))
dr
Essentially, we apply the experimental analysis to our simulated data: we treat our rates
calculated from the full distance-dependent diffusion model as experimental data, and use
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our simulated peq(r) as the Trp-Cys distribution, allowing an effective constant diffusion
coefficient to be obtained.
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Figure 7.3: Decays of tryptophan triplet state. Overall decays calculated from simulations
with the ff03* (black), ff03w (red), and ff03ws (green) force fields are shown for peptides
AGQn for n = 1− 6, together with the corresponding experimental decays (broken purple
lines). Symbols: simulation data; lines: single exponential fits to data.
7.4 Results and Discussion
In order to compare our results directly with experiment, we compute quenching rates
using a step function for the dependence of the quenching rate q on the Trp-Cys separation
rcw, that is q(rcw) = qcH(rc − rcw), where qc = 8× 108 s−1 is the constant quenching rate
in contact, H(x) is the Heaviside step function and rc = 0.4 nm is the contact distance.
The distance rcw is taken as the minimum distance between the sulfur in the cysteine
side-chain and the heavy atoms of the tryptophan indole ring system286,293. The observed
quenching rate is then determined from the decay of the triplet survival probability S(t) =
〈exp[− ∫ t0+tt0 q(rcw(t′))dt′]〉t0 , where the average is over equilibrium initial conditions t0,
obtained by taking every saved frame of the simulation as a valid starting point.
Overall decay curves for the triplet population determined using the step function form
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for q(rcw) are shown in Figure 7.3, compared with experimental decays
287. The simulation
data for Amber ff03ws is in excellent agreement with the experiment for n = 2 − 5 and
reasonably close for n = 6, considering the difficulty of sampling that peptide. As expected,
there are large differences amongst the force fields, with quenching rates for ff03ws being
significantly slower than for those ff03* and ff03w. Part of the difference between ff03*
and ff03ws is expected to be due to the ∼ 3-fold lower viscosity of the TIP3P water model
relative to TIP4P/2005 (the latter being very close to the true value)293. However, this
is clearly not the only effect, since the decay for the ff03w force field, which also uses
TIP4P/2005 water, is only slightly slower than that for ff03*. Therefore, the change in
equilibrium conformational distribution from ff03w to ff03ws must also play a role in the
observed difference.
We summarize the peptide-length dependence of the observed quenching rate in Figure
7.4. This confirms that the observed rate is in excellent agreement with the experimental
data for ff03ws, while at the opposite extreme, ff03* results in rates which are almost
independent of peptide length. The ff03ws results approximately follow an n
3/2
b dependence
of the reaction-limited quenching time on the number of peptide bonds nb, as expected
for a Gaussian chain287. The power law which best fits the data is n1.38±0.12b which is
also in agreement with the trend in experiment toward n
3/2
b for longer AGQ sequences
287,
as well with the fit to data for a different peptide sequence (n1.36±0.26b )
285. Interestingly,
these quenching rates exhibit a very different scaling compared with loop formation rates
in single stranded DNA304.
We can obtain more insight into the contributions to the observed relaxation rate by
splitting it into diffusion-controlled and reaction-controlled parts287, via k−1obs = k
−1
D+ +k
−1
R .
We determine the reaction-limited kR by integrating over the Trp-Cys distance distri-
bution, kR =
∫∞
0 q(rcw)P (rcw)drcw. The diffusion limited rate can be obtained by us-
ing a step function for the survival probability S(t) and averaging over time origins t0,
S(t) = 〈H(tc(t0) − t − t0)〉t0 . Here, tc(t0) is the first time after t0 when the Trp and Cys
contact, H(x) is again the Heaviside step function, and all time points in the simulation
where the probes are not already in contact are used as separate time origins t0. This
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Figure 7.4: Dependence of quenching times (inverse of quenching rates) on chain length.
Top, middle and bottom rows show the overall, reaction-limited and diffusion-limited
quenching times, respectively. Simulation data for Amber ff03*, ff03w and ff03ws are
shown by black, red and green symbols, respectively. Filled and empty symbols are for
step-function and exponential distance dependence respectively. Experimental data are
shown by purple symbols, and n
3/2
b scaling expected for a Gaussian chain by the broken
line. Left panels are rates calculated directly from simulation and right panels are those
calculated from 1D diffusion model using SSS theory.
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calculation (Figure 7.4) reveals that for all of the peptides, the observed rates are in fact
closer to the reaction-limited rates, although there is a non-negligible contribution from
diffusion. Interestingly, the slowdown in the diffusion-limited rate from ff03* to ff03w (by
changing from TIP3P to TIP4P/2005) is very close to the 2-3 fold expected from the change
of water viscosity. There is an additional slowdown in the diffusion limited rate when mov-
ing from ff03w to ff03ws, which presumably arises from the larger configurational space
which must be explored due to the more expanded chain57. In summary, it is clear that
most of the improved agreement with experiment which we obtain by using Amber ff03ws
comes from the reaction-limited rate. A similar calculation using a more sophisticated
distance-dependence of the quenching (Figure 7.4) leads to similar results.
To understand the relationship between the chain dynamics and its structural prop-
erties, we characterize the equilibrium ensemble of conformations by the distribution of
distances between the tryptophan and cysteine, shown in Figure 7.5. These reveal distinct
differences amongst the different force fields, more apparent for larger numbers of AGQ
repeats: the simulations with Amber ff03* and ff03w tend to be quite collapsed, while
those with ff03ws are relatively expanded. Notably, the mode of the distance distributions
for ff03* hardly shifts as a function of chain length n, remaining near ∼ 1 nm. For ff03w,
weak expansion of the chain as a function of n from ∼ 1 to 1.5 nm is observed. In contrast,
AGQn expands with n for the ff03ws force field as expected for a chain in good solvent. We
have quantified the polymer scaling properties of AGQn peptides by fitting the dependence
of the mean Trp-Cys distance on the number of peptide bonds nb to a power law rcw = An
ν
b
(similar results are obtained using the end-to-end distance), with the prefactor A fixed to
0.6 nm for all peptides. The exponents of 0.30 (0.02) and 0.36 (0.01) for ff03* and ff03w
respectively are indicative of a chain in poor solvent305, while the ff03ws exponent of 0.47
(0.01) is close to the average exponent of 0.46 (0.05) determined experimentally for un-
folded and disordered proteins306. The trends for the reaction limited rates are consistent
with the equilibrium distance distributions, with the collapsed ff03* and ff03w being very
similar to one another, and relatively independent of chain length. Lastly, we note that
an important distinction relative to the distributions frequently assumed in interpreting
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Figure 7.5: Distribution of Trp-Cys distance for each chain length nb for AGQn peptides,
for three force fields. Symbols show the mean distance and curves are power law fits.
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experiments287,288, is the existence of an additional short-range peak for the contact pop-
ulation in Figure 7.5. The lifetime of this population is 0.4-0.9 ns for the ff03ws force field,
depending on the peptide.
Next, we test an important approximation commonly used to analyze experimental
data on contact formation, namely that the dynamics of the chain can be approximated
as one-dimensional diffusion along the Trp-Cys distance coordinate. 1D diffusion models
are commonly also used to interpret single molecule FRET or optical tweezer experiments
also probing a single distance307,308. We have fitted the distance rcw(t) from our sim-
ulations to a 1D diffusion model, using an established Bayesian approach300,301,309,310.
Briefly, the method attempts to find the diffusive model, defined by a potential of mean
force F (rcw) = − ln peq(rcw) and position-dependent diffusion coefficients D(rcw), whose
propagators best match the observed history of the simulations (details in Methods). The
diffusion coefficients thus obtained are shown in Figure 7.6 for ff03ws as a function of the
number of AGQ repeats n in the peptides.
The diffusion coefficients we estimate are quite comparable to those obtained for the
same peptide from direct analysis of contact quenching data, ∼ 0.2 nm2ns−1 287, and from
MD simulations, 0.3 − 0.9 nm2ns−1 293 (after considering the low viscosity of the TIP3P
water model used), as well as with diffusion coefficients estimated for an unfolded protein
from single molecule FRET in water ∼ 0.1 nm2ns−1 307. However, our analysis reveals
a significant distance-dependence to the diffusion coefficient not included in prior work.
Specifically, the diffusion coefficients vary relatively little at large separations, but strongly
decrease at short probe-quencher distances, most likely due to the increased chain density
at small distances, as well as hydrodynamic effects as the Trp and Cys approach each
other. Remarkably, the D(rcw) curves are nearly superimposable for short and intermediate
separations rcw of Trp and Cys, for all of the peptides. Each peptide deviates from this
common curve only when it approaches its maximum extension (vertical broken lines in
Figure 7.6). This is not a finite size effect, as we obtain almost identical results for n = 3
with a larger simulation box (Figure 7.6).
Although we have been able to determine a “best-fit” one-dimensional model, this does
117
0 1 2 3 4 5 6 7
r
cw
 (nm)
0
0.2
0.4
0.6
0.8
D
(r c
w
) (
nm
2 n
s-
1 )
n=1 2 3 4 5 6
D
const
Figure 7.6: Position-dependent diffusion coefficients D(rcw), for each peptide AGQn, n =
1− 6. Error bars calculated from division of data into 5 non-overlapping blocks. Vertical
lines indicate the backbone extension for a fully extended chain. Empty symbols for n = 3
are results from a 5 nm simulation box (vs 4 nm for solid symbols). Horizontal line is
constant diffusion coefficient Dconst needed to fit the data for n = 3− 6.
not guarantee that the dynamics of this model is faithful to that of the full simulation
(projected onto the same coordinate). We checked this by using Szabo-Schulten-Schulten
(SSS) theory303 to compute rates from the diffusion model for all simulations and compare
them with those computed without dynamical approximations from the simulations. The
results, shown in Figure 7.4 are in excellent agreement with the direct analysis of the
simulations. We can also estimate the effective constant diffusion coefficient Dconst required
to match the measured diffusion-limited quenching rates. For n = 1−2, we obtain Dconst ∼
0.3 nm2 ns−1, and for n = 3−6, Dconst ∼ 0.15 nm2 ns−1 (the latter value in close agreement
with the experimental estimate287 of ∼ 0.17 nm2 ns−1). This is also expected from ESI eq.
2 as the D(r) at short separations are weighted much more, rationalizing the experimental
observation that the diffusion coefficient for describing contact formation is about an order
of magnitude smaller than the relative bimolecular Trp-Cys diffusion coefficient287. Thus,
contact formation experiments provide complementary information on diffusivity to that
obtained from experiments monitoring equilibrium distance fluctuations by FRET cross-
correlation, which should be more sensitive to the diffusion coefficient close to the Fo¨rster
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radius307; therefore a future combination of these two experiments performed on the same
polypeptide could probe the distance-dependence of the diffusion coefficient found in our
calculation.
Our results indicate that 1D diffusion models can capture contact formation dynamics
quite accurately, justifying their use in interpreting experiment. This is a remarkable result
because there are many situations where end-end distance is not a good reaction coordi-
nate 308,311. However, the simulation results suggest additional complexity beyond what
could reasonably be assumed a priori when interpreting the experimental data: namely,
the distance distribution functions P (rcw) include an additional contact peak at short
separations, and the diffusion coefficients D(rcw) exhibit strong distance-dependence at
the short separations most important for determining the diffusion-limited rate of contact
formation: indeed, effective position-independent diffusion coefficients obtained by fitting
SSS theory to experimental quenching rates would be almost entirely determined by the
diffusion coefficients at the shortest probe-quencher separations. These results should aid
in interpreting contact quenching experiments, as well as other experiments probinng a
single distance coordinate, including single molecule FRET, optical tweezers, and atomic
force microscopy experiments.
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Chapter 8
Probing the structural
characteristics of same family
peptides with their underlying
conformational dynamics
8.1 Introduction
Calcitonin gene related peptide312,313 (CGRP) and islet amyloid polypeptide314,315 (IAPP,
also known as amylin) are 37-residue long intrinsically disordered proteins that function
as hormones. They are part of the calcitonin peptide (Ct) family, which includes IAPP,
CGRP, calcitonin (Ct), adrenomedullin (AM), AM 2/intermedin and calcitonin-receptor
stimulating peptide (CRSP)316–318. Ct peptides are produced from cleavage of the inactive
portion of their precursor proteins and play important roles in a variety of physiological
processes including ionic balance, neurotransmission, glucose metabolism and cardiovas-
cular and endocrine homeostasis. CGRP and IAPP are of particular biomedical interest.
CGRP is expressed predominantly in the nervous system, it acts as a vasodilator and is
responsible for the transmission of pain signals in peripheral nervous system312,313. As a
neuropeptide it triggers migraine attacks319–323. Antagonists of CGRP, able to bind to the
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CGRP receptor but not to activate it, are used to treat migraines313,319,321,324,325. IAPP
is predominantly found in the gut system. It is produced and co-secreted together with
insulin in the beta cells of the pancreas and it acts as a hormone, inducing satiety, regulat-
ing gastric emptying and glucose levels in the blood122,314,326,327. In individuals with type
II diabetes IAPP forms amyloid fibers in the beta cells of the pancreas leading to or con-
tributing to beta cell death121,125,187,326,328–331. A non-aggregating synthetic analogue of
IAPP (Pramlintide) is used in conjunction with insulin in the treatment of both type I and
type II diabetes, to prevent glucose levels from becoming too high after meals326,332–338.
Though CGRP and IAPP are produced in different tissues and carry out distinct func-
tions, they share 40% sequence similarity and have very similar receptors, which they are
able to bind to and cross-activate339–346. Comparative studies between these two peptides
are therefore instrumental to understand their stability in solution and the mechanism by
which they bind to their receptors. Despite the presence of strong evidences regarding
functions of the peptides, neither the structure of the receptors nor of the peptides has
yet been resolved347,348. To complicate the issue, CGRP and IAPP are highly intrinsically
disordered, with very little residual secondary structure requiring experiments which can
resolve high heterogeneity8,172. While there is no substitute for experiments, molecular
simulations can offer a unique avenue to study highly heterogeneous ensembles of these
proteins. Given the fact that IAPP is a quite aggregation prone peptide in vitro, making
experimental work even more challenging, MD simulations can serve as an especially useful
tool to resolve the ensembles of the peptides in aqueous solution.
Molecular dynamics (MD) simulations for given accurate potential energy functions, in
fact, have started to become a routinely used technique to obtain atomistic insight from
the experiments for disordered proteins10,44,349. Recently developed and improved pro-
tein/water force fields have shown to provide better representation of disordered protein
ensembles253,255 as evaluated by the structural experimental measurables. In addition, the
particular force field used in this work, Amber ff03ws253 (Amber ff03w/TIP4P200538,294
with 10% increased protein-water interactions), have also shown to improve kinetics of dis-
ordered proteins so that the direct estimates of timescales associated with the atomic level
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Figure 8.1: Amino acid sequences of CGRP and hIAPP. C2C7 residues form disulphide
bond. The N-terminus is free while the C-terminus is amidated. Residue 37 of both
peptides is mutated to W as in the experiments. Common residues in both peptides are
highlighted yellow.
end-to-end contact formation in disordered proteins reproduce the same results as in the
tryptophan triplet quenching by cysteine experiments14. This experimental technique pro-
vides two rates which can be directly calculated from MD simulations: the reaction limited
rate (related to the equilibrium conformational ensemble, end-to-end distance distribution)
and the diffusion limited rate (related to the diffusive dynamics of contact formation). On
the other hand, simulations can also provide molecular level understanding of the structural
ensemble of these peptides which cannot be obtained directly form these experiments.
Recently experimental data of end-to-end contact formation for IAPP and CGRP have
become available, using tryptophan triplet quenching by cysteine169,350. We introduce
tryptophan residues at the C-terminus and probe the quenching by cysteine-cysteine bond
exactly in the experiments (Figure 1). The rates directly calculated from the simula-
tion yield a reasonably well agreement with the experimental results. Structural proper-
ties calculated from equilibrium ensembles of these peptides reveal a significantly similar
N-terminal region (including disulphide loop) for CGRP and IAPP, and a significantly
different C-terminal region. In particular, high structural similarity in N-terminus and dis-
similarity in C-terminus agrees with a widely accepted two-step binding model of CGRP
and IAPP, in which C-terminal part involves in first step, initial binding of the peptides
to the receptors while the N-terminal part of the peptides are taken as primary site of
receptor-ligand binding (step two), resulting in receptor activation and response351,352. In
other words, structural diversity found in C-terminus can potentially be linked with differ-
ence in their affinity for the same receptor whereas N-terminal similarity can potentially
be linked with both peptides ability to activate cell response through the same receptor.
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On the other hand, IAPP, known to have amyloid aggregation has a considerable fraction
of α-helices over C-terminal region, covering its amyloidogenic region, whereas CGRP has
zero fraction of helices over the same region, which can potentially explain the differences
in their amyloidogenic characteristics.
8.2 Methods
8.2.1 Simulation techniques
In this work, we provide equilibrium sampling of CGRP and IAPP using two different
simulation techniques. The first one is an enhanced sampled parallel tempering molecu-
lar dynamics simulation in well-tempered ensemble (hereafter: ptwte) and the other one
is exhaustive serial molecular dynamics simulations averaged over a number of indepen-
dent runs (hereafter: serial). Ptwte is a temperature replica-exchange based simulation
technique45 in combination with well-tempered ensemble177. The use of well-tempered
ensemble amplifies the tails of potential energy distribution in each replica, maintaining
the same average potential energy, thereby reduces the number of replicas required to ob-
tain sufficient exchange acceptance percentage177,211. Here we use sixteen replicas within
a temperature range of 300-520 K and attempt exchanges between adjacent replicas every
1 ps. Replica temperatures are adjusted, initially based on geometric spacing between
300 K and highest temperature of interest, to obtain uniform acceptance probability (of
approximately 35%) between all adjacent replica pairs245. All the replicas are started from
unstructured configurations. Each replica is initially equilibrated at its temperature for
100 ps. During the first 50 ns of the production phase, well-tempered ensemble is turned
on for all replicas, but 300 K replica, as applied previously214,215. In further extensions of
the run, energy bias accumulated in the first 50 ns is loaded as a static bias on the biased
replicas. Both peptides are simulated for 200 ns per replica, last 150 ns of 300 K trajectory
is analyzed. GROMACS-4.6.741,193 molecular dynamics engine is used with Plumed 2.1200
plug-in for metadynamics calculations.
We use Amber ff03ws protein force field253 in combination with TIP4P/2005 water
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model294 with strengthened protein-water interactions, which corrects overly collapsed
nature of disordered ensemble253. The peptide in each case is solvated in a truncated
octahedron box with 6.5 nm spaced faces (6743 water molecules). Simulation box for
each initial condition is equilibrated for 100 ps in NVT ensemble followed by 100 ps in
NPT ensemble, where pressure is maintained at 1 bar using isotropic Berendsen pressure
coupling353. Further production run is performed in NVT ensemble for ptwte for 200
ns/replica, only last 150 ns/replica is analyzed for the results section.
Ptwte provides an efficient sampling of the phase space for relatively much less com-
putation time, yet sacrifices the dynamics of the system. To be able perform a direct
time-resolved analysis, we also run serial simulations of both peptides selecting various
different initial conditions, twelve independent for each peptide, from the equilibrium en-
semble obtained by ptwte. Serial runs are performed in NPT ensemble maintaining the
pressure at 1 bar using Parrinello-Rahman coupling with coupling constant of 5 ps. We
simulate each independent initial condition until we see most of the initial conditions com-
pleted their quenching, which is 2.5 µs for each initial condition, totalling 30 µs serial
simulation data for each protein. For both ptwte and serial runs, systems are propagated
using stochastic Langevin dynamics with a friction coefficient of 1/ps. Electrostatic in-
teractions are calculated using the particle-mesh Ewald method47 with a real space cutoff
distance of 0.9 nm. A 1.2 nm cutoff distance is used for the van der Waals interactions.
8.2.2 Tryptophan triplet quenching calculation
We directly compute the quenching rates using a step function for the dependence of the
quenching rate q on the Trp-Cys separation rcw, that is q(rcw) = qcH(rc − rcw), where
qc = 8 × 10−8 s−1 is the constant quenching rate in contact, H(x) is the Heaviside step
function and rc = 0.4 nm is the contact distance. The distance rcw is the minimum distance
between the sulfur in the cysteine side-chain and the heavy atoms of the tryptophan indole
ring system286,293.
Survival probability of the tryptophan triplet state is then calculated from
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S(t) = 〈exp[−
∫ t0+t
t0
q(rcw(t
′))dt′]〉t0 , (8.1)
where the average runs over equilibrium initial conditions t0, obtained by taking every
saved frame of the simulation as a valid starting point. The contributions to the observed
relaxation rate can be split into diffusion-controlled and reaction-controlled parts287,
k−1obs = k
−1
D+ + k
−1
R . (8.2)
The reaction-limited rate, kR, can be evaluated by integrating over the Trp-Cys distance
distribution,
kR =
∫ ∞
0
q(rcw)P (rcw)drcw. (8.3)
The diffusion limited rate can be obtained by using a step function for the survival
probability S(t), assuming instantaneous quenching upon contact, and averaging over time
origins t0,
S(t) = 〈H(tc(t0)− t− t0)〉t0 . (8.4)
Here, tc(t0) is the first time after t0 when the Trp and Cys contact, H(x) is the Heaviside
step function, and all time points in the simulation where the probes are not already in
contact are used as separate time origins t0.
In addition to the direct calculation of rates from our serial simulations, we also use our
equilibrium ptwte simulation to calculate the rates. Given that reaction-controlled rate is
only function of equilibrium contact population, it still can directly be calculated using
equation . For diffusion-controlled rates we use Szabo-Schulten-Schulten (SSS) theory303
assuming a diffusion model with a constant diffusion coefficient for both peptides,
k−1D+ =
∫ rmax
rc
[ ∫ rmax
r peq(s)ds
]2
Dconstpeq(r)
dr. (8.5)
We obtain a diffusion coefficient, Dconst of 0.03 nm
2/ns to match directly calculated
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Figure 8.2: Survival probabilities of tryptophan triplet state. Diffusion-limited (top)
and observed (bottom) decays calculated as an average of all independent runs from
serial MD simulations, presented together with the corresponding experimental decays
(dashed lines). Symbols illustrate simulation data whereas solid lines are exponential
fits to data. Diffusion-limited S(t) of CGRP fits to single exponential decay function
exp(−4.39t) whereas that of IAPP fits better to a double exponential decay function
A exp(−3.53t)+(1−A) exp(−0.28t) where the partial weight A is 0.83. Similarly, observed
S(t) of CGRP fits to single exponential decay function exp(−1.90t) whereas that of IAPP
fits better to a double exponential decay function A exp(−1.56t) + (1 − A) exp(−0.039t)
where the partial weight A is 0.83.
and SSS calculated diffusion-controlled rates for serial simulations. Using this diffusion
coefficient, we calculate diffusion-controlled rates for ptwte simulation for both peptides
from equation 5. Finally, the observed rate from ptwte simulations is calculated using
equation 2.
8.3 Results and Discussion
Contact quenching pump-probe experiments are a sensitive measure of configurational dy-
namics in disordered peptides169,286,287,350. However, interpretation of the data usually
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Table 8.1: Measured rates in µs−1 for CGRP and IAPP in aqueous solution at 300 K.
Errors in serial and ptwte simulation measurements are evaluated as standard deviation
between independent simulations and blocked standard errors calculated from the standard
deviation among the block averages dividing data into two equal non-overlapping blocks,
respectively.
CGRP IAPP
Simulation (direct) Experimenta Simulation (direct) Experimentb
kobs 2.4 ± 0.3 0.57 ± 0.04 1.8 ± 0.7 0.93 ± 0.07
kR 4.4 ± 0.6 0.93 ± 0.09 3.2 ± 0.7 1.2 ± 0.1
kD+ 5.3 ± 0.6 1.5 ± 0.3 4.1 ± 0.7 3.6 ± 0.6
aSizemore et al.350 at pH 4.9 and 20 C.
bVaiana et al.169 at pH 4.9 and 20 C.
requires fairly strong assumptions about the nature of the probe-quencher distance distri-
bution and dynamics. The great advantage of this technique, however, is that it provides
experimentally measured rates which correspond to a well-defined motion, which can be di-
rectly calculated from simulations, offering a unique test on dynamics in simulations14,293.
Using molecular dynamics simulations provides direct quantification of the timescales asso-
ciated with contact formation for given distance dependence of the contact quenching rate
without other simplifying assumptions. Recently, experimental data of end-to-end contact
formation for IAPP and CGRP have become available using these experiments169,350 and,
here, we calculate these rates from MD simulations. Diffusion limited and observed survival
probabilities, S(t), are calculated as described in Methods and are shown in Figure 8.2 to-
gether with the experimental estimates. S(t) decay curves obtained from the simulation are
also fitted to the exponential decay functions. While CGRP fits best to a single exponential
decay curve giving a diffusion-limited and observed rates of 4.39µs−1 and 1.90µs−1 respec-
tively, IAPP fits better to double exponential decay functions. It shows two timescales,
one (with approximately nine-fold higher weight) is on the same order of magnitude as
CGRP rates and the other is much smaller than the former, both for diffusion-limited and
observed rates. First time constant, i.e. the rate, is obtained as 3.53µs−1 and 1.56µs−1,
respectively for diffusion-limited and observed cases with a weight of approximately 0.9,
whereas the smaller time constants with 0.1 weight are obtained as 0.28 and 0.039µs−1.
Both of CGRP rates are obtained 3-4 times faster than the experimental rates which are 1.5
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and 0.57 µs−1, where as the larger rates obtained from IAPP agree very well with the ex-
perimentally obtained rates, which are 3.6 and 0.93 µs−1, respectively for diffusion-limited
and observed cases.
In addition to the fitting of S(t) curves, we calculate diffusion-limited, reaction-limited
and observed rates of each independent simulation from equations 4, 2 and 1 and tabulate
the averaged rates in Table 8.1 as direct estimates. We also provide SSS predicted estimates
from the equilibrium ptwte simulations where SSS theory is used to determine diffusion-
controlled part of the rate, kD and equation 3 is used to predict reaction controlled part of
the rate, kR. While the rates obtained applying SSS theory is also faster than experimental
rates, it predicts the same order as in the experimental predictions, i.e. it finds end-to-end
contact formation rate for CGRP slower than that for IAPP. It appears that SSS predicts
kD+ already very close to directly calculated ones, almost the same in the error range.
The most drastic change between direct estimate (serial simulations) and SSS estimate
(ptwte simulations), however, is in the kR, ultimately making kobs of IAPP larger than
that of CGRP. What is the reason behind this drastic difference in kR? As described in
the tryptophan triplet quenching calculations, kR is the only function equilibrium end-to-
end distance distribution for given quenching rate. As we take that quenching is active
with a constant rate only when the distance is less than a cutoff distance, 0.4 nm, the
only determining factor of kR is the contact population, i.e. the population below cutoff
distance. In Figure 8.3, we show the distribution of the end-to-end distance where contact
population falls in the grey shaded region.
The differences in the contact populations clearly show where the difference between
kR of serial and ptwte simulations are coming from. This analysis, in fact, shows how
sensitive the quenching measurements are to the structural property, end-to-end contact
formation, that it is associated with. For example, a difference in the contact probability,
which is very close within the uncertainty estimates, yields two fold or more difference in
kR. One way to predict could be the size of error bars, i.e. deviation between independent
runs and the other one could be smoothness of the distribution profiles. Though the
smoothness could simply be the result of averaging over much more data points compared
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Figure 8.3: Normalized probability distribution of the distance measured between W and
C-C bond for both peptides. Top paned indicates the distributions from serial simulations
whereas the bottom panel shows those from ptwte simulations. Grey shaded region on both
panels indicates the contact population. Errors in serial and ptwte simulation measure-
ments are evaluated as standard deviation between independent simulations and blocked
standard errors calculated from the standard deviation among the block averages dividing
data into two equal non-overlapping blocks, respectively.
to ptwte (each run separately is 2.5 µs in serial simulations whereas ptwte is analyzed from
150 ns/300 K replica data), the size of error bars (evaluated as standard deviation between
each individual replica for serial)are being more or less on the same order of magnitude as in
ptwte is a stronger indication that we have reasonably well-converged data also from serial
simulations. Minimizing the uncertainty for the peptides yielding very close timescales, like
CGRP and IAPP, would be important for the interpretation of these timescales from direct
calculations due to the extreme sensitivity of the measurable. However, serial simulations
might take quite long simulation time, particularly for this force field, as it provides much
larger conformational space compared to its older counterparts14. A deep interpretation of
these timescales from the experiments has already been presented before350. For the scope
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of this paper, i.e. focusing on the comparison of structural properties of these peptides in
aqueous solution, which have not been resolved at this scale before to our knowledge, we
find reasonably well agreement with the experimentally obtained rates. In the following
structural analysis sections, we discuss underlying structural reasons where the differences
kinetic differences between CGRP and IAPP are potentially coming from.
Though it is very well known that both CGRP and IAPP can bind to highly similar
receptors and cross-activate the cell response with their 40% sequence similarity, the extent
of their structural similarity in the solution still remain mostly unknown. Intrinsic disor-
der, i.e. lack of a well-defined 3D structure, is experimentally predicted for both of these
peptides136,354. Several NMR studies have predicted that N-terminus of IAPP samples
α-helices transiently in the solution, though136,137,355. Also, there is a clear evidence that
N-terminus of CGRP, next to the disulphide loop, samples α-helices in 50% trifloroethanol
solution 354 or in dimethyl sulfoxide solution356, which are increased hydrophobicity envi-
ronments. On the other hand, the other half of the peptide, nearby C-terminus, contains
a particular region, residues 20–29, predicted to involve a key role in its amyloidosis of
IAPP155. In our previous work, we have found that sampling of partial α-helices over this
region correlates perfectly well with aggregation propensity of various IAPP mutants11,279,
which can support a role for helical intermediates in amyloidosis of the peptide139,206,
particularly involving this region. Unlike IAPP, CGRP is known not to form amyloid ag-
gregates and it has no sequence similarity with IAPP in region 20–29. So, comparative
structural analysis of these peptides can be key to understand the similarities between these
peptides in terms of their cross-reactivity and the differences in terms of their aggregation
behavior. Here we analyze our simulation trajectories for the secondary structure content,
both total and residual, following two different methods, one based on hydrogen bonding
patterns and the other based on regular patterning of backbone dihedral angles in the
related regions of (φ,ψ) space. Figure 8.4 shows the total (Figure 8.4A) and per-residue
(Figure 8.4B) fraction of the secondary structures sampled based on the assignment by
the hydrogen bonding criterion, so-called DSSP48. We present our DSSP based results in
a three state way, such that α-helix, 3-(10) helix and 5-helix; β-sheet (alone); and bend,
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Figure 8.4: Secondary structures sampled by CGRP and IAPP based on DSSP algorithm
(see the text). Errors are the blocked standard errors calculated by dividing the data into
ten equal non-overlapping blocks.A. Average total fraction of various secondary structures.
B. Average per-residue fractions of secondary structures.
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turn, β-bridge and “unassigned” structures are cumulatively grouped into alpha, beta and
coil states, respectively357. While both peptides are predominantly coil-like, consistent
with the experimental predictions, there are some partially formed secondary structures
sampled transiently, including a total of approximately 6.5% and 20% sampled α-helices
respectively for CGRP and IAPP. While there is a 7.5% β-structure fraction for CGRP,
its fraction is insignificant for IAPP. Circular dichroism (CD) of CGRP in aqueous solu-
tion predicts 10 to 20% α-helices in aqueous solution358–360, whereas β-sheet proportion
is predicted to be around 40%359,360. While the structure percentages are higher in CD
data, which might be difficult to yield reliable quantitative estimates for IDPs due to lack
a well-defined reference coil spectra, our results still predict the presence of the partial
secondary structures along similar lines, i.e. β-sheet content is slightly more than α-helical
content.
Per-residue secondary structures (Figure 8.4B) indicates that the source of the sig-
nificant difference in α-helices of these peptides is the C-terminal region whereas the N-
terminal region is mostly conserved in terms of α-helical propensity. Finding of partial
N-terminal helices is consistent with the previous experimental findings both for CGRP
and IAPP. CGRP is predicted to sample helices in N-terminal by NMR in organic solvent
solutions354,356,360. Although we do not find a long or highly persistent stretches of he-
lices, such as covering entire 8-18 region as in experimental studies, this much discrepancy
might be a result of solvent difference, as some organic solvents such as trifloroethane are
known to promote helices. Several solution NMR studies of IAPP also find the evidence of
N-terminal helices presence136,137,355. On the other hand, partial C-terminal helices that
we find in IAPP are both consistent with our previous findings11,279 and with experimental
findings355. Strikingly, CGRP shows zero population of helices over this region, similar to
rat IAPP279, which can potentially explain the reason why CGRP does not form amyloid
aggregates as opposed to IAPP. On the other hand, β-sheet propensities for CGRP are most
apparent in region involving the middle of the peptide, residues presumably resembling an
anti-parallel β-sheet structure, while IAPP does not show a significant β-structure.
As an alternative secondary structure prediction, we follow a purely backbone dihedral
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Figure 8.6: Contact maps of whole ensemble and five most persistent structural clusters
(from left to right) formed upon RMSD based clustering of CGRP (top) and IAPP (bottom)
together with the structures collected from an RMSD based clustering using 0.4 nm cutoff
distance. Backbones of structures are colored based on secondary structures (purple: 4-
or more residue long α-helix stretches, blue: shorter α-helices, yellow: short β-bridges or
longer stretches of β-sheet, white: coil, cyan: bend/turn). Heavy atoms involving in C-C
bonding are illustrated green. Percentages of the clusters are indicated on the right corner.
angle based prediction to quantify the secondary structures populated by these peptides,
which also helps visualize longest blocks of secondary structures sampled in the equilibrium
ensemble. We classify the (φ,ψ) space into structure relevant regions (alpha, beta, ppII) as
mentioned in Chapter 5. Then, we determine the blocks of residues sampling in a specific
region of (φ,ψ) space for each configuration following the SS-map algorithm361. Starting
from the longest possible block of a particular structure (x-axis), fractions (color code) of
blocks are assigned for residue intervals (y-axis) involving in given block as presented in
Figure 8.5. If there are common residues in structure blocks of same length, fraction adds up
for common residues. Figure 8.5 indicates that the most prominent structure (for relative
longer lengths of structures) for both peptides is the α helix. Similar to the prediction by
DSSP, N-terminal helices and C-terminal most region (33-37) helices are fairly consistent
between both peptides, whereas in 21-31 region, which covers amyloidogenic region of
IAPP, helices are specific to IAPP with a significant propensity, which are up to 10-residue
long. On the other hand, β structures have slightly higher propensity for CGRP, yet they
are still very short stretches of the structure; there is no significant β propensity beyond
4-residue long strands. Lastly, there is a visible propensity of similar length ppII helices,
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too, especially in N-terminal region, which is common in both peptides. However, ppII
length and propensity is a bit higher for CGRP in the region nearby C-terminal (25-33),
IAPP has α-helices over this region as opposed to CGRP.
In addition to the equilibrium populations of secondary structures, we also present
time-resolved residual secondary structure content from each independent trajectory of
serial simulations in Figure 8.7 (CGRP) and 8.8 (IAPP) to visualize the the structures
with respect to time. Moreover, the secondary structure content of individual trajectories
can provide a structural evidence about their pace of end-to-end contact formation rates
contributing to the average. Some of the CGRP trajectories, for example, have higher
β-sheet content compared to other CGRP trajectories (and compared to IAPP trajecto-
ries) whereas some IAPP trajectories have higher α-helix content compared to the others.
In particular, we further ask whether there is an obvious correlation between secondary
structure fractions and the pace of the observed rate of contact formation, i.e. faster or
slower. For this purpose, we provide the scatter plots of observed rates with respect to
secondary structure fractions, α, β and coil (Figure 8.9). α and coil are showing negligible
correlations with their observed rate, whereas β has a possible weak correlation with the
observed rates. Though it may be hard to conclude a direct linear correlation between any
structure and the observed rates, there is an obvious observation from β as follows: when
the fraction beta of the trajectory is higher than 0.1, rates are typically fast, however, vice
versa is not always true, i.e., if the fraction beta is low, rates could be fast or slow. So
higher β fraction can possibly be linked with faster rates.
While both peptides are predominantly disordered, secondary structure calculations
predict that both IAPP and CGRP partially sample some structures. To help visualizing
their ensemble containing these partial structures and to have a more solid idea about
persistent atomic contacts, we map residue-residue contacts of heavy, i.e. non-hydrogen,
atoms of backbone of both peptides (Figure 8.6, first column) using a 0.6 nm contact cutoff
distance. In addition, we perform an RMSD based structural clustering167 of the ensembles
and present top five clusters of each peptide together with their contact maps (Figure 8.6,
last five columns). Overall ensemble contact maps do not predict highly persistent contacts
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Further  details  of  each  replica  contributes  to  the  average:  Time-resolved  dssp-based 
secondary  structures  for  each  replica: 
CGRP: 
 
 
48 Figure 8.7: Time-resolved DSSP based secondary structures of each serial simulations for
CGRP peptide.
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IAPP: 
 
 
 
 
 
49 
Figure 8.8: Time-resolved DSSP based secondary structures of each serial simulations for
IAPP peptide.
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Figure 8.9: Correlation plot of observed quenching times (1/kobs) and total fraction of
various structures for each contributor of cgrp (green) and iapp (blue) serial simulations.
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between any residue pairs, except the disulphide loop region. Contacts sampled by IAPP
on upper part of the diagonal, which is consistent with the helices, are apparent, though.
While the cluster percentages are typically low as expected of a disordered peptide, all top
cluster of IAPP, except 5, show these C-terminal helices. N-terminal helices are also visible
clusters 5 of both peptides and cluster 3 of CGRP. Low propensity β-structures sampled
by CGRP can also be seen in the same clusters (3 and 5).
8.4 Conclusions
In this work, using exhaustive serial and enhance-sampled equilibrium MD simulations,
we analyze conformational dynamics and structural properties of two Calcitonin-family
peptides, CGRP and IAPP, sharing 40% sequence similarity and cross-activating the cell
response with their ability to bind very similar receptors. We quantitatively determine
the timescales associated with conformational dynamics of these disordered peptides as
in tryptophan quenching experiments and obtain reasonably well agreement with the ex-
perimental results without any reweighting or rescaling. On the other hand, equilibrium
structural ensembles obtained at atomic resolution provide direct measure and compari-
son of structural properties of these peptides without the need of interpretation of kinetic
measurements. While there is no obvious correlation between structural properties and
the rates, we found that increased β-structure fraction might yield faster rates presumably
specific to this case, as the β-structure for this case is like an anti-parallel β-sheet connected
in the middle of the sequence. Considering the facts that these peptides are yielding very
similar rates also in the experiment and quenching calculation is highly sensitive to the
structural property that it is associated with, it may require much longer simulation times
to differentiate these peptides from each other for this kinetic property. In addition, we
have found that the trajectories of IAPP contributing to high heterogeneity, i.e. multiple
timescales, are the ones having the slowest rates compared to the average. In particular,
their population below contact distance are highly small (Figure Sx), accordingly, contact
form/break events may be away from high statistical significance, which can ultimately
cause such a heterogeneity in the decay curve.
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Of particular interest in this paper is to gain structural insight from atomistic simu-
lations when these peptides are in aqueous solution. We have found that most structural
properties such as low propensity α-helices are highly similar in N-terminal half of the
peptides covering the disulphide loop region, which is known to be essential for them to be
functional343,344,346. Also importantly, our observation for high similarity at N-terminus
and high variation at C-terminus appears to be consistent with the widely accepted two-step
binding model for these same family GPCR receptor ligands351,352. In this model, briefly,
C-terminus of the peptides binds to the extracellular domain of receptor first, followed by
binding of N-terminal region, which also incorporates disulphide bond region, to the trans-
membrane region of the receptor which yields receptor activation and cell response. As
CGRP and IAPP can bind very similar receptors, yet with a different affinities340,343,344,
the variation that we observe in C-terminal region can potentially be responsible for their
different affinities (step one). Highly similar N-terminus of these ligand peptides that we
observe, on the other hand, allows the peptides cross-activate the cell response (step two).
These findings can make us one step closer to a better understanding of a family of GCPR-
ligand binding and development of novel drugs targeting GCPRs, which holds a quite large
market in pharmacology362.
Apart from their binding and functioning, the striking difference in C-terminal region
between these peptides; IAPP has quite high fraction of α-helix, whereas CGRP has none,
especially over amyloidogenic-called 20–29 region, can also be correlated with amylodogenic
activity of these peptides. We previously found a similar analogy in rat IAPP and human
IAPP, i.e. the largest structural difference in non-amyloidogenic rat IAPP was that it
does not sample helices near this region at all11,279. CGRP and IAPP has no sequence
similarity over that region. Though 20–29 region of CGRP does not have a particular
sequence similarity to that of rat IAPP, either, just like rat IAPP, CGRP does not have any
helices over that region, which makes our results support C-terminal helical intermediates
mediating aggregation of IAPP139,206, also evidence a structural reason why this region
can be amyloidogenic.
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Chapter 9
Folding thermodynamics
comparison of closely related
β-hairpins
9.1 Introduction
Protein folding is a dynamic process that involves a complex series of events that are all
required to occur successfully for proteins to fold into their native structures. One such
structural event can be the formation of β-hairpin structures in short peptides. These small
peptides can fold independently and exhibit many of the main features of folding of full-
size proteins, including hydrogen bonding, hydrophobic interactions and two-state folding
kinetics and thermodynamics363–369. Having less than twenty amino acids, they provide
advantages for simulation studies as they allow one to obtain converged thermodynamic
quantities such as folding free energy surfaces.
A frequently studied example of these peptides is the 16-residue B1 domain of strep-
tococcal protein G370, GB1 hairpin371. It has been shown to fold independently with a
folding time of 6 µs at 300 K372, consistent with predictions based on theoretical and coarse
grained models373. Other regularly studied β-hairpins are the designed Tryptophan zip-
pers (TrpZips) which are 12- and 16-residue peptides that contain two pairs of stabilizing
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Tryptophan residues and varying turn sequences365. TrpZip1, TrpZip2365 and TrpZip3-
1367 are 12 residue TrpZip peptides differing only in the turn sequence. The different turn
sequences of these TrpZips causes their different folding stabilities. On the other hand,
TrpZip4 is a triple mutant of GB1 hairpin, in which the three of the residues in the β-sheet
region are replaced by tryptophans maintaining the same turn sequence. Trp mutations
bring about the exceptional stability of TrpZip4 by packing of the cross-strand pairs of
indole rings365. Folding thermodynamics comparison of TrpZip1, TrpZip2, TrpZip3-1 and
TrpZip4 based on these experimental data has revealed that TrpZip4 has the most stable
hairpin fold, followed by TrpZip2, TrpZip1 and TrpZip3-1 in the given order.
Folding mechanism and kinetics of β-hairpin have been studied extensively both by
experiment and simulation. Most of the experimentally suggested β-hairpin folding mech-
anisms support a “zipper” mechanism, where native hydrogen bonds and hydrophobic
contacts form sequentially starting at the turn363,367,369,372. In another work, mutations
introducing charges at termini were found to affect the folding rate, which was difficult to
rationalize by the “zipper” folding mechnanism368. The hairpin has also been the subject
of many simulation studies209,374–403. Simulation studies put greater emphasis on “hy-
drophobic collapse” than turn formation and hydrogen bonding as a key event in hairpin
folding mechanism although conclusions vary widely. We have previously reported that
hairpin folding mechanism and thermodynamics properties similar to the experiments can
be inferred397 using Amber03* force field247. Folding was found to be initiated by the
formation of correct turn397, consistent with the experiment as the rate limiting step has
been reported to be the formation of the turn367. Additionally, we have reported that
subsequent native interactions could be formed either from the turn or from the hairpin
termini which helped explain previous experimental results on charge mutations at the
termini397.
In another simulation work, using Amber03* force field, we also found that Lys-10
residue in turn position in GB1 adopts its native αL conformation concomitant with fold-
ing209. This could suggest that the transition of Lys-10 turn position to αL conformation
(rarely populated in unfolded peptides and proteins209) could be an additional key event
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in the folding of GB1 hairpin. Therefore, replacing the Lys-10 turn position in GB1 with a
more flexible Gly residue, which will help sampling of αL conformation, might help stabi-
lize the GB1 hairpin. A previous study by Fesinmeyer et al.366 showed that replacing the
native DDATKT sequence of GB1 with NPATGK which includes K10G mutation resulted
in a 4.5 kJ/mol stabilization of the hairpin fold. Here we introduce a new peptide, GB1
K10G, to study the effect of K10G mutation in turn position on stability of the hairpin
fold.
In this work, we also aim to answer the following important question: Can molecu-
lar simulations reproduce the experimentally predicted folding stability differences within
closely related hairpin peptides? Specifically, we investigate the capability of Amber03*/TIP3P
(protein/water) model to predict mutational effects on β-hairpin stability and structure by
simulations of GB1, GB1 K10G, TrpZip4, TrpZip1, TrpZip2 and TrpZip3-1. By calculating
the free energies of unfolding at room temperature and folding midpoint temperatures of
the peptides, we find that TrpZip4 has the highest stability among the peptides followed
by GB1 K10G, TrpZip1, GB1, TrpZip2 and TrpZip3-1 in the given order. K10G muta-
tion increases the stability of GB1 significantly; GB1 K10G yields a stability very close
to the stability of TrpZip4, which supports our argument about sampling of αL confor-
mation. Our results exhibit a fair agreement with previous experimental findings except
for TrpZip2 which will be discussed thoroughly. We also calculate the propensities of sec-
ondary structure elements and φ-ψ map of turn residues of equilibrium folded and unfolded
populations of the peptides. Contoured free energy φ-ψ maps of peptides show the adop-
tion of expected turns types in folded populations and potentially explain unstable folded
structure of TrpZip3-1.
9.2 Simulation and Analysis Methods
In this study, we simulate 16-residue β-hairpin peptides GB1, GB1 K10G and TrpZip4 as
well as 12-residue β-hairpin peptides TrpZip1, TrpZip2 and TrpZip3-1, whose sequences
are given in Table 9.1.
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Table 9.1: Peptide sequences simulated in this study. Turn residues are in bold and mutated
residues are underlined.
GB1 GEWTYDDATKTFTVTE
GB1 K10G GEWTYDDATGTFTVTE
TrpZip4 GEWTWDDATKTWTWTE
TrpZip1 SWTWEGNKWTWK
TrpZip2 SWTWENGKWTWK
TrpZip3-1 SWTWDATKWTWK
9.2.1 Replica-exchange molecular dynamics
Replica-exchange molecular dynamics (REMD)45 simulations of the peptides are performed
using Gromacs41,193, employing Amber ff03* protein force field (Amber ff03246 with modi-
fied Ψ potential247) along with TIP3P water model256. This particular force field has been
shown to alleviate known bias problems towards a particular secondary structure404. All
replicas in each simulation are initiated from fully unfolded configurations of the peptides,
which are solvated in a truncated octahedron box with 3.5 nm spaced faces for 16-residue
hairpins and 3.2 nm spaced faces for 12-residue ones. Na+ and Cl− ions are also added
to neutralize the system charge. Long-range electrostatics are calculated using particle
mesh Ewald method47 with 0.9 nm real space cutoff. For van der Waals interactions, cut
off value of 1.4 nm is used. Systems are propagated using stochastic Langevin dynamics
with a friction of 1/ps for 500 ns per replica. Thirty two replicas are used for 16-residue
peptides with a temperature range of 278-595K and twenty four replicas are used for 12-
residue peptides with temperature range of 278-505 K at constant volume. Exchanges
between adjacent replicas are attempted every 10 ps and ∼25% acceptance probability is
obtained. 500 ns per replica has been previously shown to be enough time for converged
results209 for these peptides with an equilibration time of 200 ns per replica. For each
peptide considered here, we calculate the running average of backbone root mean square
deviation (dRMS) (see definition below in the next subsection) , as a function of sampling
time to verify the convergence in our simulations (Figure 9.1).
For all analysis and calculations in the following sections, peptide configurations sam-
pled in the last 300 ns are used to calculate equilibrium properties. Backbone clustering
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Figure 9.1: The change in backbone dRMS with respect to time of 303 K replica for each
hairpin peptide. Solid red lines represent running average of 50 ns/replica data. Data up
to vertical green line is discarded as equilibration.
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of equilibrium trajectories are performed by the Gromos method167 with 0.15 nm cutoff
distance.
9.2.2 Fraction folded analysis
A folded configuration is defined as having a backbone root mean square deviation (dRMS)
< 1.5 A˚ to the native structure, where dRMS = [N
−1
bb
∑
(i,j)(rij − r0ij)2]1/2. The sum runs
over the Nbb backbone native contacts (i, j) which are separated by distance rij in the
configuration of interest and by r0ij in the native state. Based on the native structure, a
contact between a backbone atom of residue i and a backbone atom of residue j is defined
to be native if |i − j| > 2 and distance between the two atoms is less than 4.5 A˚399.
Here, 1.5 A˚ cutoff distance reflects the putative location of the barrier between folded and
unfolded states of the hairpin peptides (Figure 9.2). In Figure 9.3, we show that small
changes in this cutoff distance (from 1.25 to 3.0 A˚) yield very similar fraction folded versus
temperature curves.
The reference folded frame for dRMS calculations of GB1 was obtained from the protein
data bank (PDB) entry 1GB1370, employing 41-56 region for B1 domain. The reference
folded frames of TrpZip1, TrpZip2 and TrpZip4 were obtained from PDB entries 1LE0365,
1LE1365 and 1LE3 365, respectively. Since the folded structures for newly proposed GB1
K10G mutant and TrpZip3-1 are not available, the reference frames are prepared by chang-
ing Lys-10 of native structure GB1 to Gly for GB1 K10G and by changing Glu-5, Gly-6
and Asn-7 of native structure TrpZip1, respectively to Asp, Ala and Thr for TrpZip3-1.
9.2.3 Equilibrium thermodynamic analysis
Based on the fraction folded data, we conduct an equilibrium thermodynamic analysis to
analyze thermal unfolding of all the peptides. In this work, we assume thermal unfolding
of our peptides fits two-state unfolding equilibrium:
F←−→ U. (9.1)
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Figure 9.2: Potential of mean force (PMF) projected on backbone dRMS. The vertical red
lines indicate dRMS = 1.5 A˚ value, which is defined as folded cutoff.
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Figure 9.3: Fraction folded with respect to temperature for each hairpin peptide. Legend
shows the different folded cutoff values used for fraction folded calculation in A˚. The red
lines indicate the 1.5 A˚ dRMS cutoff.
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Figure 9.4: Fraction folded with respect to temperature for each hairpin peptide based on
dRMS, fraction of native contacts, Qaa and fraction of native hydrogen bonds, Qaa criteria.
Folded state cutoffs taken as are 1.5 A˚ and 0.6, respectively for dRMS and Qaa. Error bars
are calculated from block averaging of the data using ten blocks.
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We check the two-state folding/unfolding assumption by calculating the fraction folded
based on two additional reaction coordinates: fraction of all-atom native contacts405, Qaa,
and fraction of native hydrogen bonds, Qhb, where native hydrogen bonds are defined
within 3.36 A˚ distance between donor and acceptor pairs of reference structures. All three
reaction coordinates, backbone dRMS, Qaa and Qhb produce very similar thermal melting
curves (Figure 9.4) thereby providing support for the two-state assumption. The only
notable difference between dRMS and Qhb based folded fraction estimates is observed for
TrpZip2. Defining native and unfolded fractions in the equilibrium ensemble as [N ] = ρF
and [U ] = (1−ρF ), the change in Helmholtz’s free energy upon unfolding can be calculated
as:
∆A = Au −Af = −kT ln(1− ρF
ρF
), (9.2)
where subscripts f and u refer to the folded and unfolded states, respectively, and k is
the Boltzmann constant. In several previous studies, it has been shown that ∆(PV ) term
is quite small210,403,406,407 (where P is pressure and V is volume) and can be ignored from
the analysis. Therefore, we assume that ∆G ≈ ∆A for comparison with experimental data,
where G is the Gibbs free energy.
In the Results and Discussion section, we report and compare folding midpoint tem-
peratures that are directly observed from our data and the free energy of unfolding at the
room temperature calculated from Equation 9.2.
9.3 Results and Discussion
9.3.1 Ab initio folding of hairpin peptides
In this work we aim to study the effects of mutations on β-hairpin folding with extensive
REMD simulations using an all-atom protein model with explicit solvent. Monomers of
β-hairpin peptides starting from their fully unfolded structures are simulated in water.
Ab initio folding of the peptides is successful for all peptides except TrpZip3-1, which did
not fold at any of the temperatures. Figure 9.5 shows the most persistent structure of
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GB1 GB1 K10G TrpZip4
TrpZip1 TrpZip2 TrpZip3-I
Figure 9.5: Most populated structure of studied hairpins based on backbone clustering
with 0.15 nm cutoff distance.
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each hairpin peptide. While the most populated clusters of GB1, GB1 K10G, TrpZip4,
TrpZip1 and TrpZip2 reflect representative structures of their folded populations, the most
populated cluster of TrpZip 3-1 is a low percentage unfolded conformation. Percentages of
the clusters are 44.6, 77.1, 91.2, 65.0, 21.5 and 2.3 for GB1, GB1 K10G, TrpZip4, TrpZip1,
TrpZip2 and TrpZip3-1, respectively.
Figure 9.6: The change in backbone dRMS with respect to time of 303 K replica of TrpZip3-I
trajectory starting from folded configuration.
To further verify the unstable nature of the folded structure for TrpZip3-1, we run an
additional REMD simulation in which each parallel replica is started from the folded struc-
ture and simulated for 500 ns per replica. The folded structure at 303 K completely unfolds
after ∼290 ns (Figure 9.6) after which backbone dRMS always samples values greater than
1.5 A˚. We calculate secondary structure propensities for the last 200 ns of this ensem-
ble (not shown here), which are similar to those of the ensemble obtained from unfolded
starting condition at 303 K.
9.3.2 Thermodynamic stability of hairpins
To study folding/unfolding thermodynamics of the peptides, we calculate the folded frac-
tion (ρF ) of the equilibrium ensembles at each temperature using the backbone dRMS
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Table 9.2: Thermodynamic folding/unfolding transition parameters of peptides from sim-
ulation and experiment
Tm (K) ∆G
303K
u
a (kcal/mol)
Simulation Experiment Simulationb Experimentc
GB1 316 297372 0.06±0.09 -0.21372
GB1 K10G 390 – 1.56±0.07 –
TrpZip4 405 343.1365 1.77±0.16 1.63365
TrpZip1 330 323365 0.32±0.13 0.53365
TrpZip2 <278 345365 -0.87±0.08 1.29365
TrpZip3-1 – 289.95367 – -0.42367
aWe calculate free-energy of unfolding at 303 K following the Equation 2 which assumes that systems
follow two-state folding/unfolding equilibrium.
bWe obtain error estimates on free energy from the uncertainity of folded fraction at 303 K.
cExperimental (spectroscopic) values corresponding to 303 K are calculated from the thermal unfolding
parameters reported in the indicated references.
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Figure 9.7: Thermal unfolding of peptides: Calculated equilibrium fraction folded data
based on dRMS from REMD trajectories as a function of temperature are shown with
symbols along with a thermodynamic fit shown in solid lines. Equilibrium fraction folded,
ρF , is fitted to ρF (T ) = 1/(1 + exp[−(∆G)/kT ]) where enthalpy and entropy of unfolding
are ∆H(T ) = ∆H0 + ∆Cp(T − T0) and ∆S(T ) = ∆S0 + ∆Cp ln(T/T0), respectively,
assuming that systems follow two-state folding/unfolding equilibrium. Grey horizontal
dashed line represents the folding midpoint.
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criterion described in the methods section. Figure 9.7 shows the thermal unfolding of the
peptides based on their calculated folded fractions at each temperature. Folding midpoint
temperature (Tm), which corresponds to ρF = 0.5, and free-energy of unfolding at 303
K, ∆G303Ku , are tabulated in Table 9.2 for each peptide together with previously found
experimental values.
∆G303Ku and Tm indicate the highest stability of folded structure for TrpZip4, which
is consistent with previous experimental findings in terms of both being the most stable
among TrpZips and being more stable than GB1365. Compared to GB1, keeping the same
turn residues, Tryptophan mutations in flanking β-sheet regions increase the stability of
hairpin fold by ∼1.7 kcal/mol. GB1 K10G has the second most stable hairpin fold, which
exhibits much higher stability than GB1 indicating that K10G mutation of GB1 also largely
stabilizes the hairpin fold by 1.5 kcal/mol. This supports our initial hypothesis that flexible
Glycine replacement of the turn residue in αL conformation can increase the stability of
GB1 hairpin.
Stability of TrpZip1 (third most stable) and GB1 (fourth most stable) also agrees well
with experiment by 0.27 kcal/mol difference in ∆G303Ku and 20 K difference in Tm. Tr-
pZip2 has originally been found to be more stable than Trpzip1 in the experiment365,
yet, here we find that TrpZip2 is much less stable than Trpzip1. However, in the same
experimental work, authors also discussed that TrpZip2 was unexpectly more stable than
TrpZip3 (not studied here). Moreover, in several other works, TrpZip2 has been reported to
show heterogenous folding408–411. Affected by the probe, spectroscopic methods may yield
divergent folding/unfolding thermodynamics parameters for the peptides having heteroge-
neous folding. The study by Yang et al.408 showed three clusters of melting transitions
of TrpZip2 ranging from 15◦C to 160◦C. Therefore, direct comparison of thermodynamic
folding/unfolding parameters with experimental results may not be straightforward for
TrpZip2.
For TrpZip3-1, ab initio folding is not observed in our simulations starting from the
unfolded initial condition. Additionally in a separate REMD simulation, the folded initial
condition completely unfolds, which can be due to its marginal stability as found in exper-
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iments367. So, it agrees with previous experimental findings in the sense that it is known
to the least stable among other TrpZips studied here, yet disagrees with experiment as the
folded state is completely destabilized.
9.3.3 Secondary structure propensities
The folded structure of β-hairpins contains two anti-parallel β-sheets connected with a
turn structure in the middle. In addition to the folded structure, equilibrium ensembles
of these β-hairpin peptides at room temperature have a significant percentage of unfolded
structures. We calculate the propensities of the secondary structure elements of separated
equilibrium folded and unfolded populations of the peptides by DSSP algorithm48 on a
per-residue basis at room temperature which are shown in Figure 9.8. In the folded pop-
ulation, compared to the GB1 and GB1 K10G, TrpZip4 extends the β-sheet structure by
one residue on each side (residue 2 and 15) while keeping the same turn propensity as in
GB1 and GB1 K10G. Unfolded populations of GB1 K10G and TrpZip4, which are rela-
tively small due to their high folded fraction, exhibit higher propensity for both β-sheet
and turn formation than GB1. Another difference between TrpZip4 and other sixteen
residue peptides appears in β-sheet propensities of unfolded population, outer residues of
TrpZip4 show increased β-sheet propensity whereas inner β-sheet residues prefers to be
structureless.Unfolded population of GB1 K10G has the largest propensity of turn in cen-
tral residues compared to other peptides which can imply that K10G mutation enhances
the folding stability by improving the stability of the turn to a significant extent.
The shorter TrpZips display lower β-sheet propensity in the unfolded populations, yet
β-sheet propensity of unfolded population of TrpZip1 is still higher than that of unfolded
population of GB1. While it is expected that TrpZip3-1 would have no β-sheet propensity,
it has a turn propensity which is higher than that of unfolded populations of both TrpZip1
and TrpZip2 for i+ 1 and i+ 2 position of turn. It is not completely unexpected that turn
may form, as the turn sequence DATK has been shown here to work well for GB1 and
TrpZip4. TrpZip3-1 exhibits significant turn propensity at i+ 1, i+ 2 and i+ 3 positions
but not in position i. In stable DATK turns (GB1 and TrpZip4), all four positions are
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Figure 9.8: Propensities of per-residue secondary structure elements in equilibrium folded
and unfolded populations of the peptides.
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found to contribute to the turn structure, indicating that TrpZip3-1 may not be able to
form its stable turn as in GB1 or TrpZip4 because of ith position, which will be further
elaborated in the following section.
9.3.4 Turn properties
Number of studies have reported that the β-turns are important contributors of the hairpin
folding stability366,367,372,412.Interplay between formation of the turn and hydrophobic core
and hydrogen bond formation has been shown to play crucial roles in the folding of the
hairpin367,413.We have also previously shown that hairpin folding is initiated by correct
formation of turn397. β-turns are defined by four consecutive residues, whose positions
are defined as i, i + 1, i + 2 and i + 3, and classified into nine groups according to the
sequence of dihedral angles that they occupy414,415. The hairpins in this study comprise
three different types of β turns: type I (GB1, GB1 K10G, TrpZip3-1, TrpZip4), type I′
(TrpZip2) and type II′ (TrpZip1).
Since most TrpZips differ only in the turn sequence, analysis of φ-ψ angles of turn
residues may help explain stability differences of these peptides. We measure the sampling
of individual turn residues in (φ-ψ) space for folded (Figure 9.9) and unfolded (Figure 9.10)
portions of the equilibrium trajectories. In the folded populations, the sixteen residue
peptides exhibit relatively narrow sampling in φ-ψ space yet dihedral angle groupings of
GB1 were not as tight as GB1 K10G and TrpZip4 for residues i+2 and i+3. Dihedral
angles of GB1 have populations outside of the expected type I turn regions in the φ-ψ
space. Here, K10G mutation is proposed especially to help sampling of αL conformation
at i+ 3 position. Though folded populations of all GB1, GB1 K10G and TrpZip4 already
adopt αL conformation at i+3 position, unfolded populations highlight the difference: GB1
and TrpZip4 infrequently populate αL conformation (high free energy) whereas GB1 K10G
still has quite stable free energy minimum at αL for i+ 3 turn position. This suggests that
K10G mutation helps sampling of αL conformation at position i+3, thereby increasing the
thermodynamic stability of the hairpin structure.
Twelve residue peptides, which differ only in turn types, exhibit two-residue turns.
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Figure 9.9: Map of φ−ψ angles in equilibrium folded populations of proteins, except where
noted for TrpZip3-1. Free energies are contoured in kcal/mol using the same scale. Arrows
in the whole turn section (from occupied angles of i+ 1 to occupied angles of i+ 2) denote
the angles of expected turns types of folded populations of the peptides.
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Figure 9.10: Map of φ-ψ angles of turn residues in unfolded populations of β-hairpin
peptides, free-energies are contoured in kcal/mol.
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Dihedral angles (Figure 9.9) and secondary structure assignments (Figure 9.8) show that
only residues i + 1 and i + 2 are forming turn with the adoption of correct turn type
(Figure 9.9, column whole turn), while residues i and i + 3 are found in the β-sheet
structure. Though, Figure 9.8 shows significant turn propensity both for TrpZip1 and
TrpZip2 in unfolded populations, angles at positions i+1 and i+2 of unfolded populations
indicate that correct turn types are not frequently sampled (Figure 9.10). Especially at i+1
position of TrpZip2, the correct angles are rarely sampled which might explain unexpectedly
low stability of TrpZip2. The type I′ turn type being more stable than type II′ turn are
majorly attributed to the higher occurance of type I′ in nature416. Yet, it does not rule
out the possibility of type II′ turn providing a more stable hairpin structure to the same
short peptide depending on the context.
Last 12-residue variant TrpZip3-1 with the turn type of GB1 (type I) does not fold but
it has significant turn propensity at central residues. The (φ-ψ) map of TrpZip3-1 turn
residues shows that residues at positions i+ 1 and i+ 2 sample the expected angles of the
turn type I (Figure 9.9). The ith residue has the largest population in the β region as in
TrpZip1 and Trpzip2, and some smaller population in αR region. i + 3 position, on the
other hand, has the largest population in the αR region. So, stable DATK turn of GB1
and TrpZip4 is not able to sample appropriate regions for all four turn positions to put
the rest of the sequence in β-sheet conformation in case of TrpZip3-1. Hence, lacking of
appropriate complete turn formation of TrpZip3-1 might prevent formation and elongation
of β-sheet of the hairpin, consequently preventing folding. Additionally in a previous work
on TrpZip3-1367, low stability of TrpZip3-1 has been rationalized with the lack of a pair of
residues D46 and T51 in loop of GB1 (i.e. 46-DDATKT-51), whose particular importance
in rigidity and stability of the loop region of GB1 was emphasized in a different previous
study417. So, it might be possible that the replacement of bounding D46 and T51 residues
with Tryptophan residues hinder the folding rather than stabilize it for TrpZip3-I case.
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9.4 Conclusions
In this work, by performing REMD simulations using Amber03*/TIP3P (protein/water)
model, we study the differences in thermodynamic stability of closely related hairpin pep-
tides. We find the stabilities of β-hairpins in the order of TrpZip4, GB1 K10G, TrpZip1,
GB1, TrpZip2 and TrpZip3-1. Significant improvement in stability of GB1 with K10G mu-
tation clearly supports the key role of αL conformation sampling at that position. Overall,
our exhaustive simulations are able to reproduce the experimentally predicted stability dif-
ferences between the peptides, except much lower stability of TrpZip2 and unsuccessful ab
initio folding of TrpZip3-1 in our case. While lower stability of TrpZip2 is in contradiction
with previous circular dichroism spectroscopy results, several other experimental studies
have highlighted its heterogeneous folding and the possibility of divergent measurements
of stability parameters experimentally. Hence, the lower stability of TrpZip2 is not a clear
mismatch with the experimental values. For TrpZip3-1, lack of complete turn formation,
most probably, prevents its folding. As a future aspect, other force fields can be explored
to test the robustness of the simulation data.
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COMPUTATIONAL	TECHNIQUES	
Acquired	skills	and	experience	during	Ph.D.	studies:		
• Molecular	Dynamics	(MD)		
• Prepackaged	programs:	GROMACS,	PLUMED,	CHARMM,	VMD,	AmberTools	
• CHARMM/AMBER	based	potential	energy	functions	(classical	force	fields)	
• Enhanced	Sampling	Techniques	of	Molecular	Dynamics:		
- Replica-exchange	molecular	dynamics	
- Metadynamics,	Well-tempered	metadynamics,	Multiple	Walkers,	Parallel-tempering	in	well-tempered	ensembles,	
Bias-exchange	metadynamics	
- Umbrella	Sampling	
- Umbrella	Sampling	with	Hamiltonian	exchange	
- Solute	tempering	
- Reweighting	techniques	
• MD	simulations	of	Protein/DNA	at	bio-nano	interfaces:	Lipid	membrane	bilayers,	self-assembled	monolayers,	carbon	
nanotubes,	graphite,	graphene	
• MD	simulations	of	modified	proteins:		Phosphorylation/Glycosylation	
• Small	molecule	parameterization	(CGenFF/Gaussian09)	
• Scripting	in	Fortran,	Python,	Bash,	C	Shell,	Tcl,	MATLAB,	awk	
• Engineering	programs:	MATLAB	(Simulink),	MathCad,	ChemCad,	CadKey	
• Other	software:	xmgrace,	gnuplot,	latex	
	
LABORATORY	TECHNIQUES	
Acquired	skills	and	experience	as	an	undergraduate	researcher	and	MSc	student:	
• Recombinant	DNA	techniques:		
- Extraction	of	bacterial	plasmid	DNA/yeast	chromosomal	DNA	
- DNA	amplification:	primer	design	and	Polymerase	Chain	Reaction	(PCR)	
- Agarose	Gel	Electrophoresis	(AGE)	
- DNA	restriction/ligation	and	purification	
- Bacterial	transformation	(E.	coli),	Yeast	transformation	(P.	pastoris)	
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• Incubation	on	solid	media	/	Cultivation	in	lab-scale	bioreactors	(shakers)		
• Batch/semi-batch/continuous	pilot	scale	bioreactor	operations		
• Sodium	Dodecyl	Sulphate	Polyacrylamide	Gel	Electrophoresis	(SDS-PAGE)	
• Immunoblotting	techniques	(Western	blot	and	Dot	blot)	
• Phage	Display	Techniques/Phage	Elisa	Binding	Assay		
• Isothermal	Titration	Calorimetry	(ITC)		
• Surface	Plasmon	Resonance	(SPR)		
• UV/Vis	Spectrophotometry,	numerous	enzyme	activity	assays	
• High	Performance	Liquid	Chromatography	(HPLC)		
• High	Performance	Capillary	Electrophoresis	(HPCE)	
• Genome	scale	metabolic	network	modeling	and	metabolic	flux	analysis	(combined	theoretical	approach	and	
experimental	results)	
	
	
AWARDS,	SERVICE,	ORGANIZATIONS	&	OTHER	ACTIVITIES	
	
• Peer	Review	Serviced	Journals:	PLoS	ONE	
• Invited	to	DE	Shaw	Research	Graduate	and	PostDoc	Women’s	Forum	delivered	a	research	talk	entitled	“Understanding	
Unfolded	and	Intrinsically	Disordered	Proteins	via	Molecular	Simulations”	(June	16,	2017)		
• Invited	to	present	Prof.	PG	Debenedetti’s	Group,	Princeton	University,	Princeton	NJ,	“Atomistic	Simulations	of	
Unfolded/Intrinsically	Disordered	Protein	Ensembles	and	Biological	Self-Assembly”	(March	16,	2017)	
• AICHE,	COMSEF	Graduate	Student	Award	(2016)	
• Biophysical	Society,	Student	Research	Achievement	Award	(SRAA)	(2016)	
• Biophysical	Society,	Education	Committee	Travel	Award	(2016)	
• Chevron	Oil	Company	Recognizing	Excellence	and	Achievement	(REACH)	Award	(2015)	
• Invited	to	attend	Introduction	to	QM/MM	Computational	Chemistry	Modeling:	Many	Roles	of	Polarization	workshop	
University	of	California,	Berkeley,	August,	3-4,	2015,	funded	by	NSF	and	EPSRC	(Theory	Subdivision	of	American	Chemical	
Society	division	of	Physical	Chemistry)	
Hybrid	simulation	techniques	covered:	QM/MM	with	fixed	charge	and	polarizable	(AMOEBA)	force	fields	(MM)	and	several	
different	levels	of	DFT	(QM)	(QChem/IQmol	and	ONETEP	packages)	
• American	Chemical	Society	(ACS)	member,	2016-present	
• American	Institute	of	Chemical	Engineers	(AICHE)	member,	2014-present	
• Biophysical	Society	Intrinsically	Disordered	Proteins	Subgroup,	Graduate	Student	Representative	(2015-2016	council)	
• Biophysical	Society	member	2013-present	
• METU	Graduate	Courses	Performance	Award,	Graduate	School	of	Natural	and	Applied	Sciences	(2012)	
• “Hasan	Orbey”	Excellence	in	Research	Award	for	MSc	degree	(METU),	2011	
• The	Scientific	and	Technological	Research	Council	of	Turkey	(TUBITAK)	Fellowship	of	Project	109R015	(September	2010-August	
2011)	
• Professional	Licensed	(TR	063133)	Bridge	Player:	National	(Turkey)	Youth	“Under-21”	Team	and	“Girls”	Team	nominee	for	three	
consecutive	years	(2006/2007/2008),	several	national	(Turkey)	degrees	in	Teams	and	Pairs	championships	in	“Youth”	and	
“Ladies”	categories.		
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